patient_id	TCGA.A1.A0SE.01	TCGA.A1.A0SH.01	TCGA.A1.A0SJ.01	TCGA.A1.A0SK.01	TCGA.A1.A0SM.01	TCGA.A1.A0SO.01	TCGA.A1.A0SP.01	TCGA.A2.A04N.01	TCGA.A2.A04P.01
total_genes_patients	820	820	820	820	28	28	820	820	820
number_modules	42	41	36	33	12	7	46	37	39
#genes_module1	15	2	16	7	1	3	4	4	90
#genes_module2	48	29	206	61	7	3	101	182	169
#genes_module3	38	233	123	63	2	2	73	183	28
#genes_module4	78	204	42	183	1	11	77	19	11
#genes_module5	167	4	41	25	2	1	47	35	49
#genes_module6	169	26	130	263	3	6	6	4	172
#genes_module7	11	30	11	74	5	2	1	68	55
#genes_module8	14	13	22	3	3	NA	17	19	39
#genes_module9	11	10	57	4	1	NA	30	12	9
#genes_module10	10	61	5	9	1	NA	5	23	29
#genes_module11	13	46	1	12	1	NA	114	1	8
#genes_module12	26	19	3	19	1	NA	58	40	19
#genes_module13	43	26	26	10	NA	NA	27	9	24
#genes_module14	4	12	4	16	NA	NA	38	73	20
#genes_module15	6	18	7	13	NA	NA	7	48	2
#genes_module16	20	2	1	3	NA	NA	25	6	3
#genes_module17	15	8	6	12	NA	NA	10	11	22
#genes_module18	54	7	8	1	NA	NA	29	5	5
#genes_module19	24	2	19	13	NA	NA	4	3	4
#genes_module20	3	30	15	1	NA	NA	3	2	3
#genes_module21	1	1	9	3	NA	NA	33	7	13
#genes_module22	8	1	9	1	NA	NA	25	11	3
#genes_module23	8	1	10	1	NA	NA	1	12	2
#genes_module24	4	2	6	4	NA	NA	16	7	3
#genes_module25	1	2	3	1	NA	NA	4	8	3
#genes_module26	1	1	6	2	NA	NA	1	6	4
#genes_module27	1	4	3	3	NA	NA	3	2	1
#genes_module28	1	4	3	1	NA	NA	3	1	3
#genes_module29	1	1	9	6	NA	NA	5	4	2
#genes_module30	2	2	6	1	NA	NA	12	4	3
#genes_module31	2	1	2	2	NA	NA	1	1	2
#genes_module32	1	6	1	2	NA	NA	1	4	7
#genes_module33	3	1	1	1	NA	NA	1	1	1
#genes_module34	1	1	6	NA	NA	NA	5	1	6
#genes_module35	4	1	2	NA	NA	NA	3	1	2
#genes_module36	2	3	1	NA	NA	NA	2	1	1
#genes_module37	1	1	NA	NA	NA	NA	6	2	1
#genes_module38	2	2	NA	NA	NA	NA	3	NA	1
#genes_module39	3	1	NA	NA	NA	NA	1	NA	1
#genes_module40	2	1	NA	NA	NA	NA	1	NA	NA
#genes_module41	1	1	NA	NA	NA	NA	4	NA	NA
#genes_module42	1	NA	NA	NA	NA	NA	5	NA	NA
#genes_module43	NA	NA	NA	NA	NA	NA	3	NA	NA
#genes_module44	NA	NA	NA	NA	NA	NA	3	NA	NA
#genes_module45	NA	NA	NA	NA	NA	NA	1	NA	NA
#genes_module46	NA	NA	NA	NA	NA	NA	1	NA	NA
genes_in_module1	1-Mar,AUTS2,CHL1,EGR3,GLI3,HSD17B14,KCNJ3,KIAA0040,KLF2,NCF2,PRICKLE1,RASSF6,REEP1,TMC4,ZMYND11	1-Mar,TLR7	1-Mar,ADCYAP1,ARHGEF6,CDKL5,CHL1,EGR3,IRF2,LAMP1,NEIL2,NSUN7,P2RY12,RASSF6,SMAD1,STAC2,TAGAP,TBL1X	1-Mar,GRM8,MS4A7,NLRP4,RASSF6,RGS1,SLC8A1	1-Mar	1-Mar,PIK3R5,PITPNM3	1-Mar,CRYM,PCMTD1,ZNF750	1-Mar,BANK1,GPR65,MS4A2	1-Mar,ABHD12,ACYP2,ARMC3,ATF7IP,ATXN1,BATF,BCL6,BRPF1,BTN3A2,C11orf24,CALM1,CD200R1,CD274,CDKL5,CHL1,CLCN4,COG6,CTDSP1,DAPP1,DHTKD1,DIRAS1,DMD,DSE,DTNB,FGF12,FGF9,FLT1,FOXP1,GPD2,GPR82,GRIN2D,HELB,HES1,HIST1H4C,HIST1H4H,HPS6,HSD17B14,HTRA4,IFNA8,IRF2,KLF6,L3MBTL2,LIMK1,LYN,MACROD2,MESP1,MORC3,MYADM,NFKB1,NFKBIA,NKX2-8,NKX6-1,NMBR,OPTN,P2RY10,PARP15,PDXK,PLEKHA1,PNPLA6,PPIG,PRKCE,RASSF6,RND1,RSRC1,SATB1,SCNN1B,SHB,SIRPA,SLC19A1,SLC43A2,SLMAP,SMAD1,SMARCA2,SOCS1,SPRY1,TBL1X,TLR10,TLR7,TMC4,TMEM143,TMEM175,TNFAIP3,VCAN,ZDHHC14,ZEB2,ZMYND11,ZNF512B,ZNF575,ZZEF1
genes_in_module2	ABCB10,AP1M1,B3GNTL1,CA8,CACNA2D3,CBR4,CCND3,COPS6,COQ2,CRY1,DDX47,DGKE,DHRS9,DOCK10,ERF,GARS,HERC5,HRK,IGF2R,INTS2,INVS,ISY1,ITM2C,LPIN1,LY6G5C,MRPL30,MRPS18A,MTG1,NUDT10,OPN3,PDCL2,PLG,RNF157,SCAMP5,SDK1,SMAD3,SPAG9,TAF8,TBC1D7,TELO2,TMEM37,TNFAIP3,TRIM44,UXS1,WDR75,XPO6,ZDHHC14,ZG16	ARID2,CACNA2D3,CBR4,CCND3,COQ2,DDIT4,DDX47,DNAJC12,DOCK10,ERF,GARS,HERC5,INTS2,MRPL30,MTG1,NR4A2,OSBPL3,PDCL2,RNF157,SCAMP5,SMAD3,SNX5,SOCS2,TAF8,TBC1D7,TNFSF14,WDR75,ZCCHC3,ZDHHC22	ACOXL,ADAM6,ADAMTS6,ADD1,AFF1,ARRDC3,ATP1B3,ATP6V1G1,ATXN1,B3GNTL1,BACH2,BCL3,BEND4,BIRC5,BOD1,C22orf34,C22orf42,C4orf22,CAB39,CACNA2D3,CAMK2D,CBR4,CCL3L1,CCL4L2,CCND3,CD200R1L,CDKL4,CFL2,CKAP2,CLTC,COQ2,CTDSP1,CTNNB1,CXCR4,CYP20A1,CYP2R1,CYTIP,DCTD,DDX1,DDX10,DEFB131,DEFT1P,DHRS9,DNAJC13,DOCK10,DPY30,DTNB,EHMT1,EIF1B,EIF4A3,EMID1,ENPP1,ESRRA,EXD2,EXOSC8,FAM155A,FBXO48,FHAD1,FLJ42393,FNBP1,FNDC3A,FYTTD1,GCNT1,GPR107,GPR183,GRAPL,GRHPR,GTF2A1,GUSBP3,HACL1,HERC5,HES2,HES5,HEXB,HIVEP1,HNRNPA1L2,HNRNPD,HSDL2,IFNA1,IGF2R,IL17REL,IL22RA2,INPP5D,INSC,INTS10,INVS,IPO11,ISY1,ITPR1,KBTBD12,KCTD16,KDM3B,KDM4C,KIAA0922,KRT222,L3MBTL2,LDLRAD2,LOC100133315,LOC100303749,LPIN1,LSM2,LUC7L3,LY6G5C,MAML3,MAPKAPK3,MDH1,MIPEP,MIR572,MIR623,MMP23A,MPHOSPH8,MRPL30,MRPS18A,MSI2,N6AMT1,NBAS,NEDD4L,NEK1,NFATC1,NFKB1,NLK,NR4A3,NUDT10,NUP160,PAN3,PARP14,PARVG,PDCL2,PIGF,PLG,POMP,PPIG,PPP1R2P9,PRDM1,PRKCE,PRPSAP2,RASGEF1B,RBM26,RFPL1S,RHBDF2,RNF157,RNF5P1,RPL15,RPS12,RPS6KA5,RSRC1,SASH1,SEC24D,SETMAR,SHQ1,SIAH2,SKA1,SLC26A1,SLC35D3,SLC37A2,SLC44A1,SMARCA2,SMARCE1,SNRNP48,SNX18,SNX30,SPAG9,STIM2,TADA2A,TAF8,TARS,TBC1D7,TET3,TGFBR2,TLR10,TMEM104,TMEM37,TOM1,TRIM44,TTC39C,TTF1,UBASH3B,UBR7,UHRF2,USP25,USP36,UTP3,UTRN,UXS1,VEZF1,VPS13D,VPS26B,VRK2,VWA3B,WDR75,WEE1,XPO7,ZBTB25,ZBTB38,ZC3H12C,ZCCHC6,ZCCHC7,ZDHHC14,ZDHHC22,ZMYND19,ZNF311,ZNF354A,ZNF608,ZNF639,ZNF74,ZSWIM6	AKAP13,AMN1,ARHGEF5,ARID2,ATP6V1G1,BAIAP2L1,BMPR2,CDKN1B,CLIC5,CRTC3,CRY1,CXCR4,DDX47,DTNB,EHMT1,EMID1,EPS15L1,EXOSC8,FHAD1,FLT1,FNDC3A,HIST1H4C,HIVEP1,HS6ST1,JAM3,KIAA0922,MIPEP,MPEG1,MPHOSPH8,MXI1,NEDD4L,NEK2,NFKBIA,NGRN,NUDT10,OPTN,PAN3,PDCL2,PIK3AP1,PNPLA8,PRDM4,RHEBL1,RNF157,SDK1,SETMAR,SLC38A1,SLC44A1,SMAD3,SRC,STIM2,SYNGR4,TNFSF11,UHRF2,VEZF1,VPS26B,WDR47,WNT4,ZMYND11,ZMYND19,ZNF365,ZNF486	PDCD1LG2,PDXK,PGGT1B,PIAS1,PLEKHA1,PNPLA6,POMP	PCMTD1,PDCD1LG2,PGGT1B	ABHD12,ADAP1,ADAR,ADD1,ADO,AFF1,ARID5B,ARMC5,B3GNTL1,BATF3,BCL3,BEND4,BHLHE41,BOD1,C1orf220,C22orf42,C4orf22,C7orf50,CAMK2D,CAPN8,CCL3L1,CCL4L2,CDKN1B,CMIP,COQ2,CTSB,CYP2W1,CYTH3,DCTD,DEFB131,EMID1,ERF,FA2H,FAM177B,GNA12,GPR137B,GRIP1,GSDMD,GUSBP3,HERC5,HNRNPD,HSD17B14,INTS10,IPO11,ITCH,ITIH5,KCTD16,KDM3B,KIAA0922,KLRF1,KRT222,LOC100303749,LOC374443,LOC388242,LOC441204,LOC613038,LUC7L3,LYRM1,MACROD2,MAML3,MBOAT7,MIR30B,MIR572,N6AMT1,NEK1,NEK2,NFKB1,NFKBIA,OPN3,OPTN,OSBPL3,OTUD7B,PDCL2,PPP1R15A,PRTFDC1,REEP3,RFPL1S,RNF213,RP9P,SDK1,SLC26A1,SNORA36B,SNX18,SRC,STARD10,STIM2,SYNGR4,TADA2A,TELO2,TMEM150B,TRAPPC9,TRIB1,TRIL,TSEN15,UBXN8,USP6NL,ZBTB10,ZNF354A,ZNF365,ZNF608,ZNF821	ACOXL,ADO,AFF1,ALDH1L2,ANKMY2,ARHGEF5,ARID2,ATP1B3,ATXN1,B3GNTL1,BAIAP2L1,BEND4,BEND5,BHLHA15,BMPR2,C17orf64,C1orf141,C1orf220,C22orf42,C4orf22,CAMK2D,CBR4,CCND3,CD200R1L,CD46,CDKL4,CLTC,COQ2,CRTC3,CRY1,CXCR4,CYTH3,CYTIP,DDIT4,DEFT1P,DGKE,DHRS9,DNAJC13,DOCK10,DPH2,DPY30,EHMT1,EMID1,EPS15L1,ERF,EXD2,FAM3C,FBRSL1,FBXO48,FLJ37201,FLJ42393,FOXO3,GARS,GNG7,GRHPR,GRIP1,GTF2A1,GTF2IRD2,HECTD3,HES2,HNRNPD,HS6ST1,IFNA1,IFNA2,IL22RA2,INSC,INTS2,IRX4,ISY1,ITIH5,JAZF1,JUND,KBTBD12,KDM4C,KRT222,LDLRAD2,LMTK3,LOC100133315,LOC441204,LPIN1,LSM2,LUC7L3,LY6G5C,MAML3,MAP1LC3B2,MBOAT7,MGC12916,MIR572,MMP23A,MRPL30,MRPS18A,MXI1,NACC1,NBAS,NEDD4L,NGRN,NSUN4,NUDT10,NUP160,OPTN,OR10P1,OSBPL3,PARP14,PDCL2,PIP4K2A,PLG,PNPLA8,POLE2,PPIAL4A,PPIAL4C,PPP1R15A,PPP1R2P9,PRDM1,PSAP,RASGEF1B,REEP3,RFPL1S,RHBDF2,RIMKLA,RNF157,RNLS,ROR1,RP9P,RPA2,RPS12,S1PR1,S1PR4,S1PR5,SCAMP5,SKA1,SLC35D3,SLC37A2,SLCO3A1,SMAD3,SMYD3,SNRNP35,SNRNP48,SNX30,SNX5,SPAG9,SRC,SRRM3,STARD10,STIM2,SYNGR4,SYNM,TADA2A,TAF8,TBC1D7,TECPR1,TET3,THAP5,TMEM104,TMEM150B,TMEM209,TMEM37,TNFSF14,TOM1,TRIL,TRIM44,TSEN15,TTC39C,TYW1,UBASH3B,USP36,USP6NL,UTRN,UXS1,VPS13D,VRK2,VWA3B,WDR60,WDR75,ZBTB38,ZC3H12C,ZCCHC7,ZDHHC14,ZDHHC22,ZG16,ZNF398,ZNF74,ZNF844	ACOXL,ADAM6,ADAP1,ADO,AFF1,ALDH1L2,AMN1,ANKMY2,AP1M1,ARID2,ATP1B3,BACH2,BAIAP2L1,BEND4,BHLHA15,BHLHE41,BOD1,C10orf128,C22orf34,C22orf42,C4orf22,C7orf50,CACNA2D3,CAMK2D,CBR4,CC2D2B,CCL3L1,CCL4L2,CCND3,CD200R1L,CD320,CDKL4,CDKN1B,COQ2,CRTC3,CYP2W1,CYTH3,CYTIP,DDIT4,DDX47,DEFB131,DEFT1P,DHRS9,DNAJC12,DNAJC13,DOCK10,DPY30,EMID1,EPS15L1,EXD2,EXOSC8,FAM155A,FBRSL1,FBXO48,FLJ37201,FLJ42393,FNDC3A,FOXO3,GARS,GOLGA8B,GPR183,GRAPL,GRIP1,GSDMD,GUSBP3,HNRNPA1L2,HNRNPD,IFNA2,IL17REL,INPP5D,IPO11,IRX4,ISY1,ITCH,ITIH5,ITPR1,JAZF1,KBTBD12,KBTBD7,KDM3B,KDM4C,KIAA0922,KLRF1,LEPROTL1,LMTK3,LOC100303749,LOC374443,LOC388242,LOC441204,LOC613038,LUC7L3,LY6G5C,LYRM1,MAML3,MAP1LC3B2,MBOAT7,MGC12916,MIPEP,MIR30B,MIR572,MIR623,MRPL30,MXI1,N6AMT1,NACC1,NBAS,NEK1,NGRN,PDCL2,PIP4K2A,PLG,POMP,PRDM4,PSAP,RFPL1S,RNF5P1,RNLS,RP9P,RPS12,S1PR4,S1PR5,SDK1,SETD1A,SHQ1,SKA1,SLC35D3,SLC38A1,SMAD3,SNRNP35,SNRNP48,SNX18,SNX5,SRRM3,STARD10,STIM2,SYNM,TAF8,TBC1D7,TECPR1,TELO2,TET3,THAP5,TMEM150B,TMEM209,TMEM37,TNFSF14,TRAPPC9,TRIL,TTC39C,TYW1,UBR7,UBXN8,UXS1,VDAC3,VRK2,VWA3B,WDR60,WDR75,XPO6,ZBTB10,ZCCHC3,ZDHHC22,ZFR2,ZG16,ZKSCAN2,ZNF398,ZNF74,ZNF844,ZSWIM6
genes_in_module3	ARHGEF12,CAPZB,CD274,CEPT1,CMTM3,COG6,COMMD6,CSF1,DIRAS1,EIF3G,FEM1A,FLI1,FTH1,GAS7,IL17D,KCNK4,L3MBTL2,LAMP1,LDHD,LONP2,MACF1,MAN1C1,MLLT1,MPHOSPH8,NFATC1,PARS2,PDCD1LG2,PDIK1L,PEX14,PHF13,PNPLA6,RNF11,SGTA,SMARCA2,UBB,VPS26B,YIPF1,ZNF791	6-Sep,ABHD12,ACYP2,ADAMTS6,ADARB1,ADCYAP1,AFF1,AKAP13,ANK3,ANXA4,AP4M1,ARHGEF6,ARL1,ATF7IP,ATG10,ATG16L1,ATP6V1G1,AUTS2,BCAT2,BCL2,BCL3,BCL6,BPGM,BRPF1,BTN3A2,CAB39,CALM1,CAPZB,CASP10,CCND2,CD200R1,CD274,CD2AP,CD53,CDKL5,CEPT1,CLCN4,CNOT6,COG6,COMMD6,COPS6,CSF1,CTDSP1,CTNNB1,CTR9,CTSB,CYP20A1,CYP2R1,DCTD,DDAH1,DDX1,DIRAS1,DMD,DPH2,DTNB,DTWD1,DUSP4,DUSP5,EDN1,EGR3,EIF1B,EIF3G,EIF4A3,ELK3,ENPP2,ETV6,EXTL1,FAIM,FAM3C,FBXO16,FFAR2,FGF12,FLT1,FNBP1,FOXJ1,FOXP1,FUT1,FYTTD1,GGNBP2,GLI3,GNA12,GNB2,GOLGA2,GPR107,GPR162,GPR82,GRHPR,GRIN2D,GRM8,GTF2I,HADHB,HDAC3,HDAC9,HES1,HEXB,HEXIM1,HPS6,HSD17B14,HTRA4,IGF1R,IKZF3,IL10RB,IL12RB2,IL17D,INPP5A,INTS10,INVS,IRF2,KCNH8,KCNJ3,L3MBTL2,LAMP1,LDLR,LEPROTL1,LGMN,LIMK1,LYN,MACF1,MACROD2,MADCAM1,MAN1C1,MCF2L2,MLLT1,MORC3,MORN1,MOSPD2,MPHOSPH8,MSI2,MYADM,NACA,NEIL2,NEK6,NFATC1,NFKB1,NFKBIA,NHLRC2,NIPA1,NKX2-8,NKX6-1,NLGN4X,NR4A3,NSUN7,P2RY10,PARP15,PART1,PDCD1LG2,PDIK1L,PDXK,PEX14,PGGT1B,PHF13,PIAS1,PIGF,PLEKHA1,PNPLA6,PPIG,PPP2R5C,PUF60,RASSF6,RASSF8,RBBP4,RBM26,REEP1,RHBDD1,RHEB,RND1,RNF11,RNF213,RPL15,RSRC1,RTN2,RYK,SATB1,SEC24D,SETMAR,SFXN3,SGTA,SHB,SIAH2,SIRPA,SLC23A2,SLC39A6,SLC8A1,SLC9A8,SLMAP,SMAD1,SMARCA2,SMARCE1,SP4,SPAG9,SPATA12,SPRY1,ST8SIA4,STK24,STRBP,SYK,TBC1D13,TCEA2,TCF12,TFG,TGFBR2,TLE3,TLR10,TMC4,TMEM143,TMEM175,TMEM43,TNFAIP8,TNFRSF10D,TNFRSF1B,TNIP2,TRIB1,TRIB2,TRIO,TXNDC5,UBL3,USP25,USP8,UTP14A,UTP3,VCPIP1,VEZF1,WEE1,XPO7,YIPF1,ZEB2,ZNF185,ZNF227,ZNF501,ZNF575,ZNF639,ZNF750,ZNF791	6-Sep,ACYP2,ADARB1,ARHGAP25,ARHGEF12,ARID1B,ATG10,ATG16L1,BASP1,BIRC3,BRPF1,BTN3A2,C11orf24,C9orf40,CASP10,CASP8,CCR1,CCR6,CD200R1,CD274,CD2AP,CER1,CHST7,CLCN4,COG6,COL19A1,COMMD6,CTLA4,CTR9,CTTN,DAPP1,DOCK2,DSCR9,EIF2S3,EPM2A,EXTL1,FAIM,FAM120B,FGF12,FGF9,FLI1,FLT1,FOXJ1,FTH1,GFI1B,GFOD1,GGNBP2,GOLGA2,GPR160,GPR82,HADHB,HDAC3,HIST1H4H,HMGN3,HPCAL1,IFNA8,IKZF3,IL10RB,IL17D,ITM2C,JAM3,JARID2,KCNH8,KCNJ3,KCNK4,LGMN,LIMD1,LPXN,MCF2L2,MNAT1,MORC3,MOSPD2,MS4A1,NAV2,NEK6,NKX2-8,NKX6-1,NLGN4X,NMBR,OGT,P2RY10,PARP15,PCDHGB7,PDCD1LG2,PDIK1L,PDXK,PEX14,PHF13,PORCN,PPP2R5C,PRDM15,PSMA1,REEP1,RHBDD1,RYK,SATB1,SHB,SLC25A37,SNX9,SPATA12,ST8SIA4,STK24,STRBP,SUB1,SYK,TFG,TLR7,TNFAIP3,TNFAIP8,TNFRSF10D,TNFRSF1B,TNIP2,TRIB2,TRIO,TXNDC5,USPL1,UTP14A,VCAN,VPREB1,ZEB2,ZNF227,ZNF501,ZNF575	ABHD12,AP4M1,ARHGEF12,BPGM,C20orf196,CALM1,CEBPG,CHL1,CKAP2,CLCN4,COG6,COMMD6,DDAH1,DDX59,DHTKD1,DIRAS1,DUSP5,EPB41,EPM2A,FBXO21,FOXJ1,FUT1,FYTTD1,GFI1B,GFOD1,GGNBP2,GNB2,GTF2I,HHAT,HSD17B14,IGF1R,IL17D,INPP5A,KLF2,LAMP1,MESP1,NAV2,NHLRC2,NSUN7,PARS2,PDIK1L,PHF13,PPIG,RBBP4,RPS6KA5,RTN2,RYK,SEPHS1,SGTA,SHB,SIRPA,SMAD1,SNX9,SP4,SPRY1,STAC2,STRBP,SYK,TRAFD1,UTP14A,ZNF227,ZNF501,ZNF791	PDCL2,POLE2	PDCL2,POMP	ACYP2,AKAP13,AP4M1,ARHGAP25,ARHGEF6,ATG16L1,ATP1B3,BATF,BCL6,BPGM,BTN3A2,CD2AP,CDKL5,CEPT1,CHL1,CLCN4,COG6,COL19A1,COMMD6,CSF1,CTDSP1,CTR9,CYP20A1,DDAH1,DDX1,DMD,DPH2,EPM2A,FAM120B,FGF9,FOXP1,FTH1,FYTTD1,GPR82,GRM8,GTF2A1,HACL1,HMGN3,KCNJ3,LAMP1,LIMK1,LSM2,MACF1,MORN1,MTF2,NAV2,NKX2-8,NLGN4X,NMBR,P2RY10,PDIK1L,PHF13,REEP1,RHBDD1,RHEB,RPA2,RSRC1,SATB1,SLC10A2,SLMAP,SNX9,SPATA12,STK24,STK33,TFG,TLE3,TNFAIP3,TNFRSF1B,UTP14A,YIPF1,ZEB2,ZNF501,ZNF639	6-Sep,ACYP2,ADAR,AKAP13,AP4M1,ARHGAP25,ARID1B,ATP6V1G1,ATP8B2,BASP1,BCAT2,BIRC3,BTN3A2,C11orf24,C9orf40,CAB39,CASP10,CASP8,CD274,CD28,CD2AP,CDC123,CER1,CFL2,CITED1,CLCN4,COPS6,CREB5,CTR9,CTTN,CYBB,CYCS,CYP20A1,CYP2R1,DAPP1,DDX1,DDX10,DDX59,DHTKD1,DSCR9,DTNB,EDN1,EIF2S3,EIF3G,EIF4A3,ELK3,ENPP1,EPB41,EPM2A,ESRRA,FAM120B,FBXO21,FFAR2,FGF12,FLI1,FNBP1,FTH1,FYTTD1,GCNT1,GFI1B,GFOD1,GNB2,GOLGA2,GPR107,GPR82,GRM8,GTF2I,HADHB,HELB,HERC5,HES1,HHEX,HIST1H4C,HMGN3,HSD17B14,HSP90B1,IFNA8,IGF1R,IGF2R,IKZF3,IL10RB,INVS,JARID2,KCNJ3,KCNK4,KIAA0922,KLF6,LIMK1,LPXN,MACF1,MADCAM1,MAN1C1,MAPKAPK2,MCF2L2,MDH1,MLLT1,MNAT1,MORC3,MORN1,MOSPD2,MSI2,NACA,NAV2,NFATC1,NFKBIA,NKX2-8,NKX6-1,NMBR,NR4A3,OGT,PARP15,PARS2,PDCD1LG2,PDIK1L,PEX14,PHF13,PIAS1,PIGF,PNPLA6,PORCN,PPIG,PRCC,PRKCE,PRTFDC1,PSMA1,PTPN1,PUS1,RASSF6,RBBP4,RBM17,RHBDD1,RHEB,RHEBL1,RND1,RNF213,RPS26,RSRC1,RTN2,RYK,SEC24D,SEPHS1,SGTA,SH2B3,SHB,SIAH2,SIRPA,SLC39A6,SLC9A8,SMARCE1,SOCS2,SP4,STAC2,STRBP,SUB1,TAL2,TARS,TBL1X,TFG,TLE3,TMEM143,TNFAIP3,TRA2A,TRAFD1,TRIO,TRMT1,TTF1,TXNDC5,UBB,UHRF2,USP25,UTP14A,UTP3,VEZF1,VPREB1,VPS26B,WEE1,ZBTB25,ZCCHC6,ZMYND19,ZNF227,ZNF575,ZNF639,ZNF791	ARHGEF12,C9orf40,CMTM3,DDX10,EPB41,ESRRA,EXTL1,FLI1,FNBP1,FTH1,GFI1B,GOLGA2,GPR107,HEXIM1,INVS,JAM3,LDHD,MAN1C1,MMP15,MORN1,PDIK1L,PHF13,RPA2,SMARCE1,SPG7,TAL2,TTF1,ZMYND19
genes_in_module4	6-Sep,ADARB1,ATG10,ATP1B3,ATXN2L,BASP1,BIRC5,BTN3A2,CADPS,CASP10,CCND2,CYP2R1,DAPP1,DDX1,DSCR9,DTWD1,EIF1B,EIF2S3,EIF4A3,EPM2A,FGF12,FNBP1,GFI1B,GFOD1,HACL1,HDAC9,HELB,HEXB,HIST1H4C,HIST1H4H,HMGN3,HPCAL1,HSP90B1,INTS10,JARID2,LGMN,LSM2,MCF2L2,MDH1,MNAT1,MOSPD2,MSI2,NLK,NR4A3,NSMAF,NUP160,PARP15,PDXK,PORCN,PPP1R15A,PRDM15,PRTFDC1,PSMA1,PUS1,RHEB,RHEBL1,RPS26,RSRC1,SFXN3,SH2B3,SLC25A37,SOCS2,SPATA12,ST8SIA4,SUB1,TARS,TNFAIP8,TNFRSF10D,TRIB2,TTF1,TXNDC5,USP25,UTP3,VASH2,ZBTB25,ZMYND19,ZNF398,ZNF639	ACOXL,ADAM6,ADAP1,ADD1,ADO,AMN1,ANKMY2,AP1M1,ARRDC3,ATXN1,B3GNTL1,BAIAP2L1,BEND4,BEND5,BHLHA15,BHLHE41,BMPR2,BOD1,C10orf128,C17orf64,C1orf141,C22orf34,C22orf42,C4orf22,C7orf50,CAMK2D,CC2D2B,CCL3L1,CCL4L2,CD200R1L,CDKL4,CDKN1B,CLIC5,CLTC,CRTC3,CXCR4,CYP2W1,CYTH3,CYTIP,DEFB131,DEFT1P,DHRS9,DNAJC13,DPY30,EHMT1,EMID1,EPS15L1,EXD2,FAM102B,FAM155A,FAM46C,FAM72B,FBXO48,FCGR1B,FEM1A,FLJ37201,FLJ42393,FNDC3A,FPGT,GNG7,GOLGA8B,GPR183,GPR20,GRIP1,GSDMD,GTF2A1,GTF2IRD2,GUSBP3,HEATR5B,HECTD3,HES2,HES5,HIVEP1,HNRNPA1L2,HNRNPD,HS6ST1,HSDL2,IFNA1,IFNA2,IL17REL,INPP5D,INSC,IPO11,IRX4,ISY1,ITCH,ITPR1,JAZF1,JUND,KBTBD12,KBTBD7,KCTD16,KDM3B,KDM4C,KIAA0922,KLRF1,KRT222,LDLRAD2,LMTK3,LOC100303749,LOC374443,LOC441204,LRRK2,LSM2,LUC7L3,LY6G5C,MAML3,MAP3K10,MBOAT7,MIPEP,MIR30B,MIR572,MIR623,MIR760,MMP23A,MRPS18A,MXI1,N6AMT1,NACC1,NBAS,NEDD4L,NEK1,NGRN,NSUN4,NUDT10,OR10P1,PAN3,PARP14,PARS2,PARVG,PIK3AP1,PLXNC1,PNPLA8,POMP,PPP1R15A,PPP1R2P9,PRKCE,PSAP,RASGEF1B,REEP3,RFPL1S,RHBDF2,RIMKLA,RNF5P1,RNLS,ROR1,RP9P,S1PR1,S1PR4,S1PR5,SDK1,SHQ1,SKA1,SLC26A1,SLC38A1,SLC44A1,SNRNP48,SNX18,SNX30,SRC,SRRM3,STARD10,STIM2,SYNGR4,SYNM,TACC1,TADA2A,TECPR1,TET3,THAP5,TMEM104,TMEM150B,TMEM209,TMEM37,TOM1,TRAPPC9,TRIL,TRIM44,TTC39C,TYW1,UBR7,UBXN8,USP36,UXS1,VDAC3,VPS13D,VRK2,VWA3B,WDR47,WDR60,ZBTB10,ZBTB38,ZCCHC6,ZCCHC7,ZFR2,ZNF311,ZNF354A,ZNF365,ZNF398,ZNF486,ZNF608,ZNF74,ZNF844,ZSWIM6	ADAMTS13,AMN,ANXA4,ARSG,CAPZB,CNOT6,CP,CRELD2,CYBB,DGKE,DMD,DNMT3A,ESPNL,F12,F9,FGD2,GJA3,HEXIM1,HYAL3,HYLS1,IL13RA1,LMO2,LRP2BP,MORN1,OTUD5,PART1,PARVB,PGGT1B,PTPN3,RCAN2,SLC10A2,SLC19A1,SLMAP,SPTBN1,TAL2,TBC1D13,TMEM175,TMEM43,UCP3,USP9X,WNT8A,XCR1	ACBD3,ACYP2,ADAMTS6,ADAR,ADARB1,AKR1B10,AP1M1,ARHGEF6,ARID1B,ARL1,ARMC3,ATF7IP,ATG10,ATG16L1,ATP8B2,BASP1,BCAT2,BCL3,BCL6,BRPF1,BUB3,C11orf24,C9orf40,CAB39,CAPZB,CASP10,CD200R1,CD274,CD2AP,CD46,CDC123,CDKL5,CEPT1,CITED1,CNOT6,COPS6,CSF1,CTDSP1,CTNNB1,CTR9,CTTN,CYCS,CYP2R1,DCTD,DDX1,DDX10,DSCR9,DTWD1,EIF1B,EIF2S3,EIF3G,EIF4A3,ELK3,ELOVL5,ENO3,ENPP1,FAIM,FAM120B,FFAR2,FGF9,FLI1,FTH1,GAS7,GOLGA2,GPR107,GPR82,GRIN2D,HACL1,HADHB,HDAC3,HDAC9,HELB,HES1,HEXB,HLX,HMGN3,HPCAL1,HPS6,HSP90B1,IKZF3,IL10RB,IRF2,IRF2BP2,ITM2C,JARID2,KCNJ3,KCNK4,KIAA0040,KLF6,L3MBTL2,LDLR,LGMN,LIMD1,LIMK1,LPXN,MACF1,MADCAM1,MAG,MAPKAPK2,MAPKAPK3,MCF2L2,MDH1,MLLT1,MNAT1,MORC3,MOSPD2,MSI2,MTF2,MYADM,MYBL2,NACA,NEK6,NID1,NKX2-8,NKX6-1,NLK,NTNG1,OGT,OTUD5,PARP15,PDCD1LG2,PDXK,PEX14,PGGT1B,PIAS1,PIGF,PLEKHA1,PNPLA6,PORCN,PPP2R5C,PRDM15,PSMA1,PTPN1,PUS1,RABEP1,RASSF8,RBM26,RND1,RNF213,SATB1,SEC24D,SFXN3,SIAH2,SLC10A2,SLC19A1,SLC39A6,SLC9A8,SLMAP,SMARCE1,SPATA12,ST8SIA4,SUB1,TAGAP,TARS,TBC1D13,TBL1X,TCEA2,TCF12,TFG,TLR10,TMC4,TMEM130,TMEM143,TMEM175,TMEM43,TNFAIP3,TNFRSF1B,TNIP2,TRIB2,TRIO,TRMT1,TTF1,TXNDC5,UBB,UTP3,VPREB1,YIPF1,ZBTB25,ZEB2,ZNF512B,ZNF575,ZNF750,ZZEF1	PDIK1L	NSMAF,PCDHGB7,PDIK1L,PEX14,PHF13,PIAS1,PIGF,PLEKHA1,PNPLA6,POLA2,PORCN	ACBD3,AMDHD2,ARMC3,BASP1,BIRC3,C20orf196,CMTM3,CTTN,DAPP1,DDX59,DEXI,ENPP2,FBXO16,FFAR2,GGNBP2,GLI3,GRIN2D,HDAC3,HDAC9,HHAT,HLX,IKZF3,INPP5A,IRF2,IRF2BP2,IRX4,KIAA0040,KLF6,KMO,LYN,MAP3K10,MAPKAPK2,MED30,MORC3,MYADM,MYBL2,NEIL2,NID1,NKX6-1,NSUN7,PART1,PCDHGB7,PDXK,PLEKHA1,PRCC,PTPN1,PTPRC,RASSF8,RBM17,RIN2,RTN2,SCNM1,SCNN1B,SCOC,SEC24D,SIRPA,SLC38A1,SLC9A8,SOCS1,SP4,SPRY1,STAC2,SUB1,TARS,TLR10,TMC4,TMEM175,TNIP2,TRIO,VASH2,VCAN,VCPIP1,WWOX,XPO7,ZMYND11,ZNF227,ZNF575	ADARB1,ATF7IP,CKAP2,ETV6,FGF9,GPR162,IL17D,LAMP1,LYN,MPHOSPH8,NSMAF,PDXK,RASSF8,RBM26,SCNM1,STK24,TRHR,USPL1,VCPIP1	BIRC3,DBNDD1,DEF8,GCNT1,KCNK4,LONP2,NEK6,NR4A3,PEX14,STRBP,WWOX
genes_in_module5	ACBD3,ACYP2,AFF1,AMDHD2,AP4M1,ARHGEF6,ARID1B,ARL1,ATF7IP,ATG16L1,ATP6V1G1,BATF,BCAT2,BCL6,BPGM,BRPF1,CAB39,CD200R1,CD2AP,CD46,CDC123,CDKL5,CDKN1B,CITED1,CLCN4,CNOT6,COL19A1,CTDSP1,CTR9,CYP20A1,DCTD,DDAH1,DDX59,DEXI,DHTKD1,DMD,DSE,DTNB,DUSP4,DUSP5,EDN1,ELK3,ELOVL5,ENPP1,ETV6,FAIM,FAM120B,FBXO16,FBXO21,FFAR2,FOXJ1,FOXP1,FUT1,FYTTD1,GCNT1,GGNBP2,GNB2,GOLGA2,GPR107,GPR160,GPR162,GPR82,GRHPR,GRIN2D,GTF2A1,GTF2I,HADHB,HES1,HEXIM1,HLX,HPS6,HTRA4,IKZF3,IL10RB,IL13RA1,INPP5A,IRF2,IRX4,KCNH8,KLF6,LIMD1,LIMK1,LYN,MAG,MAP3K10,MAPKAPK2,MORC3,MYADM,NACA,NAV2,NEIL2,NEK2,NEK6,NFKBIA,NHLRC2,NID1,NIPA1,NKX2-8,NLGN4X,NMBR,NR4A2,NSUN7,OTUD5,P2RY10,P2RY12,PART1,PCDHGB7,PGGT1B,PIAS1,PIGF,PLEKHA1,PPIG,PPP2R5C,RASSF8,RBM17,RHBDD1,RND1,RNF213,RPL15,RTN2,RYK,SASH1,SATB1,SCNN1B,SCOC,SEPHS1,SETMAR,SHB,SIAH2,SLC38A1,SLMAP,SMAD1,SMARCE1,SNX9,SOCS1,SP4,SPRY1,STRBP,SYK,TAGAP,TAL2,TBL1X,TCF12,TFG,TGFBR2,TLE3,TLR10,TLR7,TMEM130,TMEM143,TMEM175,TNIP2,TRA2A,TRAFD1,TRIO,USP6NL,UTP14A,VCAN,VCPIP1,VEZF1,XPO7,ZCCHC7,ZEB2,ZNF227,ZNF501,ZNF575,ZNF750	CCL22,CHFR,PIK3R5,PITPNM3	ALDH1L2,ARL1,CDYL2,CMIP,CRY1,CSF1,DTWD1,FA2H,FAM102B,FBRSL1,FBXO21,GOLGA8B,HRK,LONP2,MAF,MAP1LC3B2,MGC12916,MIR760,NIPA1,PIAS1,PLXNC1,PRDM4,PUS1,RPA2,S1PR1,SCAMP5,SLC43A2,SMAD3,SNRNP35,SOCS2,SPG7,TIMM22,TLE3,UBB,UBXN8,USP8,VDAC3,WWOX,ZC3H18,ZNF276,ZNF821	ABR,AEBP1,ARHGAP25,CADPS,CCDC91,CHFR,CLDN10,DNMT3A,ESPNL,F9,GPD2,GPR65,HYLS1,IL19,KYNU,MORN1,NCF2,NLGN4X,NMBR,PIK3R5,RBM17,SCOC,TAL2,UCP3,ZNF185	PEX14,PHF13	PDXK	6-Sep,BRPF1,CADPS,CASP10,CITED1,CKAP2,COPS6,CYP2R1,DDX10,DEF8,DTWD1,EIF1B,ELOVL5,ENPP1,EPB41,FGF12,FOXJ1,GPR160,HADHB,HIST1H4H,JARID2,LGMN,LIMD1,MCF2L2,MNAT1,MOSPD2,MPHOSPH8,MRPS18A,NTNG1,PEX14,PIAS1,PIGF,PORCN,PPIG,PPP2R5C,PSMA1,RBM26,RPL15,RPS6KA5,SEMA7A,SLC39A6,TCF12,TMEM130,TRIB2,TXNDC5,USPL1,ZBTB25	AEBP1,AMN,BUB3,CADPS,CCL22,CCR1,CHML,CHST12,CMTM3,CNNM1,CRELD2,CRYM,CSF1,DEF8,DOCK2,EPS8L3,ESPNL,F12,GPR141,HYAL3,IKZF1,ITGAE,KLHDC7B,LBR,NPC1L1,PART1,PARVB,PGGT1B,PIK3R5,PITPNM3,SATB1,TMEM43,TNFRSF10D,WNT8A,XCR1	6-Sep,ANXA4,BCOR,BLK,BUB3,CASP10,CCR1,CHRNB3,CHST7,CNNM1,CNOT6,CP,CRYM,DOCK2,ENPP2,ESPNL,F12,F9,FUT1,GJA3,GRIN2B,IKZF1,IL13RA1,KYNU,LPXN,LRP2BP,MBNL3,MYBL2,NLRP4,NPC1L1,ODF1,OGT,OTUD5,PARVB,PCDHGB7,PGGT1B,PITPNM3,RASIP1,RCAN2,SEMA7A,SLC23A2,TCF3,TMEM130,TMEM43,TNFRSF10D,USP9X,WNT8A,ZNF185,ZNF501
genes_in_module6	ACOXL,ADAM6,ADAMTS6,ADAP1,ADD1,ALDH1L2,AMN1,ANKMY2,ARID2,ARMC5,ARRDC3,ATXN1,BACH2,BAIAP2L1,BATF3,BCL3,BEND4,BHLHA15,BHLHE41,BMPR2,BOD1,C17orf64,C1orf220,C4orf22,C7orf50,CALM1,CAMK2D,CAPN8,CC2D2B,CCL3,CCL3L1,CCL4L2,CD200R1L,CDKL4,CLTC,CTNNB1,CTSB,CXCR4,CYP2W1,CYTH3,CYTIP,DEFB131,DEFT1P,DNAJC13,DPY30,EHMT1,EPS15L1,EXD2,FAM177B,FAM3C,FBRSL1,FBXO48,FLJ37201,FLJ42393,FOXO3,FPGT,GNA12,GOLGA8B,GRIP1,GSPT1,GTF2IRD2,GUSBP3,HDAC3,HEATR5B,HIVEP1,HNRNPD,HS6ST1,HSDL2,IFNGR1,IL22RA2,INPP5D,INSC,IPO11,ITIH5,ITPR1,JAZF1,JUND,KBTBD12,KCTD16,KDM3B,KIAA0922,KLRF1,KRT222,LEPROTL1,LMTK3,LOC100303749,LOC374443,LOC388242,LOC441204,LOC613038,LRRK2,LUC7L3,LYRM1,MAML3,MAP1LC3B2,MAPKAPK3,MARCKS,MBOAT7,MIR572,MIR760,MXI1,N6AMT1,NBAS,NEK1,NFKB1,NOTCH2NL,OPTN,OR10P1,PARP14,PIK3AP1,PIP4K2A,PLXNC1,PNPLA8,PPP1R2P9,PRDM1,PRDM4,PRKCE,RASAL2,RASGEF1B,RHBDF2,RNF5P1,RNLS,RP9P,RPS12,RPS6KA5,SEC24D,SETD1A,SHQ1,SLC26A1,SLC35D3,SLC44A1,SMYD3,SNORA36B,SNRNP35,SNRNP48,SNX18,SNX30,SRRM3,STIM2,SYNGR4,TACC1,TADA2A,TECPR1,TET3,THAP5,TMEM104,TMEM150B,TMEM209,TRIL,TSEN15,TYW1,UBR7,UBXN8,USP36,USP8,UTRN,VDAC3,VRK2,VWA3B,WDR60,WEE1,ZBTB38,ZCCHC6,ZKSCAN2,ZNF311,ZNF354A,ZNF486,ZNF608,ZSWIM6	ARMC5,BATF3,C1orf220,CAPN8,DEXI,FAM177B,GPR137B,ITIH5,LOC388242,LOC613038,LYRM1,NOTCH2NL,OPN3,OPTN,PIP4K2A,PPIAL4A,PPIAL4C,RASAL2,SETD1A,SMYD3,SNORA36B,TSEN15,USP6NL,XPO6,ZKSCAN2,ZMYND11	ABCB10,ABHD12,ADAP1,ADO,AKAP13,ANKMY2,AP1M1,AP4M1,ARID2,ARMC5,ATF7IP,BAIAP2L1,BATF3,BCAT2,BEND5,BHLHA15,BHLHE41,C10orf128,C1orf141,C1orf220,C7orf50,CA8,CAPN8,CC2D2B,CDKN1B,CRTC3,CYP2W1,CYTH3,DDIT4,DDX47,DEXI,DNAJC12,DPH2,EIF3G,EPS15L1,ERF,FAM177B,FAM3C,FAM46C,FAM72B,FCGR1B,FEM1A,FLJ37201,GARS,GNA12,GNG7,GPR162,GPR20,GRIP1,GSDMD,GTF2I,GTF2IRD2,HECTD3,HPS6,ITCH,JAZF1,JUND,KLRF1,LOC374443,LOC388242,LOC441204,LOC613038,LRRK2,LYRM1,MAP3K10,MBOAT7,MED30,MIR30B,MLLT1,MTG1,MXI1,NACA,NACC1,NGRN,NHLRC2,NSUN4,OPN3,OR10P1,OTUD7B,PARS2,PIK3AP1,PIP4K2A,PNPLA8,PPIAL4A,PPIAL4C,PPP1R15A,PRCC,PSAP,RASSF8,RHEB,RHEBL1,RIMKLA,RNF11,RNLS,ROR1,RP9P,RPS26,S1PR4,S1PR5,SDK1,SETD1A,SMYD3,SNORA36B,SOCS1,SP4,SRRM3,SYNGR4,SYNM,TECPR1,TELO2,THAP5,TMEM150B,TMEM209,TNFSF14,TRA2A,TRAPPC9,TRIL,TRMT1,TSEN15,TYW1,USP6NL,VCPIP1,WDR60,XPO6,ZCCHC3,ZFR2,ZKSCAN2,ZNF398,ZNF791,ZNF844	ABCB10,ACOXL,ADAM6,ADAP1,ADD1,ADO,AFF1,ALDH1L2,ANKMY2,ARID3B,ARID5B,ARRDC3,ATP1B3,ATXN1,B3GNTL1,BACH2,BATF3,BEND4,BEND5,BHLHA15,BHLHE41,BIRC5,BOD1,C10orf128,C17orf64,C1orf141,C1orf220,C22orf34,C22orf42,C4orf22,C7orf50,CACNA2D3,CAMK2D,CAPN8,CBR4,CC2D2B,CCL3L1,CCL4L2,CCND3,CD200R1L,CD320,CDKL4,CLTC,COQ2,CYP20A1,CYP2W1,CYTH3,CYTIP,DDIT4,DEFB131,DEFT1P,DGKE,DHRS9,DNAJC12,DNAJC13,DOCK10,DPH2,DPY30,EDN1,ERF,ESRRA,EXD2,FAM102B,FAM155A,FAM177B,FAM3C,FAM46C,FAM72B,FBRSL1,FBXO48,FCGR1B,FEM1A,FLJ37201,FLJ42393,FNBP1,FOXP1,FPGT,GARS,GCNT1,GNA12,GNG7,GOLGA8B,GPR137B,GPR162,GPR183,GRAPL,GRHPR,GRIP1,GTF2A1,GTF2IRD2,GUSBP3,HEATR5B,HECTD3,HERC5,HNRNPA1L2,HNRNPD,HRK,HSDL2,IFNA1,IFNA2,IFNGR1,IGF2R,IL17REL,IL22RA2,INPP5D,INSC,INTS2,INVS,ISY1,ITCH,ITIH5,JAZF1,JUND,KBTBD12,KCTD16,KDM3B,KDM4C,KLRF1,KRT222,LDLRAD2,LMTK3,LOC100133315,LOC100303749,LOC374443,LOC441204,LPIN1,LRRK2,LSM2,LUC7L3,LY6G5C,MAML3,MAP1LC3B2,MAP3K10,MBOAT7,MGC12916,MIR572,MIR623,MIR760,MMP23A,MRPL30,MRPS18A,MTG1,N6AMT1,NACC1,NBAS,NEK1,NFKB1,NIPA1,NOTCH2NL,NR4A2,NR4A3,NSUN4,NUP160,OR10P1,OTUD7B,PARP14,PARVG,PIP4K2A,PLG,PLXNC1,POLA2,POLE2,POMP,PPIAL4A,PPIAL4C,PPP1R15A,PPP1R2P9,PRCC,PRDM1,PRICKLE1,PRKCE,PRPSAP2,PSAP,PSAT1,RASAL2,REEP3,RFPL1S,RHBDD1,RHBDF2,RHEB,RIMKLA,RNF11,RNLS,ROR1,RP9P,RPA2,RPL15,RPS12,RPS26,RSRC1,S1PR1,S1PR4,S1PR5,SASH1,SHQ1,SKA1,SLC26A1,SLC35D3,SLC37A2,SLC43A2,SLCO3A1,SMARCA2,SMYD3,SNORA36B,SNRNP35,SNRNP48,SNX30,SOCS2,SPAG9,SRRM3,STARD10,SYNM,TADA2A,TAF8,TBC1D7,TECPR1,TET3,TGFBR2,THAP5,TIMM22,TLE3,TMEM104,TMEM150B,TMEM209,TMEM37,TNFSF14,TOM1,TRA2A,TRIL,TRIM44,TSEN15,TTC39C,TYW1,UBASH3B,UBL3,UBR7,USP25,USP36,USP6NL,USP8,UTRN,UXS1,VASH2,VPS13D,VRK2,VWA3B,WDR60,WDR75,ZBTB38,ZC3H12C,ZCCHC3,ZCCHC6,ZCCHC7,ZDHHC14,ZFR2,ZG16,ZNF311,ZNF354A,ZNF398,ZNF608,ZNF639,ZNF74,ZNF844	NSMAF,PIGF,PIP4K2A	PIK3AP1,PIP4K2A,PLG,PLXNC1,PNPLA8,POLE2	ALDOC,BLK,CA5A,CTCFL,PGGT1B,RASIP1	CCL3,ITPR1,PIK3AP1,ZNF354A	ADAMTS6,ADARB1,AMDHD2,AP4M1,ARHGEF6,ARL1,ATG10,ATG16L1,ATXN2L,BCAT2,BCL2,BPGM,C20orf196,CAB39,CASP8,CCND2,CD2AP,CD69,CDC123,CFL2,CKAP2,COL19A1,COMMD6,COPS6,CREB5,CRY1,CTNNB1,CTR9,CTSB,CYP20A1,DDX1,DTWD1,DUSP4,DUSP5,EGR3,EIF1B,EIF2S3,EIF3G,ELK3,ELOVL5,ENPP1,EPM2A,FAIM,FAM120B,FAM3C,FBXO16,FBXO21,FFAR2,FYTTD1,GAS7,GGNBP2,GLI3,GNA12,GNB2,GPR160,GPR162,GRHPR,GRM8,GTF2I,HADHB,HDAC3,HDAC9,HEXB,HMGN3,HPCAL1,HSP90B1,IL10RB,IL17D,INPP5A,INTS10,ITM2C,JARID2,KCNJ3,LAMP1,LDLR,LGMN,LIMD1,LPIN1,LSM2,MADCAM1,MAG,MAPKAPK3,MCF2L2,MDH1,MED30,MLLT1,MNAT1,MOSPD2,MRPS18A,MS4A2,NACA,NEIL2,NFATC1,NHLRC2,NIPA1,NLGN4X,NSMAF,NUP160,OSBPL3,PCDH8,PDCD1LG2,PIAS1,PIGF,POLA2,PORCN,PPP2R5C,PRDM15,PROCR,PRTFDC1,PTPN1,PUS1,RABEP1,RASSF8,RBM17,RBM26,REEP1,RHBDD1,RHEB,RHEBL1,RPL15,RPS26,RTN2,RYK,SCOC,SEC24D,SEPHS1,SFXN3,SGTA,SH2B3,SIAH2,SLC10A2,SLC25A37,SLC9A8,SLCO3A1,SP4,SPAG9,SPATA12,ST8SIA4,STK24,SUB1,TARS,TCF12,TFG,TGFBR2,TLE3,TNFAIP8,TNIP2,TOM1,TRA2A,TRAFD1,TRHR,TRIB2,TRIO,TRMT1,TXNDC5,UBB,UBL3,UHRF2,USP25,USP8,USPL1,UTP14A,UTP3,VCPIP1,VPREB1,WEE1,XPO7,ZBTB25,ZNF227,ZNF365,ZNF639,ZNF791
genes_in_module7	ANGPTL7,CCL22,CER1,CRELD2,DBNDD1,KLHDC7B,MORN1,PIK3R5,RBBP4,SLC10A2,TNFRSF1B	ALDH1L2,CDYL2,CMIP,FA2H,FBRSL1,FOXO3,GRAPL,IFNGR1,IGF2R,IL22RA2,LOC100133315,MAF,MAP1LC3B2,MGC12916,NMBR,PLG,PRDM1,PRDM4,RPS12,SASH1,SLC35D3,SLC37A2,SLC43A2,SNRNP35,TIMM22,UBASH3B,UTRN,ZC3H18,ZNF276,ZNF821	ABR,CCL22,CHFR,CHRNB3,DBNDD1,DEF8,EPS8L3,ITGAE,PIK3R5,PITPNM3,SLC7A5	6-Sep,ADAMTS13,AMN,ANGPTL7,ANK3,ANXA4,ARSG,BANK1,BCOR,CASP8,CCDC17,CCR1,CCR6,CD22,CD53,CER1,CHML,CHST12,CHST7,CNNM1,CRELD2,CTLA4,CYBB,DAPP1,DMD,DOCK2,EPS8L3,F12,FASLG,FCRL4,FGD2,GALNT6,GJA3,GPR141,GRAP2,GRIN2B,HIST1H4H,HYAL3,IFNA8,IL13RA1,ITGAE,KLHDC7B,KMO,LBR,LMO2,LPP,LRP2BP,MBNL3,MS4A1,MS4A2,NOS3,NPC1L1,NR4A1,P2RY10,P2RY12,PARVB,PCDHGB7,PITPNM3,PTPN3,PTPRC,RASIP1,RCAN2,RIN2,SCNM1,SEMA7A,SLC23A2,SPTBN1,TCF3,TLR7,TMEM154,USP9X,VCAN,WNT8A,XCR1	PIK3AP1,PLXNC1,PNPLA8,PPIAL4A,PPIAL4C	PPIAL4A,PPIAL4C	PIK3AP1	ABCB10,ABHD12,ABR,ADAMTS6,AMDHD2,ATG10,ATG16L1,ATXN2L,BRPF1,CD53,CEPT1,CNOT6,CTDSP1,CTNNB1,DBNDD1,DCTD,DEXI,DTWD1,DUSP4,GAS7,GGNBP2,GNPTG,GSPT1,HACL1,HDAC3,HEXB,HLX,HPS6,INPP5A,IRF2BP2,KCNH8,L3MBTL2,LDHD,LGMN,MAPKAPK3,MMP15,MTF2,NEIL2,NEK2,NHLRC2,NID1,NLK,NTNG1,PCDHGB7,PLEKHA1,PPP2R5C,PROCR,RPL15,RPS6KA5,SCNN1B,SFXN3,SLC43A2,SLMAP,SOCS1,SPATA12,SPG7,ST8SIA4,TCF12,TGFBR2,TMEM175,TNFAIP8,TNIP2,USP8,VASH2,WWOX,XPO7,ZNF501,ZZEF1	ADD1,ARHGEF5,ARID5B,ARMC5,ARRDC3,BMPR2,CLIC5,CXCR4,DEXI,ERF,FEM1A,GNG7,GPR20,GTF2A1,GTF2IRD2,HEATR5B,HERC5,HIVEP1,HRK,HS6ST1,IFNA1,IGF2R,IL22RA2,KCTD16,LRRK2,MARCKS,MPHOSPH8,OR10P1,PAN3,PARP14,PARVG,PIK3AP1,PLXNC1,PNPLA8,PPP1R15A,PPP1R2P9,PRDM1,RASGEF1B,REEP3,RPS6KA5,SCAMP5,SETMAR,SLC26A1,SRC,SYNGR4,TACC1,TIMM22,USP6NL,UTRN,ZBTB38,ZCCHC7,ZNF311,ZNF354A,ZNF486,ZNF608
genes_in_module8	ABR,CCDC17,DEF8,EPS8L3,GJA3,GRAP2,HYLS1,IL12RB2,ITGAE,LPXN,MS4A1,PARVB,PITPNM3,TCF3	BIRC3,DDX10,DEF8,ESRRA,HMGN3,HRK,LPXN,MMP15,MS4A1,POLA2,PUS1,SH2B3,SPG7	ACBD3,ARHGEF5,ARID5B,AUTS2,CD46,DHTKD1,ETV6,GLI3,ITIH5,LMTK3,MYADM,OPTN,PLEKHA1,PRICKLE1,RASAL2,REEP3,SRC,TACC1,TRIB1,ZBTB10,ZMYND11,ZNF486	CHRNB3,CRYM,PCMTD1	PCDHGB7,PIK3R5,PITPNM3	NA	ABR,CER1,CHFR,CRELD2,GALNT6,GRIN2B,HYLS1,IFNA8,ITGAE,MS4A1,MS4A2,NR4A1,PARVB,PIK3R5,PTPN3,TAL2,TCF3	AMN1,ARID5B,AUTS2,CLIC5,DNAJC12,ELOVL5,FHAD1,HEATR5B,HES5,HIVEP1,HSDL2,MARCKS,N6AMT1,NEK1,NFKB1,NOTCH2NL,PLXNC1,ZNF311,ZNF486	ABR,ADCYAP1,AEBP1,AMN,ANK3,ARHGAP25,CCDC91,CCR6,CD22,CEBPG,CER1,CHFR,CHST12,CRELD2,CTLA4,CYBB,DNMT3A,DSCR9,FGD2,GALNT6,GNPTG,GPR141,HYAL3,KCNH8,LPP,MTSS1,NOS3,NR4A1,P2RY12,PART1,PCMTD1,PIK3R5,PUF60,RIN2,SNX9,SPTBN1,TCEA2,TMEM154,XCR1
genes_in_module9	AKR1B10,C9orf40,CFL2,CREB5,CYCS,DNTT,POLA2,RAD51AP1,RGS20,SCG3,STK33	ARID3B,BIRC5,EXOSC8,HIST1H4C,MED18,POLE2,PSAT1,STK33,TOX,ZG16	ADAR,AKR1B10,AMDHD2,ARMC3,ATXN2L,BPGM,C20orf196,CD22,CD69,CDC123,CEBPG,COPS6,DDX59,DIRAS1,DUSP5,ELK3,FCRL4,GNB2,GRIN2D,GSPT1,HDAC9,HELB,HHEX,HLX,HSD17B14,IGF1R,IL12RB2,INPP5A,KMO,LBR,LIMK1,LYN,MACF1,MADCAM1,MAPKAPK2,MYBL2,NEK2,NSMAF,PNPLA6,PROCR,PTPN1,PTPRC,RBBP4,RND1,RTN2,SEPHS1,SFXN3,SGTA,SIRPA,SLC9A8,SLCO3A1,TMEM130,TMEM143,TRHR,VASH2,YIPF1,ZNF512B	ENPP2,GNPTG,ODF1,TRHR	PLG	NA	ADARB1,ANKMY2,ARRDC3,CBR4,CD46,CDYL2,CR1L,DGKE,GARS,GPR162,GPR20,GSPT1,HEXB,JAZF1,LEPROTL1,LMTK3,MTG1,NLK,PIP4K2A,SETD1A,SMYD3,SNX5,SPAG9,TACC1,VDAC3,XPO6,ZCCHC3,ZKSCAN2,ZNF74,ZSWIM6	AGMAT,AKR1B10,C20orf196,GRIN2D,ITM2C,LDLR,MAP3K10,MYBL2,POLA2,PSAT1,SERPINE2,ZNF512B	ARID3B,HHEX,MTG1,NEDD4L,NUDT10,POLE2,RCBTB2,TMEM132B,TOX
genes_in_module10	ARID3B,CR1L,HHEX,OSBPL3,POLE2,PSAT1,SERPINE2,TMEM132B,TOX,ZDHHC22	ATP1B3,BASP1,C20orf196,CASP8,CEBPG,CFL2,CKAP2,CREB5,CYCS,DAPP1,DSCR9,EIF2S3,EPB41,FGF9,GFI1B,GFOD1,HACL1,HELB,HPCAL1,ITM2C,JARID2,LIMD1,LPIN1,MAG,MAPKAPK3,MDH1,MED30,MESP1,MNAT1,MTF2,NAV2,NSMAF,NUP160,OGT,PCDH8,PORCN,PRDM15,PROCR,PSMA1,PTPN1,RCBTB2,RHEBL1,RPA2,RPS26,RPS6KA5,SLC19A1,SLC25A37,SLCO3A1,SUB1,TAL2,TARS,TBL1X,TRA2A,TRMT1,TTF1,UHRF2,USPL1,VPREB1,ZBTB25,ZMYND19,ZNF512B	HIST1H4C,POLA2,POLE2,PSAT1,RCBTB2	CR1L,HHEX,ITPR1,MED18,OPN3,OSBPL3,RCBTB2,STK33,TMEM132B	POLA2	NA	ADAMTS13,BUB3,CNNM1,PITPNM3,TBC1D13	BHLHE41,CDKN1B,DDX47,EXOSC8,FAM155A,FLT1,FNDC3A,GPR183,GPR20,GSDMD,HNRNPA1L2,LOC374443,MIPEP,MIR30B,MIR623,PAN3,POMP,RNF5P1,TACC1,TOX,TRAPPC9,UBL3,VDAC3	BATF3,BEND5,C1orf141,C1orf220,CAPN8,CLTC,FAM102B,FAM177B,FAM46C,FAM72B,FCGR1B,HECTD3,INSC,INTS2,LOC100133315,MIR760,OPN3,PARS2,PPIAL4A,PPIAL4C,RIMKLA,RNF157,S1PR1,SNORA36B,TADA2A,TMEM104,TRIM44,TSEN15,WDR47
genes_in_module11	CD320,CDYL2,FA2H,FNDC3A,NSUN4,POMP,PRPSAP2,RCBTB2,ROR1,RPA2,SPG7,TNFSF14,ZC3H12C	AMN,ANGPTL7,ARHGAP25,ARSG,CCDC91,CD22,CER1,CHRNB3,CHST7,CNNM1,CRELD2,CTLA4,CYBB,DNMT3A,DOCK2,EPS8L3,F9,FGD2,GJA3,GPD2,GPR141,GRIN2B,IFNA8,KLHDC7B,LMO2,LPP,LRP2BP,MTSS1,NLRP4,NOS3,NR4A1,ODF1,OTUD5,PCDHGB7,PCMTD1,PTPN3,RCAN2,SCOC,SLC10A2,SPTBN1,TMEM154,TRHR,UCP3,USP9X,WNT8A,XCR1	PCMTD1	CMTM3,DEF8,DSE,FBXO16,INTS10,MMP15,NEIL2,PART1,SPG7,TNFRSF10D,WWOX,XPO7	PORCN	NA	ACOXL,ADAM6,ARID1B,ATXN1,BACH2,BAIAP2L1,BEND5,BHLHA15,BIRC5,BMPR2,C17orf64,C1orf141,CAB39,CALM1,CDKL4,CLIC5,CYTIP,DEFT1P,DHRS9,DPY30,DTNB,EXD2,FAM102B,FAM155A,FAM3C,FAM72B,FBXO48,FCGR1B,FHAD1,FLJ42393,FLT1,FOXO3,FPGT,GNB2,GOLGA8B,GPR183,HEATR5B,HES1,HES5,HIST1H4C,HIVEP1,HNRNPA1L2,HS6ST1,IFNGR1,IGF2R,IL22RA2,INPP5D,INSC,KBTBD7,KCNH8,LDLRAD2,LPIN1,MAN1C1,MARCKS,MDH1,MESP1,MIPEP,MIR623,MIR760,MMP23A,NBAS,NEDD4L,NFATC1,NIPA1,NOTCH2NL,NSUN4,PARS2,PLG,PNPLA8,POMP,PPIAL4A,PPIAL4C,PPP1R2P9,PRDM1,RHBDF2,RIMKLA,RNF11,RNF5P1,RPS12,S1PR1,SASH1,SETMAR,SHQ1,SIAH2,SKA1,SLC35D3,SLCO3A1,SNRNP48,SRRM3,SYNM,TECPR1,TET3,TGFBR2,THAP5,TMEM104,TMEM209,TMEM37,TNFSF11,TTC39C,TYW1,UBR7,UTRN,VEZF1,VPS13D,VRK2,VWA3B,WDR47,WDR75,WEE1,WNT4,ZC3H18,ZDHHC14,ZNF276,ZNF311	PCMTD1	B3GNTL1,C17orf64,FPGT,NOTCH2NL,NSUN4,RHBDF2,ROR1,USP36
genes_in_module12	ADO,AKAP13,ARID5B,C10orf128,CRTC3,DNAJC12,GPR20,GSDMD,IFNA1,IFNA2,ITCH,LOC100133315,MACROD2,MIR30B,NGRN,PPIAL4A,PPIAL4C,PSAP,REEP3,SRC,STARD10,SYNM,TRAPPC9,TRIB1,ZBTB10,ZNF365	AGMAT,AKR1B10,ALDOC,ARID3A,BLK,C9orf40,CA8,CD28,CD320,CITED1,CP,ESPNL,HHEX,MYBL2,NTNG1,RAD51AP1,RGS20,SCG3,SERPINE2	ENO3,NTNG1,SCG3	ADCYAP1,AUTS2,BCL2,COL19A1,EGR2,EHF,HCK,IL12RB2,KCNH8,MACROD2,MAN1C1,NFATC1,PCDH8,PRTFDC1,RAD51AP1,REEP1,SCG3,STK24,USPL1	PCMTD1	NA	ALDH1L2,AMN1,ATP6V1G1,C10orf128,C22orf34,CC2D2B,CD200R1L,DDX47,DNAJC13,EHMT1,EPS15L1,ESRRA,FBRSL1,FLJ37201,GCNT1,GPR107,GRAPL,HPS6,HRK,HSDL2,IFNA1,IL17REL,ISY1,JUND,KBTBD12,KDM4C,KLF2,LOC100133315,LRRK2,MAP1LC3B2,MGC12916,MXI1,NACC1,OR10P1,PARP14,PARVG,PLXNC1,PRDM4,PSAP,PSAT1,RNLS,S1PR4,S1PR5,SHB,SLC37A2,SLC43A2,SLC44A1,SNRNP35,SNX30,TIMM22,UBASH3B,ZC3H12C,ZCCHC6,ZCCHC7,ZFR2,ZMYND19,ZNF791,ZNF844	ADCYAP1,ARHGEF12,ARL1,BACH2,BCL3,BPGM,CD200R1,CDKL5,DSE,DUSP5,FAIM,FOXJ1,GPR160,HEXIM1,IFNGR1,KIAA0040,KLF2,MACROD2,MESP1,MYADM,NLGN4X,NR4A2,NSUN7,P2RY10,PRDM4,RASAL2,RNF11,SASH1,SCOC,SLC44A1,SMAD1,SMARCA2,SPRY1,SYK,TAGAP,TLR10,TMC4,YIPF1,ZEB2,ZMYND11	AKR1B10,ARID3A,BASP1,CA8,CD28,CITED1,CYCS,DCTD,ENO3,GSPT1,HACL1,IGF1R,NSUN7,RAD51AP1,RGS20,SCG3,SERPINE2,SLC39A6,SOCS2
genes_in_module13	ADAMTS13,AMN,ANXA4,ARHGAP25,ARSG,BANK1,CCDC91,CCR6,CD22,CHRNB3,CNNM1,CTLA4,CYBB,DNMT3A,ESPNL,F12,F9,FGD2,GNPTG,GPD2,GPR141,GRIN2B,HYAL3,IL19,KMO,LMO2,LPP,LRP2BP,NKX6-1,NLRP4,NR4A1,PCMTD1,PTPN3,PTPRC,SLC8A1,SPTBN1,TBC1D13,TMEM154,TMEM43,USP9X,WNT8A,XCR1,ZNF185	ACBD3,ADAR,AMDHD2,ARMC3,ATP8B2,C11orf24,CD46,CDC123,CTTN,DDX59,DHTKD1,GSPT1,HLX,IRF2BP2,KIAA0040,KLF6,KMO,MAPKAPK2,NID1,OTUD7B,PRCC,PRTFDC1,SCNM1,SCNN1B,SEPHS1,SOCS1	ATP8B2,BUB3,CCDC17,CCDC91,CD320,CHML,CHST12,CNNM1,CRYM,GPR141,GRM8,HTRA4,IL19,MAG,MTSS1,NID1,NLRP4,NOS3,NR4A1,ODF1,PRTFDC1,PUF60,RASIP1,RBM17,SCNM1,SLC23A2	AMDHD2,ATXN2L,CA8,GSPT1,LONP2,LYN,NSMAF,RGS20,TRIB1,VCPIP1	NA	NA	ARHGEF12,ARL1,ATF7IP,CD200R1,CD274,DIRAS1,EIF3G,FAIM,FBXO21,FEM1A,GFI1B,GRHPR,KCNK4,L3MBTL2,LPXN,NACA,NEK6,NR4A3,PARP15,PDCD1LG2,PNPLA6,POLA2,RAD51AP1,RHEBL1,RYK,SMARCA2,STRBP	CD69,ENPP2,GJA3,GRIN2B,ODF1,PCDH8,PUF60,SLC10A2,SLC19A1	ABCB10,ADAR,ATP8B2,BIRC5,CD46,CD53,CEPT1,CSF1,CYP2R1,DDX59,DGKE,DPH2,EIF4A3,FOXJ1,GPR137B,MSI2,NEK2,NID1,NLK,NTNG1,PSMA1,RNF11,VEZF1,YIPF1
genes_in_module14	CA5A,CLDN10,NTNG1,SLC7A5	BATF,EGR2,EHF,ELOVL5,GCNT1,GPR160,HCK,KLF2,P2RY12,PRICKLE1,STAC2,VCAN	CR1L,OSBPL3,SNX5,TOX	ARMC5,DEXI,GPR20,GSDMD,LOC388242,LOC613038,LYRM1,MIR30B,RNF5P1,SETD1A,SOCS1,TACC1,TELO2,TRAPPC9,XPO6,ZKSCAN2	NA	NA	CACNA2D3,CCND3,CLTC,CRTC3,CTNNB1,DOCK10,EXOSC8,FAM46C,FNDC3A,HECTD3,IL17D,ITM2C,ITPR1,LY6G5C,MAPKAPK3,MRPL30,NGRN,NR4A2,NUP160,PAN3,POLE2,PRKCE,RCBTB2,RNF157,ROR1,SCAMP5,SMAD3,SPG7,TAF8,TBC1D7,TBL1X,TRIM44,UBL3,USP36,USP8,UXS1,WDR60,ZNF398	ADAM6,ADAP1,ADD1,ARMC5,ARRDC3,BATF3,BOD1,C10orf128,C22orf34,C7orf50,CACNA2D3,CALM1,CAPN8,CC2D2B,CCL3L1,CCL4L2,CDYL2,CMIP,CTSB,CYP2W1,DEFB131,EIF1B,FAM102B,FAM177B,FAM46C,FAM72B,FCGR1B,FEM1A,GNA12,GOLGA8B,GRAPL,GUSBP3,IL17REL,INPP5D,INTS10,IPO11,ITCH,KCTD16,KDM3B,LEPROTL1,LOC100303749,LOC388242,LOC613038,LYRM1,MAF,MIR760,MTG1,NIPA1,OPN3,PARVG,PRPSAP2,RCBTB2,SDK1,SETD1A,SETMAR,SHQ1,SLC26A1,SNORA36B,SNX18,TELO2,TIMM22,UBR7,UBXN8,WDR47,XPO6,ZC3H18,ZCCHC3,ZFR2,ZKSCAN2,ZNF276,ZNF608,ZNF821,ZSWIM6	ACBD3,CTTN,DDAH1,FCRL4,HHAT,HLX,IKZF3,IRF2BP2,KIAA0040,KMO,MACF1,MAPKAPK2,MTF2,NAV2,OTUD7B,PRCC,RBBP4,RNF213,SCNM1,VASH2
genes_in_module15	ANK3,ENPP2,IFNA8,MTSS1,ODF1,UCP3	ADAMTS13,BCOR,BUB3,CADPS,CCDC17,CCR1,CHST12,DGKE,GRAP2,HIST1H4H,HYAL3,IKZF1,MBNL3,NPC1L1,PARVB,RASIP1,SEMA7A,TCF3	AGMAT,ALDOC,BLK,CD28,PCDH8,SERPINE2,STK33	AGMAT,ALDOC,BATF,CCND2,CD28,CFL2,CP,CREB5,EXTL1,GLI3,PROCR,SERPINE2,SH2B3	NA	NA	ARHGEF5,ARID3B,MED18,NUDT10,SERPINE2,ZDHHC22,ZG16	ADAMTS13,ANGPTL7,ANXA4,ARSG,BCOR,CAPZB,CCDC17,CD22,CEBPG,CHFR,CHST7,COL19A1,CP,CTLA4,DIRAS1,DMD,DNMT3A,EXTL1,F9,FGD2,FUT1,HDAC9,HIST1H4H,HPCAL1,HYLS1,IL12RB2,JAM3,LMO2,MAG,NEK6,NLRP4,NOS3,NR4A1,OTUD5,PRDM15,PTPN3,RASIP1,RCAN2,SEMA7A,SLC23A2,SNX9,SPTBN1,TBC1D13,TCF3,TNFRSF1B,TRIB2,UCP3,USP9X	EHF,RGS1
genes_in_module16	BCOR,BUB3,CASP8,CCR1,CEBPG,CHFR,CHML,CHST12,CHST7,CRYM,DOCK2,GRM8,LBR,NOS3,NPC1L1,OGT,RASIP1,RCAN2,SEMA7A,SLC19A1	NCF2,RGS1	RGS1	HTRA4,PUF60,SCNN1B	NA	NA	AEBP1,ANK3,CCL22,CD22,CEBPG,CHML,CHRNB3,CNOT6,F12,FASLG,FCRL4,FUT1,GNPTG,GPR141,HTRA4,IL19,LRP2BP,MTSS1,NLRP4,ODF1,PUF60,SLC19A1,TRHR,UCP3,WNT8A	COG6,COMMD6,HTRA4,MED30,OTUD7B,TRIB1	ADAMDEC1,EDN1,PRICKLE1
genes_in_module17	ADAR,C11orf24,CTTN,FCRL4,IGF1R,IRF2BP2,OTUD7B,PRCC,PTPN1,PUF60,SCNM1,SIRPA,SLC9A8,TCEA2,TRHR	ADAMDEC1,AEBP1,BANK1,GALNT6,GPR65,IL13RA1,RIN2,TMEM130	CCND2,CYCS,DNTT,LDLR,RAD51AP1,RGS20	CCL3,CCL4,ETV6,FCGR1A,FGF12,HES2,HES5,IRX4,KBTBD7,RASGEF1B,SCAMP5,WEE1	NA	NA	BCOR,CASP8,CCDC17,EPS8L3,ESPNL,HPCAL1,LMO2,OGT,OTUD5,TMEM43	ARHGEF6,BATF,BCL2,BCL6,NCF2,P2RY12,REEP1,SLC8A1,TLR7,TMEM130,ZNF750	ATP6V1G1,CDYL2,EHMT1,FHAD1,HES2,HSDL2,KRT222,LDLRAD2,MAF,MMP23A,PRPSAP2,PSAT1,SLC37A2,SLC44A1,SNX30,UBASH3B,VPS13D,VPS26B,ZC3H12C,ZC3H18,ZNF276,ZNF821
genes_in_module18	BEND5,C1orf141,C22orf34,C22orf42,CMIP,EMID1,FAM102B,FAM155A,FAM46C,FAM72B,FCGR1B,FHAD1,FLT1,GNG7,GPR183,GRAPL,HECTD3,HES2,HES5,HNRNPA1L2,IL17REL,KBTBD7,KDM4C,LDLRAD2,MGC12916,MIPEP,MIR623,MMP23A,NACC1,NEDD4L,PAN3,PARVG,RABEP1,RFPL1S,RIMKLA,S1PR1,S1PR4,S1PR5,SKA1,SLC37A2,SLC43A2,TIMM22,TOM1,TTC39C,UBASH3B,UBL3,VPS13D,WDR47,ZC3H18,ZFR2,ZNF276,ZNF74,ZNF821,ZNF844	CRYM,FASLG,FCRL4,GNPTG,IL19,PTPRC,RBM17	AEBP1,ANK3,FUT1,GALNT6,GNPTG,NPC1L1,RIN2,TCEA2	MAF	NA	NA	AMN,ANGPTL7,ANXA4,CAPZB,CCR1,CCR6,CD53,CHST7,CP,CTLA4,DBNDD1,DNMT3A,F9,FGD2,GPD2,GTF2I,HYAL3,IL13RA1,KYNU,LPP,NOS3,P2RY12,RBBP4,RCAN2,SPTBN1,TLR7,USP9X,XCR1,ZNF185	ARMC3,EGR2,EHF,MS4A7,RGS1	ADAMTS13,CAPZB,HYLS1,PTPN3,TBC1D13
genes_in_module19	BIRC3,CD53,CKAP2,DDX10,DPH2,EPB41,ESRRA,EXTL1,FGF9,JAM3,LDLR,MADCAM1,MAF,MMP15,MTF2,PCDH8,RBM26,STK24,TRMT1,UHRF2,USPL1,VPREB1,WWOX,ZZEF1	PRPSAP2,ZC3H12C	BMPR2,C17orf64,CALM1,CCL3,CTSB,DSE,ELOVL5,FOXO3,FOXP1,HEATR5B,HES1,HS6ST1,IFNA2,IFNGR1,INTS2,KBTBD7,RNF213,TNFSF11,UBL3	CDYL2,CMIP,CTSB,IPO11,LEPROTL1,MARCKS,SNX18,UBXN8,ZC3H18,ZDHHC22,ZNF276,ZNF821,ZSWIM6	NA	NA	BCL2,EHF,GPR65,PCDH8	CCND2,RAD51AP1,RGS20	FASLG,LMO2,PTPRC,UCP3
genes_in_module20	ADAMDEC1,GPR65,RGS1	ABR,ARHGEF12,ARID1B,BACH2,CMTM3,COL19A1,CRY1,DBNDD1,EPM2A,FAM120B,FBXO21,FLI1,FTH1,GAS7,HSP90B1,JAM3,KCNK4,LDHD,LONP2,NLK,RABEP1,SNX9,TAGAP,TNFAIP3,TRAFD1,UBB,VPS26B,WWOX,ZDHHC14,ZZEF1	CD53,CEPT1,CMTM3,DUSP4,EPB41,GAS7,HSP90B1,MMP15,MTF2,RABEP1,SEMA7A,SH2B3,TCF12,TRAFD1,ZZEF1	MED30	NA	NA	ADAMDEC1,NCF2,RGS1	LRP2BP,RIN2	RASAL2,STAC2,ZNF750
genes_in_module21	RIN2	MARCKS	EGR2,ENPP2,GPR137B,HCK,HHAT,KIAA0040,KLF2,MACROD2,TMC4	EGR3,LDHD,SLC25A37	NA	NA	ABCB10,ADAMTS6,ATG10,ATXN2L,BCAT2,CDC123,CREB5,CYCS,DHTKD1,EGR3,EIF4A3,HELB,HEXIM1,IL10RB,LONP2,MAG,MMP15,MSI2,NSMAF,PRDM15,PROCR,RGS20,SEPHS1,SLC25A37,SMARCE1,ST8SIA4,TMEM143,TNFAIP8,TNFRSF10D,TRA2A,USP25,UTP3,VPREB1	FPGT,LRRK2,MPEG1,PRICKLE1,SLC38A1,WNT4,ZNF365	AKAP13,ARID1B,AUTS2,BCL3,ETV6,GFOD1,HCK,KLF2,MAP3K10,NR4A2,SASH1,TAGAP,TRIB1
genes_in_module22	ABHD12,ATP8B2,C20orf196,DDIT4,MED30,MESP1,PROCR,ZNF512B	NEK2	BANK1,BATF,BCL2,BCL6,CITED1,GPR65,IRX4,MAN1C1,SPRY1	MTSS1	NA	NA	ADCYAP1,C11orf24,C9orf40,CD320,DDIT4,DUSP5,ELK3,FLI1,GOLGA2,HSP90B1,INVS,LDLR,MADCAM1,MLLT1,NHLRC2,PUS1,RND1,RPS26,SGTA,TOM1,TRAFD1,TRMT1,TTF1,VPS26B,ZZEF1	ANK3,CCDC91,CCR6,GPD2,IL13RA1,IL19,LPP,MS4A1,PTPRC,TMEM154,ZNF185	AGMAT,FA2H,MED18
genes_in_module23	ALDOC,BLK,CD28,CD69,CP,IKZF1,KYNU,MBNL3	MPEG1	CCL4,CLIC5,EDN1,MARCKS,MPEG1,NFKBIA,NR4A2,SLC39A6,STARD10,ZG16	NA	NA	NA	PRICKLE1	ACBD3,CHL1,DDAH1,EGR3,FBXO16,FCRL4,FOXP1,GLI3,HCK,IRF2,LONP2,RABEP1	IL12RB2,NCF2
genes_in_module24	AGMAT,ARID3A,ENO3,MED18	CCR6,MS4A2	BCOR,CADPS,CLDN10,GRAP2,KYNU,MBNL3	BIRC3,BTN3A2,GPR160,TNFAIP8	NA	NA	AP1M1,ARID2,CRY1,FNBP1,GAS7,GNG7,IFNA2,IGF1R,PRPSAP2,RABEP1,SFXN3,SH2B3,TNFSF14,UHRF2,ZBTB38,ZNF486	ARID3A,CD320,CTCFL,GRAP2,KYNU,MBNL3,TCEA2	IFNGR1,MPEG1,TNFSF11
genes_in_module25	MPEG1	DSE,MS4A7	ARID3B,MED18,TMEM132B	TOX	NA	NA	BANK1,RASAL2,RASSF6,SMAD1	AP1M1,ARID3B,BIRC5,CR1L,HRK,MED18,STK33,TMEM132B	KLHDC7B,MS4A1,SLC8A1
genes_in_module26	MS4A2	NA	FASLG,FFAR2,IRF2BP2,MESP1,NCF2,SCNN1B	VDAC3,ZBTB10	NA	NA	RASGEF1B	DNTT,ENO3,FA2H,LIMD1,SCG3,SLC25A37	BANK1,EGR2,GPR65,MS4A7
genes_in_module27	MS4A7	ABCB10,ATXN2L,LBR,VASH2	DDAH1,FBXO16,LDHD	CCL22,DBNDD1,SLC7A5	NA	NA	INTS2,MAF,TOX	CHRNB3,MTSS1	NA
genes_in_module28	MYBL2	CCL3,CCL4,TNFSF11,WNT4	FPGT,LEPROTL1,WDR47	SNX5	NA	NA	CLDN10,GJA3,MBNL3	NA	CCL22,SLC7A5,TNFRSF1B
genes_in_module29	NA	TMEM132B	ANGPTL7,KLHDC7B,LPP,MS4A2,SCOC,SLC8A1,TMEM154,ZNF185,ZNF750	ARID3A,CD69,CTCFL,DNTT,HEXIM1,IKZF1	NA	NA	ATP8B2,CFL2,DUSP4,LDHD,ZNF512B	GPR137B,HHAT,KMO,VCAN	CCL3,WNT4
genes_in_module30	TNFSF11,WNT4	CA5A,SLC7A5	AMN1,FCGR1A,KLF6,NOTCH2NL,SLC38A1,ZNF365	ADAMDEC1	NA	NA	ARSG,CD69,CHST12,DOCK2,DSCR9,IKZF1,LBR,NPC1L1,SLC23A2,SLC7A5,TCEA2,TMEM154	FCGR1A,KBTBD7,KLRF1,TNFSF11	CMIP,HES5,ZCCHC6
genes_in_module31	SLCO3A1,ZCCHC3	TELO2	EHF,MS4A7	BLK,CA5A	NA	NA	MPEG1	ZBTB10	CR1L,SMYD3
genes_in_module32	SLC23A2	CD69,CLDN10,CTCFL,DNTT,F12,KYNU	NA	FA2H,FOXO3	NA	NA	MS4A7	ALDOC,BLK,CA5A,SLC7A5	CADPS,CLDN10,CTCFL,DNTT,GRAP2,ITGAE,STK33
genes_in_module33	ADCYAP1,BCL2,SLC39A6	CHL1	WNT4	DUSP4	NA	NA	NA	CLDN10	SYK
genes_in_module34	SNX5	CHML	ARID3A,CREB5,CTCFL,GRIN2B,IKZF1,TCF3	NA	NA	NA	CCND2,ENO3,JAM3,SOCS2,UBB	CCL4	ALDOC,ARSG,CCDC17,CHML,EPS8L3,LBR
genes_in_module35	ARMC3,EHF,HHAT,STAC2	CR1L	ADAMDEC1,GPD2	NA	NA	NA	DNAJC12,HHEX,TMEM132B	ADAMDEC1	CCL4,JUND
genes_in_module36	CCL4,CLIC5	ARHGEF5,ARID5B,FHAD1	CA5A	NA	NA	NA	CYBB,SLC8A1	CA8	ANGPTL7
genes_in_module37	CTCFL	HHAT	NA	NA	NA	NA	AGMAT,AKR1B10,CD28,EIF2S3,EXTL1,SCG3	FASLG,GALNT6	CA5A
genes_in_module38	ARHGEF5,GPR137B	HYLS1,ITGAE	NA	NA	NA	NA	EDN1,GFOD1,TAGAP	NA	IL19
genes_in_module39	AEBP1,FASLG,GALNT6	ENPP1	NA	NA	NA	NA	SYK	NA	FCGR1A
genes_in_module40	EGR2,HCK	ENO3	NA	NA	NA	NA	CCDC91	NA	NA
genes_in_module41	EXOSC8	FCGR1A	NA	NA	NA	NA	CA8,CCL3,CCL4,FCGR1A	NA	NA
genes_in_module42	FCGR1A	NA	NA	NA	NA	NA	AUTS2,CXCR4,DSE,GTF2IRD2,HES2	NA	NA
genes_in_module43	NA	NA	NA	NA	NA	NA	ARID3A,DNTT,GRAP2	NA	NA
genes_in_module44	NA	NA	NA	NA	NA	NA	EGR2,ETV6,HCK	NA	NA
genes_in_module45	NA	NA	NA	NA	NA	NA	KLHDC7B	NA	NA
genes_in_module46	NA	NA	NA	NA	NA	NA	IL12RB2	NA	NA
#drugs_module1	NA	27	58	15	NA	NA	NA	5	83
#drugs_module2	53	2	67	21	5	NA	37	82	73
#drugs_module3	5	116	89	20	NA	NA	20	102	2
#drugs_module4	9	41	4	132	NA	1	121	7	10
#drugs_module5	159	NA	4	3	NA	5	8	3	68
#drugs_module6	20	1	12	72	NA	52	1	NA	109
#drugs_module7	4	52	NA	189	NA	NA	NA	6	21
#drugs_module8	NA	10	21	NA	NA	NA	67	1	91
#drugs_module9	NA	NA	110	3	52	NA	4	47	NA
#drugs_module10	NA	70	NA	NA	NA	NA	NA	12	NA
#drugs_module11	NA	98	NA	NA	NA	NA	61	NA	NA
#drugs_module12	21	1	NA	1	NA	NA	9	19	NA
#drugs_module13	80	NA	34	NA	NA	NA	5	63	4
#drugs_module14	NA	58	NA	NA	NA	NA	2	15	1
#drugs_module15	NA	NA	1	1	NA	NA	NA	39	NA
#drugs_module16	35	NA	NA	NA	NA	NA	5	NA	NA
#drugs_module17	64	NA	NA	NA	NA	NA	3	84	1
#drugs_module18	17	NA	NA	NA	NA	NA	119	NA	NA
#drugs_module19	11	NA	15	15	NA	NA	NA	NA	NA
#drugs_module20	NA	1	2	NA	NA	NA	NA	NA	NA
#drugs_module21	NA	NA	NA	NA	NA	NA	7	NA	NA
#drugs_module22	1	1	NA	NA	NA	NA	1	NA	NA
#drugs_module23	3	NA	NA	NA	NA	NA	NA	1	NA
#drugs_module24	NA	5	3	10	NA	NA	1	3	NA
#drugs_module25	NA	NA	NA	NA	NA	NA	NA	NA	NA
#drugs_module26	5	NA	NA	4	NA	NA	NA	NA	NA
#drugs_module27	NA	NA	1	NA	NA	NA	NA	NA	NA
#drugs_module28	NA	NA	NA	NA	NA	NA	NA	NA	4
#drugs_module29	NA	NA	5	NA	NA	NA	NA	1	NA
#drugs_module30	NA	NA	NA	NA	NA	NA	2	NA	NA
#drugs_module31	NA	NA	NA	1	NA	NA	NA	NA	1
#drugs_module32	2	5	NA	NA	NA	NA	NA	1	NA
#drugs_module33	NA	NA	NA	NA	NA	NA	NA	NA	19
#drugs_module34	NA	NA	63	NA	NA	NA	NA	NA	NA
#drugs_module35	NA	NA	NA	NA	NA	NA	NA	NA	NA
#drugs_module36	NA	1	NA	NA	NA	NA	NA	NA	NA
#drugs_module37	NA	NA	NA	NA	NA	NA	NA	NA	NA
#drugs_module38	NA	NA	NA	NA	NA	NA	NA	NA	NA
#drugs_module39	NA	NA	NA	NA	NA	NA	19	NA	NA
#drugs_module40	NA	NA	NA	NA	NA	NA	NA	NA	NA
#drugs_module41	NA	NA	NA	NA	NA	NA	NA	NA	NA
#drugs_module42	NA	NA	NA	NA	NA	NA	NA	NA	NA
#drugs_module43	NA	NA	NA	NA	NA	NA	NA	NA	NA
#drugs_module44	NA	NA	NA	NA	NA	NA	NA	NA	NA
#drugs_module45	NA	NA	NA	NA	NA	NA	NA	NA	NA
#drugs_module46	NA	NA	NA	NA	NA	NA	NA	NA	NA
drugs_in_module1	NA	DV1179#ANA773#AZD-8848#HYDROXYCHLOROQUINE#IMO-3100#IMIQUIMOD#CPG 52364#IMIQUIMOD#HYDROXYCHLOROQUINE SULFATE#DOCOSANOL#ANA773#HYDROXYCHLOROQUINE#IMO-3100#ISATORIBINE#RESIQUIMOD#CPG 52364#IMIQUIMOD#IMIQUIMOD#HYDROXYCHLOROQUINE#ANA971#SCV-07#ISATORIBINE#RESIQUIMOD#IMIQUIMOD#LOXORIBINE#HYDROXYCHLOROQUINE#IMIQUIMOD	TICLOPIDINE#AZD6140#TICAGRELOR#TREPROSTINIL#CLOPIDOGREL#EPOPROSTENOL#PRASUGREL#2MESADP#CLOPIDOGREL (ACTIVE METABOLITE)#CANGRELOR#CANGRELOR#[<SUP>3</SUP>H]2MESADP#COMPOUND 4 [PMID:23083103]#[<SUP>3</SUP>H]PSB-0413#ARL66096#BX 667#2MESATP#BX 048#ADP&BETA;S#ATP#COMPOUND 20O [PMID:22984835]#TICAGRELOR#ATP&GAMMA;S#AR-C67085#ADENOSINE DIPHOSPHATE#2MESAMP#INS49266#INS50589#R-138727#PSB-0739#PCMPS#PSB-0739#COMPOUND 4 [PMID:22984835]#CLOPIDOGREL BISULFATE#TICLOPIDINE HYDROCHLORIDE#PRASUGREL HYDROCHLORIDE#CLOPIDOGREL#TICAGRELOR#INS-50589#PRASUGREL#TICAGRELOR#TREPROSTINIL#CLOPIDOGREL#MC-1#TICLOPIDINE#ELINOGREL#CANGRELOR#CLOPIDOGREL#TICLOPIDINE#TICLOPIDINE#TREPROSTINIL#PRASUGREL#CLOPIDOGREL#CLOPIDOGREL#TICLOPIDINE#BRILINTA#AR-C69931 MX#PRASUGREL	L-GLUTAMIC ACID#(1<I>S</I>,3<I>R</I>)-ACPD#L-GLUTAMIC ACID#D-AP4#L-CCG-I#L-AP4#MPPG#LY341495#L-SERINE-O-PHOSPHATE#DCG-IV#AZ12216052#[<SUP>3</SUP>H]AP4#(<I>S</I>)-3,4-DCPG#EGLUMEGAD#(<I>R,S</I>)-4-PPG	NA	NA	NA	OMALIZUMAB#R112#OMALIZUMAB#GEMCITABINE#TOSITUMOMAB	FORMIC ACID@MDX-1105#MPDL3280A#MDX-1105#MPDL3280A#RG7446@CITRIC ACID#ASPARTATE BERYLLIUM TRIFLUORIDE@DYSTROPHIN#PRO044@[<SUP>3</SUP>H]CPP#LY233053#L689560#GV196771A#(<I>RS</I>)-(TETRAZOL-5-YL)GLYCINE#D-SERINE#CONANTOKIN-G#L701324#NMDA#L-ASPARTATE#SELFOTEL#D-ASPARTATE#[<SUP>3</SUP>H]CGS19755#[<SUP>3</SUP>H]CGP39653#D-AP5#CGP37849#5,7-DICHLOROKYNURENIC ACID#[<SUP>3</SUP>H]CGP61594#PHENCYCLIDINE#UBP141#[<SUP>3</SUP>H]L689560#GLYCINE#[<SUP>3</SUP>H]MDL105519#AMANTIDINE#N<SUP>1</SUP>-DANSYL-SPERMINE#KETAMINE#DIZOCILPINE#MG<SUP>2+</SUP>#D-CCPENE#[<SUP>3</SUP>H]DIZOCILPINE#[<SUP>3</SUP>H]GLYCINE#HOMOQUINOLINIC ACID#CNS-5161#DIMIRACETAM#AZD-6765#LATREPIRDINE#ORPHENADRINE#V3381#DEXANABINOL#AM-101#NEU-2000#ORPHENADRINE#L-GLUTAMIC ACID#PETHIDINE#ORPHENADRINE#TENOCYCLIDINE#ACETYLCYSTEINE@N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE@PYRIDOXAL#N6-METHYL-(R)-ROSCOVITINE, R-2-[6-(BENZYL-METHYL-AMINO)-9-ISOPROPYL-9H-PURIN-2-YLAMINO]-BUTAN-1-OL#PYRIDOXINE#O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL#ADENOSINE-5'-[BETA, GAMMA-METHYLENE]TRIPHOSPHATE@CITRIC ACID@DV1179#ANA773#AZD-8848#HYDROXYCHLOROQUINE#IMO-3100#IMIQUIMOD#CPG 52364#IMIQUIMOD#HYDROXYCHLOROQUINE SULFATE#DOCOSANOL#ANA773#HYDROXYCHLOROQUINE#IMO-3100#ISATORIBINE#RESIQUIMOD#CPG 52364#IMIQUIMOD#IMIQUIMOD#HYDROXYCHLOROQUINE#ANA971#SCV-07#ISATORIBINE#RESIQUIMOD#IMIQUIMOD#LOXORIBINE#HYDROXYCHLOROQUINE#IMIQUIMOD@HYALURONAN
drugs_in_module2	ATORVASTATIN#ROSUVASTATIN@LITHIUM@UROKINASE#TRANEXAMIC ACID#STREPTOKINASE#ALTEPLASE#RETEPLASE#ANISTREPLASE#AMINOCAPROIC ACID#TENECTEPLASE#BICINE#DESMOTEPLASE#APROTININ#ANTITHROMBIN#DESMOTEPLASE#AMEDIPLASE#ANISTREPLASE#ALTEPLASE#PLASMIN#UROKINASE#RETEPLASE#TRANEXAMIC ACID#AMINOCAPROIC ACID#TENECTEPLASE#UROKINASE#STREPTOKINASE#AMINOCAPROIC ACID#ANISTREPLASE#TENECTEPLASE#ALTEPLASE#UROKINASE#RETEPLASE#TRANEXAMIC ACID#STREPTOKINASE#RETEPLASE#ALTEPLASE#AMINOCAPROIC ACID#UROKINASE#RETEPLASE#TENECTEPLASE#STREPTOKINASE#TENECTEPLASE#UROKINASE#ALTEPLASE#TRANEXAMIC ACID#AMINOCAPROIC ACID#APROTININ#RETEPLASE#STREPTOKINASE#ANISTREPLASE#6-AMINOCAPROIC ACID#APROTININ#TRANEXAMIC ACID#BIS-TRIAZOLE DERIVATIVE 10	ATORVASTATIN#ROSUVASTATIN@PF-4523655	(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE#[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA-2,5-DIEN-1-YL]ACETONITRILE@ATORVASTATIN#ROSUVASTATIN@CITRIC ACID#ASPARTATE BERYLLIUM TRIFLUORIDE@7&BETA;-HYDROXYCHOLESTEROL#27-HYDROXYCHOLESTEROL#7&ALPHA;,25-DIHYDROXYCHOLESTEROL#7&ALPHA;,25-DIHYDROXYCHOLESTEROL#7&ALPHA;-HYDROXYCHOLESTEROL#7&BETA;, 25-DIHYDROXYCHOLESTEROL#7&BETA;, 27-DIHYDROXYCHOLESTEROL#25-HYDROXYCHOLESTEROL#7&ALPHA;,27-DIHYDROXYCHOLESTEROL@RONTALIZUMAB@2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE#2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE@NADH#2-MONOPHOSPHOADENOSINE 5-DIPHOSPHORIBOSE@MARIMASTAT@PSEUDOEPHEDRINE@UROKINASE#TRANEXAMIC ACID#STREPTOKINASE#ALTEPLASE#RETEPLASE#ANISTREPLASE#AMINOCAPROIC ACID#TENECTEPLASE#BICINE#DESMOTEPLASE#APROTININ#ANTITHROMBIN#DESMOTEPLASE#AMEDIPLASE#ANISTREPLASE#ALTEPLASE#PLASMIN#UROKINASE#RETEPLASE#TRANEXAMIC ACID#AMINOCAPROIC ACID#TENECTEPLASE#UROKINASE#STREPTOKINASE#AMINOCAPROIC ACID#ANISTREPLASE#TENECTEPLASE#ALTEPLASE#UROKINASE#RETEPLASE#TRANEXAMIC ACID#STREPTOKINASE#RETEPLASE#ALTEPLASE#AMINOCAPROIC ACID#UROKINASE#RETEPLASE#TENECTEPLASE#STREPTOKINASE#TENECTEPLASE#UROKINASE#ALTEPLASE#TRANEXAMIC ACID#AMINOCAPROIC ACID#APROTININ#RETEPLASE#STREPTOKINASE#ANISTREPLASE#6-AMINOCAPROIC ACID#APROTININ#TRANEXAMIC ACID#BIS-TRIAZOLE DERIVATIVE 10@ALPHA-HYDROXY-BETA-PHENYL-PROPIONIC ACID#ANISOMYCIN#PUROMYCIN	LITHIUM@5-[(Z)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE@[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}AMINO)PHENYL]ACETONITRILE#1-CYCLOBUTYL-3-(3,4-DIMETHOXYPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE#1-CYCLOPENTYL-3-(1H-PYRROLO[2,3-B]PYRIDIN-5-YL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE#1-(1-METHYLETHYL)-3-QUINOLIN-6-YL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE#2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE#N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE#(2E)-N-{4-[(3-BROMOPHENYL)AMINO]QUINAZOLIN-6-YL}-4-(DIMETHYLAMINO)BUT-2-ENAMIDE#3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL#RU78300#PONATINIB#RU82197#DPI59#N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE#NINTEDANIB#PHENYLPHOSPHATE#RU84687#1-[1-(3-AMINOPHENYL)-3-TERT-BUTYL-1H-PYRAZOL-5-YL]-3-PHENYLUREA#1-[1-(3-AMINOPHENYL)-3-TERT-BUTYL-1H-PYRAZOL-5-YL]-3-NAPHTHALEN-1-YLUREA#RU79073#RU79256#N6-BENZYL ADENOSINE-5-DIPHOSPHATE
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB01908	RU85493
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	multitarget	DB01254	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB01947	RU78262
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB01962	PHOSPHONOTYROSINE
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02175	MALONIC ACID
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02336	RU83876
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02432	RU90395
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02762	RU79072
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02908	RU78783
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03591	RU82209
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03628	ISO24
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03712	RU85053
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03023	"1-TERT-BUTYL-3-(4-CHLORO-PHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-YLAMINE"
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03828	RU78299
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03902	OXALIC ACID
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04080	RU78191
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	inhibitor	DB06616	BOSUTINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04272	CITRIC ACID
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03078	PASBN
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03104	RU82129
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03114	PAS219
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04495	RU81843
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04739	4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04751	PURVALANOL A
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB05184	XL228
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	GuideToPharmacologyInteractions	n/a	7731	SARACATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	GuideToPharmacologyInteractions	n/a	6048	SYK INHIBITOR III
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	GuideToPharmacologyInteractions	n/a	5976	GSK-3 INHIBITOR XIII
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	GuideToPharmacologyInteractions	n/a	6044	SU6656
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	ENMD-2076	ENMD-2076
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	DASATINIB	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	XL228	XL228
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	PONATINIB	PONATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	MASITINIB	MASITINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	KX2-391	KX2-391
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	BOSUTINIB	BOSUTINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	ChEMBL	inhibitor	CHEMBL24828	VANDETANIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	ChEMBL	inhibitor	CHEMBL288441	BOSUTINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TEND	n/a	DASATINIB	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	MyCancerGenome	inhibitor	KX2-391	KX2-391
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	MyCancerGenome	inhibitor	XL228	XL228
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	MyCancerGenome	inhibitor	SARACATINIB	SARACATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	CancerCommons	inhibitor	DASATINIB	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	XL228	XL228
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	DASATINIB	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	XL999	XL999
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	BOSUTINIB	BOSUTINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	KX2-391	KX2-391
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	SARACATINIB	SARACATINIB
SCPEP1	serine carboxypeptidase 1	DrugBank	n/a	DB07506	L-BENZYLSUCCINIC ACID
MMP24	matrix metallopeptidase 24 (membrane-inserted)	DrugBank	inhibitor	DB00786	MARIMASTAT
CCHCR1	coiled-coil alpha-helical rod protein 1	PharmGKB	n/a	PA450616	NEVIRAPINE
CCHCR1	coiled-coil alpha-helical rod protein 1	PharmGKB	n/a	PA448320	ALLOPURINOL
FGFR2	fibroblast growth factor receptor 2	DrugBank	antagonist	DB01041	THALIDOMIDE
FGFR2	fibroblast growth factor receptor 2	DrugBank	inhibitor	DB08901	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DrugBank	binder	DB00039	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	DrugBank	inhibitor	DB09078	LENVATINIB
FGFR2	fibroblast growth factor receptor 2	DrugBank	inhibitor	DB09079	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	DrugBank	n/a	DB02058	SU4984
FGFR2	fibroblast growth factor receptor 2	DrugBank	n/a	DB02491	4-[4-(1-AMINO-1-METHYLETHYL)PHENYL]-5-CHLORO-N-[4-(2-MORPHOLIN-4-YLETHYL)PHENYL]PYRIMIDIN-2-AMINE
FGFR2	fibroblast growth factor receptor 2	DrugBank	inhibitor	DB08896	REGORAFENIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PAZOPANIB	PAZOPANIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	TEND	n/a	PALIFERMIN	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	TEND	n/a	THALIDOMIDE	THALIDOMIDE
FGFR2	fibroblast growth factor receptor 2	ChEMBL	agonist	CHEMBL1201821	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	ChEMBL	inhibitor	CHEMBL1946170	REGORAFENIB
FGFR2	fibroblast growth factor receptor 2	TTD	inhibitor	DAP001025	PENTOSAN POLYSULFATE
FGFR2	fibroblast growth factor receptor 2	TTD	binder	DAP000801	"INTERFERON ALFA-2A, RECOMBINANT"
FGFR2	fibroblast growth factor receptor 2	TTD	activator	DCL001020	TRAFERMIN
FGFR2	fibroblast growth factor receptor 2	TTD	inhibitor	DCL000361	AEE-788
FGFR2	fibroblast growth factor receptor 2	TTD	binder	DAP001026	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	TRAFERMIN	TRAFERMIN
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	CVBT-141B	CVBT-141B
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	THALIDOMIDE	THALIDOMIDE
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	PALIFERMIN	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	NINTEDANIB	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	CVBT-141H	CVBT-141H
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	ENMD-2076	ENMD-2076
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	ACTB1003	ACTB1003
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	ARQ 087	ARQ 087
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	PI-88	PI-88
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	FP-1039	FP-1039
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenomeClinicalTrial	inhibitor	REGORAFENIB	REGORAFENIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenomeClinicalTrial	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	MyCancerGenomeClinicalTrial	inhibitor	BGJ398	BGJ398
FGFR2	fibroblast growth factor receptor 2	MyCancerGenomeClinicalTrial	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	ClearityFoundationClinicalTrial	n/a	ENMD-2076	ENMD-2076
FGFR2	fibroblast growth factor receptor 2	ClearityFoundationClinicalTrial	n/a	NINTEDANIB	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	ClearityFoundationClinicalTrial	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	ClearityFoundationClinicalTrial	n/a	NINTEDANIB	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	VARGATEF	VARGATEF
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	XL999	XL999
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	TSU-68	TSU-68
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	BGJ398	BGJ398
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	REGORAFENIB	REGORAFENIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	LENVATINIB	LENVATINIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	XL228	XL228
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	BRIVANIB	BRIVANIB
FGFR2	fibroblast growth factor receptor 2	TALC	antibody	FP-1039	FP-1039
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	MASITINIB	MASITINIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	XL228	XL228
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	BGJ398	BGJ398
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	NINTEDANIB	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	E-3810	E-3810
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	CancerCommons	inhibitor	BGJ398	BGJ398
FGFR2	fibroblast growth factor receptor 2	GuideToPharmacologyInteractions	n/a	6954	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	GuideToPharmacologyInteractions	n/a	7707	AZD4547
FGFR2	fibroblast growth factor receptor 2	GuideToPharmacologyInteractions	n/a	7877	BGJ-398
FGFR2	fibroblast growth factor receptor 2	GuideToPharmacologyInteractions	n/a	5936	NINTEDANIB
NPY	neuropeptide Y	DrugBank	n/a	DB03380	L-TYROSINAMIDE
NPY	neuropeptide Y	DrugBank	n/a	DB02952	ALPHA-AMINOISOBUTYRIC ACID
GLUD1	glutamate dehydrogenase 1	DrugBank	n/a	DB00142	L-GLUTAMIC ACID
GLUD1	glutamate dehydrogenase 1	DrugBank	n/a	DB00157	NADH
GLUD1	glutamate dehydrogenase 1	DrugBank	inhibitor	DB00756	HEXACHLOROPHENE
GLUD1	glutamate dehydrogenase 1	DrugBank	n/a	DB04137	GUANOSINE-5-TRIPHOSPHATE	PYRIDOXAL#N6-METHYL-(R)-ROSCOVITINE, R-2-[6-(BENZYL-METHYL-AMINO)-9-ISOPROPYL-9H-PURIN-2-YLAMINO]-BUTAN-1-OL#PYRIDOXINE#O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL#ADENOSINE-5'-[BETA, GAMMA-METHYLENE]TRIPHOSPHATE@CITRIC ACID	NA	METHOTREXATE@(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE#[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA-2,5-DIEN-1-YL]ACETONITRILE@ATORVASTATIN#ROSUVASTATIN@METHYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE#N-({(2S,3S)-3-[(BENZYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINE#N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE#N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE#2-AMINOETHANIMIDIC ACID#DIPHENYLACETIC ACID#BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE#3-AMINO-4-OXYBENZYL-2-BUTANONE#N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO-2-METHYL-BUTANE#3-METHYLPHENYLALANINE#N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-#N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCINE#N-(3-PROPYLCARBAMOYLOXIRANE-2-CARBONYL)-ISOLEUCYL-PROLINE#2-PYRIDINETHIOL#Z-ARG-LEU-VAL-AGLY-ILE-VAL-OME@5-[(Z)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE@[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}AMINO)PHENYL]ACETONITRILE#1-CYCLOBUTYL-3-(3,4-DIMETHOXYPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE#1-CYCLOPENTYL-3-(1H-PYRROLO[2,3-B]PYRIDIN-5-YL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE#1-(1-METHYLETHYL)-3-QUINOLIN-6-YL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE#2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE#N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE#(2E)-N-{4-[(3-BROMOPHENYL)AMINO]QUINAZOLIN-6-YL}-4-(DIMETHYLAMINO)BUT-2-ENAMIDE#3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL#RU78300#PONATINIB#RU82197#DPI59#N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE#NINTEDANIB#PHENYLPHOSPHATE#RU84687#1-[1-(3-AMINOPHENYL)-3-TERT-BUTYL-1H-PYRAZOL-5-YL]-3-PHENYLUREA#1-[1-(3-AMINOPHENYL)-3-TERT-BUTYL-1H-PYRAZOL-5-YL]-3-NAPHTHALEN-1-YLUREA#RU79073#RU79256#N6-BENZYL ADENOSINE-5-DIPHOSPHATE
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB01908	RU85493
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	multitarget	DB01254	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB01947	RU78262
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB01962	PHOSPHONOTYROSINE
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02175	MALONIC ACID
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02336	RU83876
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02432	RU90395
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02762	RU79072
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02908	RU78783
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03591	RU82209
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03628	ISO24
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03712	RU85053
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03023	"1-TERT-BUTYL-3-(4-CHLORO-PHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-YLAMINE"
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03828	RU78299
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03902	OXALIC ACID
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04080	RU78191
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	inhibitor	DB06616	BOSUTINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04272	CITRIC ACID
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03078	PASBN
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03104	RU82129
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03114	PAS219
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04495	RU81843
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04739	4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04751	PURVALANOL A
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB05184	XL228
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	GuideToPharmacologyInteractions	n/a	7731	SARACATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	GuideToPharmacologyInteractions	n/a	6048	SYK INHIBITOR III
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	GuideToPharmacologyInteractions	n/a	5976	GSK-3 INHIBITOR XIII
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	GuideToPharmacologyInteractions	n/a	6044	SU6656
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	ENMD-2076	ENMD-2076
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	DASATINIB	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	XL228	XL228
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	PONATINIB	PONATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	MASITINIB	MASITINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	KX2-391	KX2-391
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	BOSUTINIB	BOSUTINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	ChEMBL	inhibitor	CHEMBL24828	VANDETANIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	ChEMBL	inhibitor	CHEMBL288441	BOSUTINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TEND	n/a	DASATINIB	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	MyCancerGenome	inhibitor	KX2-391	KX2-391
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	MyCancerGenome	inhibitor	XL228	XL228
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	MyCancerGenome	inhibitor	SARACATINIB	SARACATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	CancerCommons	inhibitor	DASATINIB	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	XL228	XL228
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	DASATINIB	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	XL999	XL999
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	BOSUTINIB	BOSUTINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	KX2-391	KX2-391
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	SARACATINIB	SARACATINIB
SCPEP1	serine carboxypeptidase 1	DrugBank	n/a	DB07506	L-BENZYLSUCCINIC ACID
MMP24	matrix metallopeptidase 24 (membrane-inserted)	DrugBank	inhibitor	DB00786	MARIMASTAT
CCHCR1	coiled-coil alpha-helical rod protein 1	PharmGKB	n/a	PA450616	NEVIRAPINE
CCHCR1	coiled-coil alpha-helical rod protein 1	PharmGKB	n/a	PA448320	ALLOPURINOL
FGFR2	fibroblast growth factor receptor 2	DrugBank	antagonist	DB01041	THALIDOMIDE
FGFR2	fibroblast growth factor receptor 2	DrugBank	inhibitor	DB08901	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DrugBank	binder	DB00039	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	DrugBank	inhibitor	DB09078	LENVATINIB
FGFR2	fibroblast growth factor receptor 2	DrugBank	inhibitor	DB09079	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	DrugBank	n/a	DB02058	SU4984
FGFR2	fibroblast growth factor receptor 2	DrugBank	n/a	DB02491	4-[4-(1-AMINO-1-METHYLETHYL)PHENYL]-5-CHLORO-N-[4-(2-MORPHOLIN-4-YLETHYL)PHENYL]PYRIMIDIN-2-AMINE
FGFR2	fibroblast growth factor receptor 2	DrugBank	inhibitor	DB08896	REGORAFENIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PAZOPANIB	PAZOPANIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	TEND	n/a	PALIFERMIN	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	TEND	n/a	THALIDOMIDE	THALIDOMIDE
FGFR2	fibroblast growth factor receptor 2	ChEMBL	agonist	CHEMBL1201821	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	ChEMBL	inhibitor	CHEMBL1946170	REGORAFENIB
FGFR2	fibroblast growth factor receptor 2	TTD	inhibitor	DAP001025	PENTOSAN POLYSULFATE
FGFR2	fibroblast growth factor receptor 2	TTD	binder	DAP000801	"INTERFERON ALFA-2A, RECOMBINANT"
FGFR2	fibroblast growth factor receptor 2	TTD	activator	DCL001020	TRAFERMIN
FGFR2	fibroblast growth factor receptor 2	TTD	inhibitor	DCL000361	AEE-788
FGFR2	fibroblast growth factor receptor 2	TTD	binder	DAP001026	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	TRAFERMIN	TRAFERMIN
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	CVBT-141B	CVBT-141B
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	THALIDOMIDE	THALIDOMIDE
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	PALIFERMIN	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	NINTEDANIB	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	CVBT-141H	CVBT-141H
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	ENMD-2076	ENMD-2076
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	ACTB1003	ACTB1003
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	ARQ 087	ARQ 087
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	PI-88	PI-88
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	FP-1039	FP-1039
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenomeClinicalTrial	inhibitor	REGORAFENIB	REGORAFENIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenomeClinicalTrial	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	MyCancerGenomeClinicalTrial	inhibitor	BGJ398	BGJ398
FGFR2	fibroblast growth factor receptor 2	MyCancerGenomeClinicalTrial	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	ClearityFoundationClinicalTrial	n/a	ENMD-2076	ENMD-2076
FGFR2	fibroblast growth factor receptor 2	ClearityFoundationClinicalTrial	n/a	NINTEDANIB	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	ClearityFoundationClinicalTrial	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	ClearityFoundationClinicalTrial	n/a	NINTEDANIB	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	VARGATEF	VARGATEF
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	XL999	XL999
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	TSU-68	TSU-68
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	BGJ398	BGJ398
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	REGORAFENIB	REGORAFENIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	LENVATINIB	LENVATINIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	XL228	XL228
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	BRIVANIB	BRIVANIB
FGFR2	fibroblast growth factor receptor 2	TALC	antibody	FP-1039	FP-1039
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	MASITINIB	MASITINIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	XL228	XL228
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	BGJ398	BGJ398
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	NINTEDANIB	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	E-3810	E-3810
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	CancerCommons	inhibitor	BGJ398	BGJ398
FGFR2	fibroblast growth factor receptor 2	GuideToPharmacologyInteractions	n/a	6954	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	GuideToPharmacologyInteractions	n/a	7707	AZD4547
FGFR2	fibroblast growth factor receptor 2	GuideToPharmacologyInteractions	n/a	7877	BGJ-398
FGFR2	fibroblast growth factor receptor 2	GuideToPharmacologyInteractions	n/a	5936	NINTEDANIB
NPY	neuropeptide Y	DrugBank	n/a	DB03380	L-TYROSINAMIDE
NPY	neuropeptide Y	DrugBank	n/a	DB02952	ALPHA-AMINOISOBUTYRIC ACID
GLUD1	glutamate dehydrogenase 1	DrugBank	n/a	DB00142	L-GLUTAMIC ACID
GLUD1	glutamate dehydrogenase 1	DrugBank	n/a	DB00157	NADH
GLUD1	glutamate dehydrogenase 1	DrugBank	inhibitor	DB00756	HEXACHLOROPHENE
GLUD1	glutamate dehydrogenase 1	DrugBank	n/a	DB04137	GUANOSINE-5-TRIPHOSPHATE	(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE#[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA-2,5-DIEN-1-YL]ACETONITRILE@ATORVASTATIN#ROSUVASTATIN@LITHIUM@PF-4523655@RONTALIZUMAB@MARIMASTAT@UROKINASE#TRANEXAMIC ACID#STREPTOKINASE#ALTEPLASE#RETEPLASE#ANISTREPLASE#AMINOCAPROIC ACID#TENECTEPLASE#BICINE#DESMOTEPLASE#APROTININ#ANTITHROMBIN#DESMOTEPLASE#AMEDIPLASE#ANISTREPLASE#ALTEPLASE#PLASMIN#UROKINASE#RETEPLASE#TRANEXAMIC ACID#AMINOCAPROIC ACID#TENECTEPLASE#UROKINASE#STREPTOKINASE#AMINOCAPROIC ACID#ANISTREPLASE#TENECTEPLASE#ALTEPLASE#UROKINASE#RETEPLASE#TRANEXAMIC ACID#STREPTOKINASE#RETEPLASE#ALTEPLASE#AMINOCAPROIC ACID#UROKINASE#RETEPLASE#TENECTEPLASE#STREPTOKINASE#TENECTEPLASE#UROKINASE#ALTEPLASE#TRANEXAMIC ACID#AMINOCAPROIC ACID#APROTININ#RETEPLASE#STREPTOKINASE#ANISTREPLASE#6-AMINOCAPROIC ACID#APROTININ#TRANEXAMIC ACID#BIS-TRIAZOLE DERIVATIVE 10@SPHINGOSINE 1-PHOSPHATE#PHYTOSPHINGOSINE 1-PHOSPHATE#COMPOUND 26 [PMID:16190743]#DIHYDROSP​HINGOSINE​-1-PHOSPH​ATE#VPC03090-P#VPC03090-P#SPHINGOSINE 1-PHOSPHATE#AFD(R)#FTY720-PHOSPHATE@ANTIPSYCHOTICS@[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}AMINO)PHENYL]ACETONITRILE#1-CYCLOBUTYL-3-(3,4-DIMETHOXYPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE#1-CYCLOPENTYL-3-(1H-PYRROLO[2,3-B]PYRIDIN-5-YL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE#1-(1-METHYLETHYL)-3-QUINOLIN-6-YL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE#2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE#N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE#(2E)-N-{4-[(3-BROMOPHENYL)AMINO]QUINAZOLIN-6-YL}-4-(DIMETHYLAMINO)BUT-2-ENAMIDE#3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL#RU78300#PONATINIB#RU82197#DPI59#N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE#NINTEDANIB#PHENYLPHOSPHATE#RU84687#1-[1-(3-AMINOPHENYL)-3-TERT-BUTYL-1H-PYRAZOL-5-YL]-3-PHENYLUREA#1-[1-(3-AMINOPHENYL)-3-TERT-BUTYL-1H-PYRAZOL-5-YL]-3-NAPHTHALEN-1-YLUREA#RU79073#RU79256#N6-BENZYL ADENOSINE-5-DIPHOSPHATE
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB01908	RU85493
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	multitarget	DB01254	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB01947	RU78262
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB01962	PHOSPHONOTYROSINE
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02175	MALONIC ACID
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02336	RU83876
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02432	RU90395
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02762	RU79072
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02908	RU78783
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03591	RU82209
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03628	ISO24
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03712	RU85053
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03023	"1-TERT-BUTYL-3-(4-CHLORO-PHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-YLAMINE"
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03828	RU78299
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03902	OXALIC ACID
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04080	RU78191
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	inhibitor	DB06616	BOSUTINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04272	CITRIC ACID
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03078	PASBN
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03104	RU82129
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03114	PAS219
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04495	RU81843
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04739	4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04751	PURVALANOL A
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB05184	XL228
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	GuideToPharmacologyInteractions	n/a	7731	SARACATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	GuideToPharmacologyInteractions	n/a	6048	SYK INHIBITOR III
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	GuideToPharmacologyInteractions	n/a	5976	GSK-3 INHIBITOR XIII
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	GuideToPharmacologyInteractions	n/a	6044	SU6656
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	ENMD-2076	ENMD-2076
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	DASATINIB	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	XL228	XL228
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	PONATINIB	PONATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	MASITINIB	MASITINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	KX2-391	KX2-391
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	BOSUTINIB	BOSUTINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	ChEMBL	inhibitor	CHEMBL24828	VANDETANIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	ChEMBL	inhibitor	CHEMBL288441	BOSUTINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TEND	n/a	DASATINIB	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	MyCancerGenome	inhibitor	KX2-391	KX2-391
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	MyCancerGenome	inhibitor	XL228	XL228
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	MyCancerGenome	inhibitor	SARACATINIB	SARACATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	CancerCommons	inhibitor	DASATINIB	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	XL228	XL228
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	DASATINIB	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	XL999	XL999
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	BOSUTINIB	BOSUTINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	KX2-391	KX2-391
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	SARACATINIB	SARACATINIB
SCPEP1	serine carboxypeptidase 1	DrugBank	n/a	DB07506	L-BENZYLSUCCINIC ACID
MMP24	matrix metallopeptidase 24 (membrane-inserted)	DrugBank	inhibitor	DB00786	MARIMASTAT
CCHCR1	coiled-coil alpha-helical rod protein 1	PharmGKB	n/a	PA450616	NEVIRAPINE
CCHCR1	coiled-coil alpha-helical rod protein 1	PharmGKB	n/a	PA448320	ALLOPURINOL
FGFR2	fibroblast growth factor receptor 2	DrugBank	antagonist	DB01041	THALIDOMIDE
FGFR2	fibroblast growth factor receptor 2	DrugBank	inhibitor	DB08901	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DrugBank	binder	DB00039	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	DrugBank	inhibitor	DB09078	LENVATINIB
FGFR2	fibroblast growth factor receptor 2	DrugBank	inhibitor	DB09079	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	DrugBank	n/a	DB02058	SU4984
FGFR2	fibroblast growth factor receptor 2	DrugBank	n/a	DB02491	4-[4-(1-AMINO-1-METHYLETHYL)PHENYL]-5-CHLORO-N-[4-(2-MORPHOLIN-4-YLETHYL)PHENYL]PYRIMIDIN-2-AMINE
FGFR2	fibroblast growth factor receptor 2	DrugBank	inhibitor	DB08896	REGORAFENIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PAZOPANIB	PAZOPANIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	TEND	n/a	PALIFERMIN	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	TEND	n/a	THALIDOMIDE	THALIDOMIDE
FGFR2	fibroblast growth factor receptor 2	ChEMBL	agonist	CHEMBL1201821	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	ChEMBL	inhibitor	CHEMBL1946170	REGORAFENIB
FGFR2	fibroblast growth factor receptor 2	TTD	inhibitor	DAP001025	PENTOSAN POLYSULFATE
FGFR2	fibroblast growth factor receptor 2	TTD	binder	DAP000801	"INTERFERON ALFA-2A, RECOMBINANT"
FGFR2	fibroblast growth factor receptor 2	TTD	activator	DCL001020	TRAFERMIN
FGFR2	fibroblast growth factor receptor 2	TTD	inhibitor	DCL000361	AEE-788
FGFR2	fibroblast growth factor receptor 2	TTD	binder	DAP001026	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	TRAFERMIN	TRAFERMIN
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	CVBT-141B	CVBT-141B
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	THALIDOMIDE	THALIDOMIDE
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	PALIFERMIN	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	NINTEDANIB	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	CVBT-141H	CVBT-141H
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	ENMD-2076	ENMD-2076
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	ACTB1003	ACTB1003
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	ARQ 087	ARQ 087
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	PI-88	PI-88
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	FP-1039	FP-1039
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenomeClinicalTrial	inhibitor	REGORAFENIB	REGORAFENIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenomeClinicalTrial	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	MyCancerGenomeClinicalTrial	inhibitor	BGJ398	BGJ398
FGFR2	fibroblast growth factor receptor 2	MyCancerGenomeClinicalTrial	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	ClearityFoundationClinicalTrial	n/a	ENMD-2076	ENMD-2076
FGFR2	fibroblast growth factor receptor 2	ClearityFoundationClinicalTrial	n/a	NINTEDANIB	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	ClearityFoundationClinicalTrial	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	ClearityFoundationClinicalTrial	n/a	NINTEDANIB	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	VARGATEF	VARGATEF
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	XL999	XL999
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	TSU-68	TSU-68
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	BGJ398	BGJ398
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	REGORAFENIB	REGORAFENIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	LENVATINIB	LENVATINIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	XL228	XL228
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	BRIVANIB	BRIVANIB
FGFR2	fibroblast growth factor receptor 2	TALC	antibody	FP-1039	FP-1039
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	MASITINIB	MASITINIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	XL228	XL228
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	BGJ398	BGJ398
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	NINTEDANIB	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	E-3810	E-3810
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	CancerCommons	inhibitor	BGJ398	BGJ398
FGFR2	fibroblast growth factor receptor 2	GuideToPharmacologyInteractions	n/a	6954	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	GuideToPharmacologyInteractions	n/a	7707	AZD4547
FGFR2	fibroblast growth factor receptor 2	GuideToPharmacologyInteractions	n/a	7877	BGJ-398
FGFR2	fibroblast growth factor receptor 2	GuideToPharmacologyInteractions	n/a	5936	NINTEDANIB
NPY	neuropeptide Y	DrugBank	n/a	DB03380	L-TYROSINAMIDE
NPY	neuropeptide Y	DrugBank	n/a	DB02952	ALPHA-AMINOISOBUTYRIC ACID
GLUD1	glutamate dehydrogenase 1	DrugBank	n/a	DB00142	L-GLUTAMIC ACID
GLUD1	glutamate dehydrogenase 1	DrugBank	n/a	DB00157	NADH
GLUD1	glutamate dehydrogenase 1	DrugBank	inhibitor	DB00756	HEXACHLOROPHENE
GLUD1	glutamate dehydrogenase 1	DrugBank	n/a	DB04137	GUANOSINE-5-TRIPHOSPHATE	(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE#[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA-2,5-DIEN-1-YL]ACETONITRILE@ATORVASTATIN#ROSUVASTATIN@PF-4523655@7&BETA;-HYDROXYCHOLESTEROL#27-HYDROXYCHOLESTEROL#7&ALPHA;,25-DIHYDROXYCHOLESTEROL#7&ALPHA;,25-DIHYDROXYCHOLESTEROL#7&ALPHA;-HYDROXYCHOLESTEROL#7&BETA;, 25-DIHYDROXYCHOLESTEROL#7&BETA;, 27-DIHYDROXYCHOLESTEROL#25-HYDROXYCHOLESTEROL#7&ALPHA;,27-DIHYDROXYCHOLESTEROL@UROKINASE#TRANEXAMIC ACID#STREPTOKINASE#ALTEPLASE#RETEPLASE#ANISTREPLASE#AMINOCAPROIC ACID#TENECTEPLASE#BICINE#DESMOTEPLASE#APROTININ#ANTITHROMBIN#DESMOTEPLASE#AMEDIPLASE#ANISTREPLASE#ALTEPLASE#PLASMIN#UROKINASE#RETEPLASE#TRANEXAMIC ACID#AMINOCAPROIC ACID#TENECTEPLASE#UROKINASE#STREPTOKINASE#AMINOCAPROIC ACID#ANISTREPLASE#TENECTEPLASE#ALTEPLASE#UROKINASE#RETEPLASE#TRANEXAMIC ACID#STREPTOKINASE#RETEPLASE#ALTEPLASE#AMINOCAPROIC ACID#UROKINASE#RETEPLASE#TENECTEPLASE#STREPTOKINASE#TENECTEPLASE#UROKINASE#ALTEPLASE#TRANEXAMIC ACID#AMINOCAPROIC ACID#APROTININ#RETEPLASE#STREPTOKINASE#ANISTREPLASE#6-AMINOCAPROIC ACID#APROTININ#TRANEXAMIC ACID#BIS-TRIAZOLE DERIVATIVE 10@SPHINGOSINE 1-PHOSPHATE#PHYTOSPHINGOSINE 1-PHOSPHATE#COMPOUND 26 [PMID:16190743]#DIHYDROSP​HINGOSINE​-1-PHOSPH​ATE#VPC03090-P#VPC03090-P#SPHINGOSINE 1-PHOSPHATE#AFD(R)#FTY720-PHOSPHATE@OLESOXIME#DIHYDROXYALUMINIUM#PRLX 93936#PRLX 93936
drugs_in_module3	MDX-1105#MPDL3280A#MDX-1105#MPDL3280A#RG7446@IRON DEXTRAN@RILUZOLE@PSEUDOEPHEDRINE	FORMIC ACID@N-[O-PHOSPHONO-PYRIDOXYL]-ISOLEUCINE#ALPHA-KETOISOVALERATE#L-LEUCINE#L-GLUTAMIC ACID@MDX-1105#MPDL3280A#MDX-1105#MPDL3280A#RG7446@CITRIC ACID#ASPARTATE BERYLLIUM TRIFLUORIDE@METHYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE#N-({(2S,3S)-3-[(BENZYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINE#N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE#N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE#2-AMINOETHANIMIDIC ACID#DIPHENYLACETIC ACID#BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE#3-AMINO-4-OXYBENZYL-2-BUTANONE#N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO-2-METHYL-BUTANE#3-METHYLPHENYLALANINE#N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-#N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCINE#N-(3-PROPYLCARBAMOYLOXIRANE-2-CARBONYL)-ISOLEUCYL-PROLINE#2-PYRIDINETHIOL#Z-ARG-LEU-VAL-AGLY-ILE-VAL-OME@L-CITRULLINE@DYSTROPHIN#PRO044@[<SUP>3</SUP>H]CPP#LY233053#L689560#GV196771A#(<I>RS</I>)-(TETRAZOL-5-YL)GLYCINE#D-SERINE#CONANTOKIN-G#L701324#NMDA#L-ASPARTATE#SELFOTEL#D-ASPARTATE#[<SUP>3</SUP>H]CGS19755#[<SUP>3</SUP>H]CGP39653#D-AP5#CGP37849#5,7-DICHLOROKYNURENIC ACID#[<SUP>3</SUP>H]CGP61594#PHENCYCLIDINE#UBP141#[<SUP>3</SUP>H]L689560#GLYCINE#[<SUP>3</SUP>H]MDL105519#AMANTIDINE#N<SUP>1</SUP>-DANSYL-SPERMINE#KETAMINE#DIZOCILPINE#MG<SUP>2+</SUP>#D-CCPENE#[<SUP>3</SUP>H]DIZOCILPINE#[<SUP>3</SUP>H]GLYCINE#HOMOQUINOLINIC ACID#CNS-5161#DIMIRACETAM#AZD-6765#LATREPIRDINE#ORPHENADRINE#V3381#DEXANABINOL#AM-101#NEU-2000#ORPHENADRINE#L-GLUTAMIC ACID#PETHIDINE#ORPHENADRINE#TENOCYCLIDINE#ACETYLCYSTEINE@L-GLUTAMIC ACID#(1<I>S</I>,3<I>R</I>)-ACPD#L-GLUTAMIC ACID#D-AP4#L-CCG-I#L-AP4#MPPG#LY341495#L-SERINE-O-PHOSPHATE#DCG-IV#AZ12216052#[<SUP>3</SUP>H]AP4#(<I>S</I>)-3,4-DCPG#EGLUMEGAD#(<I>R,S</I>)-4-PPG@PEG-INTERFERON LAMBA#IFN-&LAMBDA;3#IFN-&LAMBDA;2#IFN-&LAMBDA;1@PF-00547659@PSEUDOEPHEDRINE@N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE@PYRIDOXAL#N6-METHYL-(R)-ROSCOVITINE, R-2-[6-(BENZYL-METHYL-AMINO)-9-ISOPROPYL-9H-PURIN-2-YLAMINO]-BUTAN-1-OL#PYRIDOXINE#O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL#ADENOSINE-5'-[BETA, GAMMA-METHYLENE]TRIPHOSPHATE@CITRIC ACID@2,6,8-TRIMETHYL-3-AMINO-9-BENZYL-9-METHOXYNONANOIC ACID#(2S,3S,4E,6E,8S,9S)-3-AMINO-9-METHOXY-2,6,8-TRIMETHYL-10-PHENYLDECA-4,6-DIENOIC ACID@ALPHA-HYDROXY-BETA-PHENYL-PROPIONIC ACID#ANISOMYCIN#PUROMYCIN@[<SUP>14</SUP>C]ASCORBIC ACID#URSODEOXYCHOLIC ACID@R-788#R788#R343#PACLITAXEL#N-(2-HYDROXY-1,1-DIMETHYLETHYL)-1-METHYL-3-(1H-PYRROLO[2,3-B]PYRIDIN-2-YL)-1H-INDOLE-5-CARBOXAMIDE#2-{[(1R,2S)-2-AMINOCYCLOHEXYL]AMINO}-4-[(3-METHYLPHENYL)AMINO]PYRIMIDINE-5-CARBOXAMIDE#STAUROSPORINE#ELLAGIC ACID#6-({5-FLUORO-2-[(3,4,5-TRIMETHOXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-2,2-DIMETHYL-2H-PYRIDO[3,2-B][1,4]OXAZIN-3(4H)-ONE#2-{2-[(3,5-DIMETHYLPHENYL)AMINO]PYRIMIDIN-4-YL}-N-[(1S)-2-HYDROXY-1-METHYLETHYL]-4-METHYL-1,3-THIAZOLE-5-CARBOXAMIDE#FOSTAMATINIB#PRT062607#ACU-XSP-001#R343#FOSTAMATINIB#SYK INHIBITOR#SYK INHIBITOR II#SYK INHIBITOR III#TAMATINIB@CYT-6091#ETANERCEPT#TUMOUR NECROSIS FACTOR MEMBRANE FORM#LYMPHOTOXIN-&ALPHA;	FORMIC ACID@GDC-0152#AZD5582#AT-406#SM-337#LCL161#GDC0917#AT-406#TL 32711#AEG40826#HGS1029@CONATUMUMAB#EMRICASAN#Z-IETD-FMK@MDX-1105#MPDL3280A#MDX-1105#MPDL3280A#RG7446@PREDNISONE#MELPHALAN#IPILIMUMAB#TREMELIMUMAB#IPILIMUMAB#IPILIMUMAB#TREMELIMUMAB#IPILIMUMAB#IPILIMUMAB#TREMELIMUMAB#IPILIMUMAB#TREMELIMUMAB#IPILIMUMAB#IPILIMUMAB#CP-675206#IPILIMUMAB@IRON DEXTRAN@PEG-INTERFERON LAMBA#IFN-&LAMBDA;3#IFN-&LAMBDA;2#IFN-&LAMBDA;1@RILUZOLE@N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE@PYRIDOXAL#N6-METHYL-(R)-ROSCOVITINE, R-2-[6-(BENZYL-METHYL-AMINO)-9-ISOPROPYL-9H-PURIN-2-YLAMINO]-BUTAN-1-OL#PYRIDOXINE#O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL#ADENOSINE-5'-[BETA, GAMMA-METHYLENE]TRIPHOSPHATE@2,6,8-TRIMETHYL-3-AMINO-9-BENZYL-9-METHOXYNONANOIC ACID#(2S,3S,4E,6E,8S,9S)-3-AMINO-9-METHOXY-2,6,8-TRIMETHYL-10-PHENYLDECA-4,6-DIENOIC ACID@N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE#(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE#CARFILZOMIB#BORTEZOMIB@R-788#R788#R343#PACLITAXEL#N-(2-HYDROXY-1,1-DIMETHYLETHYL)-1-METHYL-3-(1H-PYRROLO[2,3-B]PYRIDIN-2-YL)-1H-INDOLE-5-CARBOXAMIDE#2-{[(1R,2S)-2-AMINOCYCLOHEXYL]AMINO}-4-[(3-METHYLPHENYL)AMINO]PYRIMIDINE-5-CARBOXAMIDE#STAUROSPORINE#ELLAGIC ACID#6-({5-FLUORO-2-[(3,4,5-TRIMETHOXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-2,2-DIMETHYL-2H-PYRIDO[3,2-B][1,4]OXAZIN-3(4H)-ONE#2-{2-[(3,5-DIMETHYLPHENYL)AMINO]PYRIMIDIN-4-YL}-N-[(1S)-2-HYDROXY-1-METHYLETHYL]-4-METHYL-1,3-THIAZOLE-5-CARBOXAMIDE#FOSTAMATINIB#PRT062607#ACU-XSP-001#R343#FOSTAMATINIB#SYK INHIBITOR#SYK INHIBITOR II#SYK INHIBITOR III#TAMATINIB@DV1179#ANA773#AZD-8848#HYDROXYCHLOROQUINE#IMO-3100#IMIQUIMOD#CPG 52364#IMIQUIMOD#HYDROXYCHLOROQUINE SULFATE#DOCOSANOL#ANA773#HYDROXYCHLOROQUINE#IMO-3100#ISATORIBINE#RESIQUIMOD#CPG 52364#IMIQUIMOD#IMIQUIMOD#HYDROXYCHLOROQUINE#ANA971#SCV-07#ISATORIBINE#RESIQUIMOD#IMIQUIMOD#LOXORIBINE#HYDROXYCHLOROQUINE#IMIQUIMOD@CYT-6091#ETANERCEPT#TUMOUR NECROSIS FACTOR MEMBRANE FORM#LYMPHOTOXIN-&ALPHA;@HYALURONAN	L-CITRULLINE@BUPROPION#NICOTINE@R-788#R788#R343#PACLITAXEL#N-(2-HYDROXY-1,1-DIMETHYLETHYL)-1-METHYL-3-(1H-PYRROLO[2,3-B]PYRIDIN-2-YL)-1H-INDOLE-5-CARBOXAMIDE#2-{[(1R,2S)-2-AMINOCYCLOHEXYL]AMINO}-4-[(3-METHYLPHENYL)AMINO]PYRIMIDINE-5-CARBOXAMIDE#STAUROSPORINE#ELLAGIC ACID#6-({5-FLUORO-2-[(3,4,5-TRIMETHOXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-2,2-DIMETHYL-2H-PYRIDO[3,2-B][1,4]OXAZIN-3(4H)-ONE#2-{2-[(3,5-DIMETHYLPHENYL)AMINO]PYRIMIDIN-4-YL}-N-[(1S)-2-HYDROXY-1-METHYLETHYL]-4-METHYL-1,3-THIAZOLE-5-CARBOXAMIDE#FOSTAMATINIB#PRT062607#ACU-XSP-001#R343#FOSTAMATINIB#SYK INHIBITOR#SYK INHIBITOR II#SYK INHIBITOR III#TAMATINIB	NA	NA	FORMIC ACID@CITRIC ACID#ASPARTATE BERYLLIUM TRIFLUORIDE@L-CITRULLINE@DYSTROPHIN#PRO044@IRON DEXTRAN@L-GLUTAMIC ACID#(1<I>S</I>,3<I>R</I>)-ACPD#L-GLUTAMIC ACID#D-AP4#L-CCG-I#L-AP4#MPPG#LY341495#L-SERINE-O-PHOSPHATE#DCG-IV#AZ12216052#[<SUP>3</SUP>H]AP4#(<I>S</I>)-3,4-DCPG#EGLUMEGAD#(<I>R,S</I>)-4-PPG@CYT-6091#ETANERCEPT#TUMOUR NECROSIS FACTOR MEMBRANE FORM#LYMPHOTOXIN-&ALPHA;	FORMIC ACID@N-[O-PHOSPHONO-PYRIDOXYL]-ISOLEUCINE#ALPHA-KETOISOVALERATE#L-LEUCINE#L-GLUTAMIC ACID@GDC-0152#AZD5582#AT-406#SM-337#LCL161#GDC0917#AT-406#TL 32711#AEG40826#HGS1029@CONATUMUMAB#EMRICASAN#Z-IETD-FMK@MDX-1105#MPDL3280A#MDX-1105#MPDL3280A#RG7446@BUPROPION#NICOTINE@IRON DEXTRAN@L-GLUTAMIC ACID#(1<I>S</I>,3<I>R</I>)-ACPD#L-GLUTAMIC ACID#D-AP4#L-CCG-I#L-AP4#MPPG#LY341495#L-SERINE-O-PHOSPHATE#DCG-IV#AZ12216052#[<SUP>3</SUP>H]AP4#(<I>S</I>)-3,4-DCPG#EGLUMEGAD#(<I>R,S</I>)-4-PPG@PEG-INTERFERON LAMBA#IFN-&LAMBDA;3#IFN-&LAMBDA;2#IFN-&LAMBDA;1@RILUZOLE@PF-00547659@NADH#2-MONOPHOSPHOADENOSINE 5-DIPHOSPHORIBOSE@PSEUDOEPHEDRINE@N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE@N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE#(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE#CARFILZOMIB#BORTEZOMIB@ISIS 113715#TRODUSQUEMINE#TILUDRONATE#1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE#5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID#4-[3-(DIBENZYLAMINO)PHENYL]-2,4-DIOXOBUTANOIC ACID#5-(3-HYDROXYPHENYL)ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDE#N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE#ISOTHIAZOLIDINONE ANALOG#COMPOUND 12, N-ACETYL-4-[(CARBOXYCARBONYL)(2-CARBOXYPHENYL)AMINO]-N-PENTYL-1-NAPTHYLALANIAMIDE#DOUBLE OXIDIZED CYSTEINE#TILUDRONATE#6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID#PARA-(BENZOYL)-PHENYLALANINE#COMPOUND 9#(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER#5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE#2-(OXALYL-AMINO)-4,7-DIHYDRO-5H-THIENO[2,3-C]THIOPYRAN-3-CARBOXYLIC ACID#3(R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER#(4-{(2S)-2-[(TERT-BUTOXYCARBONYL)AMINO]-3-METHOXY-3-OXOPROPYL}PHENYL)METHANESELENINIC ACID#3-(3,5-DIBROMO-4-HYDROXY-BENZOYL)-2-ETHYL-BENZOFURAN-6-SULFONIC ACID (4-SULFAMOYL-PHENYL)-AMIDE#4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN#3-(OXALYL-AMINO)-NAPHTHALENE-2-CARBOXYLIC ACID#[[4-(AMINOMETHYL)PHENYL]AMINO]OXO-ACETIC ACID,#2-{4-[(2S)-2-[({[(1S)-1-CARBOXY-2-PHENYLETHYL]AMINO}CARBONYL)AMINO]-3-OXO-3-(PENTYLAMINO)PROPYL]PHENOXY}MALONIC ACID#COMPOUND 19#SP7343-SP7964#2-(OXALYL-AMINO)-BENZOIC ACID#{[2-(1H-1,2,3-BENZOTRIAZOL-1-YL)-2-(3,4-DIFLUOROPHENYL)PROPANE-1,3-DIYL]BIS[4,1-PHENYLENE(DIFLUOROMETHYLENE)]}BIS(PHOSPHONIC ACID)#NOVO NORDISK A/S COMPOUND#N-[4-(2-{2-[3-(2-BROMO-ACETYLAMINO)-PROPIONYLAMINO]-3-HYDROXY-PROPIONYLAMINO}-ETHYL)-PHENYL]-OXALAMIC ACID#3-(3,5-DIBROMO-4-HYDROXY-BENZOYL)-2-ETHYL-BENZOFURAN-6-SULFONIC ACID [4-(THIAZOL-2-YLSULFAMOYL)-PHENYL]-AMIDE#7-(1,1-DIOXO-1H-BENZO[D]ISOTHIAZOL-3-YLOXYMETHYL)-2-(OXALYL-AMINO)-4,7-DIHYDRO-5H-THIENO[2,3-C]PYRAN-3-CARBOXYLIC ACID#5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE#4-CARBAMOYL-4-{[6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBONYL]-AMINO}-BUTYRIC ACID#N-{1-[5-(1-CARBAMOYL-2-MERCAPTO-ETHYLCARBAMOYL)-PENTYLCARBAMOYL]-2-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-ETHYL}-3-{2-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-ACETYLAMINO}-SUCCINAMIC ACID#{4-[(2S,4E)-2-(1,3-BENZOTHIAZOL-2-YL)-2-(1H-1,2,3-BENZOTRIAZOL-1-YL)-5-PHENYLPENT-4-ENYL]PHENYL}(DIFLUORO)METHYLPHOSPHONIC ACID#4-BENZOYLAMINO-4-{1-{1-CARBAMOYL-2-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-ETHYLCARBAMOYL}-2-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-ETHYLCARBAMOYL}-BUTYRIC ACID#PNU177836#2-(OXALYL-AMINO)-4,7-DIHYDRO-5H-THIENO[2,3-C]PYRAN-3-CARBOXYLIC ACID#{[7-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALEN-2-YL]-DIFLUORO-METHYL}-PHOSPHONIC ACID#[(4-{4-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-BUTYL}-PHENYL)-DIFLUORO-METHYL]-PHOSPHONIC ACID#ISIS 113715#3-(CARBOXYMETHOXY)THIENO[2,3-B]PYRIDINE-2-CARBOXYLIC ACID#4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID#[{2-BROMO-4-[(2R)-3-OXO-2,3-DIPHENYLPROPYL]PHENYL}(DIFLUORO)METHYL]PHOSPHONIC ACID#3(S)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER#5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID#2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID#4-BROMO-3-(CARBOXYMETHOXY)-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID#4-BROMO-3-(CARBOXYMETHOXY)-5-(4-HYDROXYPHENYL)THIOPHENE-2-CARBOXYLIC ACID#3-(3,5-DIBROMO-4-HYDROXY-BENZOYL)-2-ETHYL-BENZOFURAN-6-SULFONIC ACID DIMETHYLAMIDE#CYSTEINESULFONIC ACID#2-(OXALYL-AMINO)-4,5,6,7-TETRAHYDRO-THIENO[2,3-C]PYRIDINE-3-CARBOXYLIC ACID#N-(ALLYLOXYCARBONYL)-4-[N-(CARBOXY-FORMYL)-2-(BENZOIC ACID)-AMINO]-L-PHENYLALANINYL-AMINO-BUTYLOXY-(6-HYDROXY-BENZOIC ACID METHYL ESTER)#COMPOUND 5, 2-(NAPHTHALEN-1-YL-OXALYL-AMINO)-BENZOICACID#6-(OXALYL-AMINO)-1H-INDOLE-5-CARBOXYLIC ACID#2-(CARBOXYMETHOXY)-5-[(2S)-2-({(2S)-2-[(3-CARBOXYPROPANOYL)AMINO] -3-PHENYLPROPANOYL}AMINO)-3-OXO-3-(PENTYLAMINO)PROPYL]BENZOIC ACID#1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID#TILUDRONATE#ISIS 113715#ISIS-PTP1B	BUPROPION#NICOTINE@IRON DEXTRAN
drugs_in_module4	NADH#2-MONOPHOSPHOADENOSINE 5-DIPHOSPHORIBOSE@N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE@PYRIDOXAL#N6-METHYL-(R)-ROSCOVITINE, R-2-[6-(BENZYL-METHYL-AMINO)-9-ISOPROPYL-9H-PURIN-2-YLAMINO]-BUTAN-1-OL#PYRIDOXINE#O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL#ADENOSINE-5'-[BETA, GAMMA-METHYLENE]TRIPHOSPHATE@N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE#(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE#CARFILZOMIB#BORTEZOMIB	(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE#[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA-2,5-DIEN-1-YL]ACETONITRILE@7&BETA;-HYDROXYCHOLESTEROL#27-HYDROXYCHOLESTEROL#7&ALPHA;,25-DIHYDROXYCHOLESTEROL#7&ALPHA;,25-DIHYDROXYCHOLESTEROL#7&ALPHA;-HYDROXYCHOLESTEROL#7&BETA;, 25-DIHYDROXYCHOLESTEROL#7&BETA;, 27-DIHYDROXYCHOLESTEROL#25-HYDROXYCHOLESTEROL#7&ALPHA;,27-DIHYDROXYCHOLESTEROL@RONTALIZUMAB@MARIMASTAT@SPHINGOSINE 1-PHOSPHATE#PHYTOSPHINGOSINE 1-PHOSPHATE#COMPOUND 26 [PMID:16190743]#DIHYDROSP​HINGOSINE​-1-PHOSPH​ATE#VPC03090-P#VPC03090-P#SPHINGOSINE 1-PHOSPHATE#AFD(R)#FTY720-PHOSPHATE@[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}AMINO)PHENYL]ACETONITRILE#1-CYCLOBUTYL-3-(3,4-DIMETHOXYPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE#1-CYCLOPENTYL-3-(1H-PYRROLO[2,3-B]PYRIDIN-5-YL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE#1-(1-METHYLETHYL)-3-QUINOLIN-6-YL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE#2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE#N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE#(2E)-N-{4-[(3-BROMOPHENYL)AMINO]QUINAZOLIN-6-YL}-4-(DIMETHYLAMINO)BUT-2-ENAMIDE#3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL#RU78300#PONATINIB#RU82197#DPI59#N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE#NINTEDANIB#PHENYLPHOSPHATE#RU84687#1-[1-(3-AMINOPHENYL)-3-TERT-BUTYL-1H-PYRAZOL-5-YL]-3-PHENYLUREA#1-[1-(3-AMINOPHENYL)-3-TERT-BUTYL-1H-PYRAZOL-5-YL]-3-NAPHTHALEN-1-YLUREA#RU79073#RU79256#N6-BENZYL ADENOSINE-5-DIPHOSPHATE
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB01908	RU85493
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	multitarget	DB01254	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB01947	RU78262
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB01962	PHOSPHONOTYROSINE
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02175	MALONIC ACID
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02336	RU83876
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02432	RU90395
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02762	RU79072
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02908	RU78783
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03591	RU82209
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03628	ISO24
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03712	RU85053
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03023	"1-TERT-BUTYL-3-(4-CHLORO-PHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-YLAMINE"
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03828	RU78299
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03902	OXALIC ACID
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04080	RU78191
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	inhibitor	DB06616	BOSUTINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04272	CITRIC ACID
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03078	PASBN
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03104	RU82129
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03114	PAS219
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04495	RU81843
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04739	4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04751	PURVALANOL A
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB05184	XL228
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	GuideToPharmacologyInteractions	n/a	7731	SARACATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	GuideToPharmacologyInteractions	n/a	6048	SYK INHIBITOR III
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	GuideToPharmacologyInteractions	n/a	5976	GSK-3 INHIBITOR XIII
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	GuideToPharmacologyInteractions	n/a	6044	SU6656
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	ENMD-2076	ENMD-2076
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	DASATINIB	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	XL228	XL228
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	PONATINIB	PONATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	MASITINIB	MASITINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	KX2-391	KX2-391
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	BOSUTINIB	BOSUTINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	ChEMBL	inhibitor	CHEMBL24828	VANDETANIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	ChEMBL	inhibitor	CHEMBL288441	BOSUTINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TEND	n/a	DASATINIB	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	MyCancerGenome	inhibitor	KX2-391	KX2-391
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	MyCancerGenome	inhibitor	XL228	XL228
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	MyCancerGenome	inhibitor	SARACATINIB	SARACATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	CancerCommons	inhibitor	DASATINIB	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	XL228	XL228
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	DASATINIB	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	XL999	XL999
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	BOSUTINIB	BOSUTINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	KX2-391	KX2-391
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	SARACATINIB	SARACATINIB
SCPEP1	serine carboxypeptidase 1	DrugBank	n/a	DB07506	L-BENZYLSUCCINIC ACID
MMP24	matrix metallopeptidase 24 (membrane-inserted)	DrugBank	inhibitor	DB00786	MARIMASTAT
CCHCR1	coiled-coil alpha-helical rod protein 1	PharmGKB	n/a	PA450616	NEVIRAPINE
CCHCR1	coiled-coil alpha-helical rod protein 1	PharmGKB	n/a	PA448320	ALLOPURINOL
FGFR2	fibroblast growth factor receptor 2	DrugBank	antagonist	DB01041	THALIDOMIDE
FGFR2	fibroblast growth factor receptor 2	DrugBank	inhibitor	DB08901	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DrugBank	binder	DB00039	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	DrugBank	inhibitor	DB09078	LENVATINIB
FGFR2	fibroblast growth factor receptor 2	DrugBank	inhibitor	DB09079	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	DrugBank	n/a	DB02058	SU4984
FGFR2	fibroblast growth factor receptor 2	DrugBank	n/a	DB02491	4-[4-(1-AMINO-1-METHYLETHYL)PHENYL]-5-CHLORO-N-[4-(2-MORPHOLIN-4-YLETHYL)PHENYL]PYRIMIDIN-2-AMINE
FGFR2	fibroblast growth factor receptor 2	DrugBank	inhibitor	DB08896	REGORAFENIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PAZOPANIB	PAZOPANIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	TEND	n/a	PALIFERMIN	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	TEND	n/a	THALIDOMIDE	THALIDOMIDE
FGFR2	fibroblast growth factor receptor 2	ChEMBL	agonist	CHEMBL1201821	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	ChEMBL	inhibitor	CHEMBL1946170	REGORAFENIB
FGFR2	fibroblast growth factor receptor 2	TTD	inhibitor	DAP001025	PENTOSAN POLYSULFATE
FGFR2	fibroblast growth factor receptor 2	TTD	binder	DAP000801	"INTERFERON ALFA-2A, RECOMBINANT"
FGFR2	fibroblast growth factor receptor 2	TTD	activator	DCL001020	TRAFERMIN
FGFR2	fibroblast growth factor receptor 2	TTD	inhibitor	DCL000361	AEE-788
FGFR2	fibroblast growth factor receptor 2	TTD	binder	DAP001026	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	TRAFERMIN	TRAFERMIN
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	CVBT-141B	CVBT-141B
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	THALIDOMIDE	THALIDOMIDE
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	PALIFERMIN	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	NINTEDANIB	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	CVBT-141H	CVBT-141H
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	ENMD-2076	ENMD-2076
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	ACTB1003	ACTB1003
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	ARQ 087	ARQ 087
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	PI-88	PI-88
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	FP-1039	FP-1039
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenomeClinicalTrial	inhibitor	REGORAFENIB	REGORAFENIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenomeClinicalTrial	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	MyCancerGenomeClinicalTrial	inhibitor	BGJ398	BGJ398
FGFR2	fibroblast growth factor receptor 2	MyCancerGenomeClinicalTrial	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	ClearityFoundationClinicalTrial	n/a	ENMD-2076	ENMD-2076
FGFR2	fibroblast growth factor receptor 2	ClearityFoundationClinicalTrial	n/a	NINTEDANIB	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	ClearityFoundationClinicalTrial	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	ClearityFoundationClinicalTrial	n/a	NINTEDANIB	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	VARGATEF	VARGATEF
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	XL999	XL999
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	TSU-68	TSU-68
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	BGJ398	BGJ398
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	REGORAFENIB	REGORAFENIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	LENVATINIB	LENVATINIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	XL228	XL228
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	BRIVANIB	BRIVANIB
FGFR2	fibroblast growth factor receptor 2	TALC	antibody	FP-1039	FP-1039
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	MASITINIB	MASITINIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	XL228	XL228
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	BGJ398	BGJ398
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	NINTEDANIB	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	E-3810	E-3810
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	CancerCommons	inhibitor	BGJ398	BGJ398
FGFR2	fibroblast growth factor receptor 2	GuideToPharmacologyInteractions	n/a	6954	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	GuideToPharmacologyInteractions	n/a	7707	AZD4547
FGFR2	fibroblast growth factor receptor 2	GuideToPharmacologyInteractions	n/a	7877	BGJ-398
FGFR2	fibroblast growth factor receptor 2	GuideToPharmacologyInteractions	n/a	5936	NINTEDANIB
NPY	neuropeptide Y	DrugBank	n/a	DB03380	L-TYROSINAMIDE
NPY	neuropeptide Y	DrugBank	n/a	DB02952	ALPHA-AMINOISOBUTYRIC ACID
GLUD1	glutamate dehydrogenase 1	DrugBank	n/a	DB00142	L-GLUTAMIC ACID
GLUD1	glutamate dehydrogenase 1	DrugBank	n/a	DB00157	NADH
GLUD1	glutamate dehydrogenase 1	DrugBank	inhibitor	DB00756	HEXACHLOROPHENE
GLUD1	glutamate dehydrogenase 1	DrugBank	n/a	DB04137	GUANOSINE-5-TRIPHOSPHATE@OLESOXIME#DIHYDROXYALUMINIUM#PRLX 93936#PRLX 93936	DROTRECOGIN ALFA@DYSTROPHIN#PRO044@ETHANOLAMINE OLEATE#ANTITHROMBIN#METHYL 5-[(4-TERT-BUTYLBENZOYL)AMINO]-2H-1,2,4-TRIAZOLE-3-CARBOXYLATE	FORMIC ACID@N-[O-PHOSPHONO-PYRIDOXYL]-ISOLEUCINE#ALPHA-KETOISOVALERATE#L-LEUCINE#L-GLUTAMIC ACID@MDX-1105#MPDL3280A#MDX-1105#MPDL3280A#RG7446@CITRIC ACID#ASPARTATE BERYLLIUM TRIFLUORIDE@IRON DEXTRAN@[<SUP>3</SUP>H]CPP#LY233053#L689560#GV196771A#(<I>RS</I>)-(TETRAZOL-5-YL)GLYCINE#D-SERINE#CONANTOKIN-G#L701324#NMDA#L-ASPARTATE#SELFOTEL#D-ASPARTATE#[<SUP>3</SUP>H]CGS19755#[<SUP>3</SUP>H]CGP39653#D-AP5#CGP37849#5,7-DICHLOROKYNURENIC ACID#[<SUP>3</SUP>H]CGP61594#PHENCYCLIDINE#UBP141#[<SUP>3</SUP>H]L689560#GLYCINE#[<SUP>3</SUP>H]MDL105519#AMANTIDINE#N<SUP>1</SUP>-DANSYL-SPERMINE#KETAMINE#DIZOCILPINE#MG<SUP>2+</SUP>#D-CCPENE#[<SUP>3</SUP>H]DIZOCILPINE#[<SUP>3</SUP>H]GLYCINE#HOMOQUINOLINIC ACID#CNS-5161#DIMIRACETAM#AZD-6765#LATREPIRDINE#ORPHENADRINE#V3381#DEXANABINOL#AM-101#NEU-2000#ORPHENADRINE#L-GLUTAMIC ACID#PETHIDINE#ORPHENADRINE#TENOCYCLIDINE#ACETYLCYSTEINE@PEG-INTERFERON LAMBA#IFN-&LAMBDA;3#IFN-&LAMBDA;2#IFN-&LAMBDA;1@RILUZOLE@PF-00547659@2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE#2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE@NADH#2-MONOPHOSPHOADENOSINE 5-DIPHOSPHORIBOSE@N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE@PYRIDOXAL#N6-METHYL-(R)-ROSCOVITINE, R-2-[6-(BENZYL-METHYL-AMINO)-9-ISOPROPYL-9H-PURIN-2-YLAMINO]-BUTAN-1-OL#PYRIDOXINE#O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL#ADENOSINE-5'-[BETA, GAMMA-METHYLENE]TRIPHOSPHATE@CITRIC ACID@2,6,8-TRIMETHYL-3-AMINO-9-BENZYL-9-METHOXYNONANOIC ACID#(2S,3S,4E,6E,8S,9S)-3-AMINO-9-METHOXY-2,6,8-TRIMETHYL-10-PHENYLDECA-4,6-DIENOIC ACID@N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE#(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE#CARFILZOMIB#BORTEZOMIB@ISIS 113715#TRODUSQUEMINE#TILUDRONATE#1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE#5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID#4-[3-(DIBENZYLAMINO)PHENYL]-2,4-DIOXOBUTANOIC ACID#5-(3-HYDROXYPHENYL)ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDE#N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE#ISOTHIAZOLIDINONE ANALOG#COMPOUND 12, N-ACETYL-4-[(CARBOXYCARBONYL)(2-CARBOXYPHENYL)AMINO]-N-PENTYL-1-NAPTHYLALANIAMIDE#DOUBLE OXIDIZED CYSTEINE#TILUDRONATE#6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID#PARA-(BENZOYL)-PHENYLALANINE#COMPOUND 9#(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER#5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE#2-(OXALYL-AMINO)-4,7-DIHYDRO-5H-THIENO[2,3-C]THIOPYRAN-3-CARBOXYLIC ACID#3(R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER#(4-{(2S)-2-[(TERT-BUTOXYCARBONYL)AMINO]-3-METHOXY-3-OXOPROPYL}PHENYL)METHANESELENINIC ACID#3-(3,5-DIBROMO-4-HYDROXY-BENZOYL)-2-ETHYL-BENZOFURAN-6-SULFONIC ACID (4-SULFAMOYL-PHENYL)-AMIDE#4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN#3-(OXALYL-AMINO)-NAPHTHALENE-2-CARBOXYLIC ACID#[[4-(AMINOMETHYL)PHENYL]AMINO]OXO-ACETIC ACID,#2-{4-[(2S)-2-[({[(1S)-1-CARBOXY-2-PHENYLETHYL]AMINO}CARBONYL)AMINO]-3-OXO-3-(PENTYLAMINO)PROPYL]PHENOXY}MALONIC ACID#COMPOUND 19#SP7343-SP7964#2-(OXALYL-AMINO)-BENZOIC ACID#{[2-(1H-1,2,3-BENZOTRIAZOL-1-YL)-2-(3,4-DIFLUOROPHENYL)PROPANE-1,3-DIYL]BIS[4,1-PHENYLENE(DIFLUOROMETHYLENE)]}BIS(PHOSPHONIC ACID)#NOVO NORDISK A/S COMPOUND#N-[4-(2-{2-[3-(2-BROMO-ACETYLAMINO)-PROPIONYLAMINO]-3-HYDROXY-PROPIONYLAMINO}-ETHYL)-PHENYL]-OXALAMIC ACID#3-(3,5-DIBROMO-4-HYDROXY-BENZOYL)-2-ETHYL-BENZOFURAN-6-SULFONIC ACID [4-(THIAZOL-2-YLSULFAMOYL)-PHENYL]-AMIDE#7-(1,1-DIOXO-1H-BENZO[D]ISOTHIAZOL-3-YLOXYMETHYL)-2-(OXALYL-AMINO)-4,7-DIHYDRO-5H-THIENO[2,3-C]PYRAN-3-CARBOXYLIC ACID#5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE#4-CARBAMOYL-4-{[6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBONYL]-AMINO}-BUTYRIC ACID#N-{1-[5-(1-CARBAMOYL-2-MERCAPTO-ETHYLCARBAMOYL)-PENTYLCARBAMOYL]-2-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-ETHYL}-3-{2-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-ACETYLAMINO}-SUCCINAMIC ACID#{4-[(2S,4E)-2-(1,3-BENZOTHIAZOL-2-YL)-2-(1H-1,2,3-BENZOTRIAZOL-1-YL)-5-PHENYLPENT-4-ENYL]PHENYL}(DIFLUORO)METHYLPHOSPHONIC ACID#4-BENZOYLAMINO-4-{1-{1-CARBAMOYL-2-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-ETHYLCARBAMOYL}-2-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-ETHYLCARBAMOYL}-BUTYRIC ACID#PNU177836#2-(OXALYL-AMINO)-4,7-DIHYDRO-5H-THIENO[2,3-C]PYRAN-3-CARBOXYLIC ACID#{[7-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALEN-2-YL]-DIFLUORO-METHYL}-PHOSPHONIC ACID#[(4-{4-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-BUTYL}-PHENYL)-DIFLUORO-METHYL]-PHOSPHONIC ACID#ISIS 113715#3-(CARBOXYMETHOXY)THIENO[2,3-B]PYRIDINE-2-CARBOXYLIC ACID#4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID#[{2-BROMO-4-[(2R)-3-OXO-2,3-DIPHENYLPROPYL]PHENYL}(DIFLUORO)METHYL]PHOSPHONIC ACID#3(S)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER#5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID#2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID#4-BROMO-3-(CARBOXYMETHOXY)-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID#4-BROMO-3-(CARBOXYMETHOXY)-5-(4-HYDROXYPHENYL)THIOPHENE-2-CARBOXYLIC ACID#3-(3,5-DIBROMO-4-HYDROXY-BENZOYL)-2-ETHYL-BENZOFURAN-6-SULFONIC ACID DIMETHYLAMIDE#CYSTEINESULFONIC ACID#2-(OXALYL-AMINO)-4,5,6,7-TETRAHYDRO-THIENO[2,3-C]PYRIDINE-3-CARBOXYLIC ACID#N-(ALLYLOXYCARBONYL)-4-[N-(CARBOXY-FORMYL)-2-(BENZOIC ACID)-AMINO]-L-PHENYLALANINYL-AMINO-BUTYLOXY-(6-HYDROXY-BENZOIC ACID METHYL ESTER)#COMPOUND 5, 2-(NAPHTHALEN-1-YL-OXALYL-AMINO)-BENZOICACID#6-(OXALYL-AMINO)-1H-INDOLE-5-CARBOXYLIC ACID#2-(CARBOXYMETHOXY)-5-[(2S)-2-({(2S)-2-[(3-CARBOXYPROPANOYL)AMINO] -3-PHENYLPROPANOYL}AMINO)-3-OXO-3-(PENTYLAMINO)PROPYL]BENZOIC ACID#1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID#TILUDRONATE#ISIS 113715#ISIS-PTP1B@CYT-6091#ETANERCEPT#TUMOUR NECROSIS FACTOR MEMBRANE FORM#LYMPHOTOXIN-&ALPHA;	NA	CITRIC ACID	GDC-0152#AZD5582#AT-406#SM-337#LCL161#GDC0917#AT-406#TL 32711#AEG40826#HGS1029@[<SUP>3</SUP>H]CPP#LY233053#L689560#GV196771A#(<I>RS</I>)-(TETRAZOL-5-YL)GLYCINE#D-SERINE#CONANTOKIN-G#L701324#NMDA#L-ASPARTATE#SELFOTEL#D-ASPARTATE#[<SUP>3</SUP>H]CGS19755#[<SUP>3</SUP>H]CGP39653#D-AP5#CGP37849#5,7-DICHLOROKYNURENIC ACID#[<SUP>3</SUP>H]CGP61594#PHENCYCLIDINE#UBP141#[<SUP>3</SUP>H]L689560#GLYCINE#[<SUP>3</SUP>H]MDL105519#AMANTIDINE#N<SUP>1</SUP>-DANSYL-SPERMINE#KETAMINE#DIZOCILPINE#MG<SUP>2+</SUP>#D-CCPENE#[<SUP>3</SUP>H]DIZOCILPINE#[<SUP>3</SUP>H]GLYCINE#HOMOQUINOLINIC ACID#CNS-5161#DIMIRACETAM#AZD-6765#LATREPIRDINE#ORPHENADRINE#V3381#DEXANABINOL#AM-101#NEU-2000#ORPHENADRINE#L-GLUTAMIC ACID#PETHIDINE#ORPHENADRINE#TENOCYCLIDINE#ACETYLCYSTEINE@PYRIDOXAL#N6-METHYL-(R)-ROSCOVITINE, R-2-[6-(BENZYL-METHYL-AMINO)-9-ISOPROPYL-9H-PURIN-2-YLAMINO]-BUTAN-1-OL#PYRIDOXINE#O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL#ADENOSINE-5'-[BETA, GAMMA-METHYLENE]TRIPHOSPHATE@CITRIC ACID@ISIS 113715#TRODUSQUEMINE#TILUDRONATE#1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE#5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID#4-[3-(DIBENZYLAMINO)PHENYL]-2,4-DIOXOBUTANOIC ACID#5-(3-HYDROXYPHENYL)ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDE#N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE#ISOTHIAZOLIDINONE ANALOG#COMPOUND 12, N-ACETYL-4-[(CARBOXYCARBONYL)(2-CARBOXYPHENYL)AMINO]-N-PENTYL-1-NAPTHYLALANIAMIDE#DOUBLE OXIDIZED CYSTEINE#TILUDRONATE#6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID#PARA-(BENZOYL)-PHENYLALANINE#COMPOUND 9#(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER#5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE#2-(OXALYL-AMINO)-4,7-DIHYDRO-5H-THIENO[2,3-C]THIOPYRAN-3-CARBOXYLIC ACID#3(R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER#(4-{(2S)-2-[(TERT-BUTOXYCARBONYL)AMINO]-3-METHOXY-3-OXOPROPYL}PHENYL)METHANESELENINIC ACID#3-(3,5-DIBROMO-4-HYDROXY-BENZOYL)-2-ETHYL-BENZOFURAN-6-SULFONIC ACID (4-SULFAMOYL-PHENYL)-AMIDE#4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN#3-(OXALYL-AMINO)-NAPHTHALENE-2-CARBOXYLIC ACID#[[4-(AMINOMETHYL)PHENYL]AMINO]OXO-ACETIC ACID,#2-{4-[(2S)-2-[({[(1S)-1-CARBOXY-2-PHENYLETHYL]AMINO}CARBONYL)AMINO]-3-OXO-3-(PENTYLAMINO)PROPYL]PHENOXY}MALONIC ACID#COMPOUND 19#SP7343-SP7964#2-(OXALYL-AMINO)-BENZOIC ACID#{[2-(1H-1,2,3-BENZOTRIAZOL-1-YL)-2-(3,4-DIFLUOROPHENYL)PROPANE-1,3-DIYL]BIS[4,1-PHENYLENE(DIFLUOROMETHYLENE)]}BIS(PHOSPHONIC ACID)#NOVO NORDISK A/S COMPOUND#N-[4-(2-{2-[3-(2-BROMO-ACETYLAMINO)-PROPIONYLAMINO]-3-HYDROXY-PROPIONYLAMINO}-ETHYL)-PHENYL]-OXALAMIC ACID#3-(3,5-DIBROMO-4-HYDROXY-BENZOYL)-2-ETHYL-BENZOFURAN-6-SULFONIC ACID [4-(THIAZOL-2-YLSULFAMOYL)-PHENYL]-AMIDE#7-(1,1-DIOXO-1H-BENZO[D]ISOTHIAZOL-3-YLOXYMETHYL)-2-(OXALYL-AMINO)-4,7-DIHYDRO-5H-THIENO[2,3-C]PYRAN-3-CARBOXYLIC ACID#5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE#4-CARBAMOYL-4-{[6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBONYL]-AMINO}-BUTYRIC ACID#N-{1-[5-(1-CARBAMOYL-2-MERCAPTO-ETHYLCARBAMOYL)-PENTYLCARBAMOYL]-2-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-ETHYL}-3-{2-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-ACETYLAMINO}-SUCCINAMIC ACID#{4-[(2S,4E)-2-(1,3-BENZOTHIAZOL-2-YL)-2-(1H-1,2,3-BENZOTRIAZOL-1-YL)-5-PHENYLPENT-4-ENYL]PHENYL}(DIFLUORO)METHYLPHOSPHONIC ACID#4-BENZOYLAMINO-4-{1-{1-CARBAMOYL-2-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-ETHYLCARBAMOYL}-2-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-ETHYLCARBAMOYL}-BUTYRIC ACID#PNU177836#2-(OXALYL-AMINO)-4,7-DIHYDRO-5H-THIENO[2,3-C]PYRAN-3-CARBOXYLIC ACID#{[7-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALEN-2-YL]-DIFLUORO-METHYL}-PHOSPHONIC ACID#[(4-{4-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-BUTYL}-PHENYL)-DIFLUORO-METHYL]-PHOSPHONIC ACID#ISIS 113715#3-(CARBOXYMETHOXY)THIENO[2,3-B]PYRIDINE-2-CARBOXYLIC ACID#4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID#[{2-BROMO-4-[(2R)-3-OXO-2,3-DIPHENYLPROPYL]PHENYL}(DIFLUORO)METHYL]PHOSPHONIC ACID#3(S)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER#5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID#2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID#4-BROMO-3-(CARBOXYMETHOXY)-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID#4-BROMO-3-(CARBOXYMETHOXY)-5-(4-HYDROXYPHENYL)THIOPHENE-2-CARBOXYLIC ACID#3-(3,5-DIBROMO-4-HYDROXY-BENZOYL)-2-ETHYL-BENZOFURAN-6-SULFONIC ACID DIMETHYLAMIDE#CYSTEINESULFONIC ACID#2-(OXALYL-AMINO)-4,5,6,7-TETRAHYDRO-THIENO[2,3-C]PYRIDINE-3-CARBOXYLIC ACID#N-(ALLYLOXYCARBONYL)-4-[N-(CARBOXY-FORMYL)-2-(BENZOIC ACID)-AMINO]-L-PHENYLALANINYL-AMINO-BUTYLOXY-(6-HYDROXY-BENZOIC ACID METHYL ESTER)#COMPOUND 5, 2-(NAPHTHALEN-1-YL-OXALYL-AMINO)-BENZOICACID#6-(OXALYL-AMINO)-1H-INDOLE-5-CARBOXYLIC ACID#2-(CARBOXYMETHOXY)-5-[(2S)-2-({(2S)-2-[(3-CARBOXYPROPANOYL)AMINO] -3-PHENYLPROPANOYL}AMINO)-3-OXO-3-(PENTYLAMINO)PROPYL]BENZOIC ACID#1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID#TILUDRONATE#ISIS 113715#ISIS-PTP1B@HYALURONAN	PYRIDOXAL#N6-METHYL-(R)-ROSCOVITINE, R-2-[6-(BENZYL-METHYL-AMINO)-9-ISOPROPYL-9H-PURIN-2-YLAMINO]-BUTAN-1-OL#PYRIDOXINE#O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL#ADENOSINE-5'-[BETA, GAMMA-METHYLENE]TRIPHOSPHATE@TALTIRELIN#METRH#PROTIRELIN	GDC-0152#AZD5582#AT-406#SM-337#LCL161#GDC0917#AT-406#TL 32711#AEG40826#HGS1029@RILUZOLE
drugs_in_module5	FORMIC ACID@N-[O-PHOSPHONO-PYRIDOXYL]-ISOLEUCINE#ALPHA-KETOISOVALERATE#L-LEUCINE#L-GLUTAMIC ACID@CITRIC ACID#ASPARTATE BERYLLIUM TRIFLUORIDE@L-CITRULLINE@DYSTROPHIN#PRO044@[<SUP>3</SUP>H]CPP#LY233053#L689560#GV196771A#(<I>RS</I>)-(TETRAZOL-5-YL)GLYCINE#D-SERINE#CONANTOKIN-G#L701324#NMDA#L-ASPARTATE#SELFOTEL#D-ASPARTATE#[<SUP>3</SUP>H]CGS19755#[<SUP>3</SUP>H]CGP39653#D-AP5#CGP37849#5,7-DICHLOROKYNURENIC ACID#[<SUP>3</SUP>H]CGP61594#PHENCYCLIDINE#UBP141#[<SUP>3</SUP>H]L689560#GLYCINE#[<SUP>3</SUP>H]MDL105519#AMANTIDINE#N<SUP>1</SUP>-DANSYL-SPERMINE#KETAMINE#DIZOCILPINE#MG<SUP>2+</SUP>#D-CCPENE#[<SUP>3</SUP>H]DIZOCILPINE#[<SUP>3</SUP>H]GLYCINE#HOMOQUINOLINIC ACID#CNS-5161#DIMIRACETAM#AZD-6765#LATREPIRDINE#ORPHENADRINE#V3381#DEXANABINOL#AM-101#NEU-2000#ORPHENADRINE#L-GLUTAMIC ACID#PETHIDINE#ORPHENADRINE#TENOCYCLIDINE#ACETYLCYSTEINE@PEG-INTERFERON LAMBA#IFN-&LAMBDA;3#IFN-&LAMBDA;2#IFN-&LAMBDA;1@5-[(Z)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE@TICLOPIDINE#AZD6140#TICAGRELOR#TREPROSTINIL#CLOPIDOGREL#EPOPROSTENOL#PRASUGREL#2MESADP#CLOPIDOGREL (ACTIVE METABOLITE)#CANGRELOR#CANGRELOR#[<SUP>3</SUP>H]2MESADP#COMPOUND 4 [PMID:23083103]#[<SUP>3</SUP>H]PSB-0413#ARL66096#BX 667#2MESATP#BX 048#ADP&BETA;S#ATP#COMPOUND 20O [PMID:22984835]#TICAGRELOR#ATP&GAMMA;S#AR-C67085#ADENOSINE DIPHOSPHATE#2MESAMP#INS49266#INS50589#R-138727#PSB-0739#PCMPS#PSB-0739#COMPOUND 4 [PMID:22984835]#CLOPIDOGREL BISULFATE#TICLOPIDINE HYDROCHLORIDE#PRASUGREL HYDROCHLORIDE#CLOPIDOGREL#TICAGRELOR#INS-50589#PRASUGREL#TICAGRELOR#TREPROSTINIL#CLOPIDOGREL#MC-1#TICLOPIDINE#ELINOGREL#CANGRELOR#CLOPIDOGREL#TICLOPIDINE#TICLOPIDINE#TREPROSTINIL#PRASUGREL#CLOPIDOGREL#CLOPIDOGREL#TICLOPIDINE#BRILINTA#AR-C69931 MX#PRASUGREL@CITRIC ACID@2,6,8-TRIMETHYL-3-AMINO-9-BENZYL-9-METHOXYNONANOIC ACID#(2S,3S,4E,6E,8S,9S)-3-AMINO-9-METHOXY-2,6,8-TRIMETHYL-10-PHENYLDECA-4,6-DIENOIC ACID@ALPHA-HYDROXY-BETA-PHENYL-PROPIONIC ACID#ANISOMYCIN#PUROMYCIN@R-788#R788#R343#PACLITAXEL#N-(2-HYDROXY-1,1-DIMETHYLETHYL)-1-METHYL-3-(1H-PYRROLO[2,3-B]PYRIDIN-2-YL)-1H-INDOLE-5-CARBOXAMIDE#2-{[(1R,2S)-2-AMINOCYCLOHEXYL]AMINO}-4-[(3-METHYLPHENYL)AMINO]PYRIMIDINE-5-CARBOXAMIDE#STAUROSPORINE#ELLAGIC ACID#6-({5-FLUORO-2-[(3,4,5-TRIMETHOXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-2,2-DIMETHYL-2H-PYRIDO[3,2-B][1,4]OXAZIN-3(4H)-ONE#2-{2-[(3,5-DIMETHYLPHENYL)AMINO]PYRIMIDIN-4-YL}-N-[(1S)-2-HYDROXY-1-METHYLETHYL]-4-METHYL-1,3-THIAZOLE-5-CARBOXAMIDE#FOSTAMATINIB#PRT062607#ACU-XSP-001#R343#FOSTAMATINIB#SYK INHIBITOR#SYK INHIBITOR II#SYK INHIBITOR III#TAMATINIB@DV1179#ANA773#AZD-8848#HYDROXYCHLOROQUINE#IMO-3100#IMIQUIMOD#CPG 52364#IMIQUIMOD#HYDROXYCHLOROQUINE SULFATE#DOCOSANOL#ANA773#HYDROXYCHLOROQUINE#IMO-3100#ISATORIBINE#RESIQUIMOD#CPG 52364#IMIQUIMOD#IMIQUIMOD#HYDROXYCHLOROQUINE#ANA971#SCV-07#ISATORIBINE#RESIQUIMOD#IMIQUIMOD#LOXORIBINE#HYDROXYCHLOROQUINE#IMIQUIMOD@HYALURONAN	NA	LITHIUM@OLESOXIME#DIHYDROXYALUMINIUM#PRLX 93936#PRLX 93936	PYRIDOXAL PHOSPHATE#L-ALANINE#3-HYDROXYHIPPURIC ACID	NA	PYRIDOXAL#N6-METHYL-(R)-ROSCOVITINE, R-2-[6-(BENZYL-METHYL-AMINO)-9-ISOPROPYL-9H-PURIN-2-YLAMINO]-BUTAN-1-OL#PYRIDOXINE#O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL#ADENOSINE-5'-[BETA, GAMMA-METHYLENE]TRIPHOSPHATE	BUPROPION#NICOTINE@2,6,8-TRIMETHYL-3-AMINO-9-BENZYL-9-METHOXYNONANOIC ACID#(2S,3S,4E,6E,8S,9S)-3-AMINO-9-METHOXY-2,6,8-TRIMETHYL-10-PHENYLDECA-4,6-DIENOIC ACID@N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE#(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE#CARFILZOMIB#BORTEZOMIB@ALPHA-HYDROXY-BETA-PHENYL-PROPIONIC ACID#ANISOMYCIN#PUROMYCIN	ETHANOLAMINE OLEATE#ANTITHROMBIN#METHYL 5-[(4-TERT-BUTYLBENZOYL)AMINO]-2H-1,2,4-TRIAZOLE-3-CARBOXYLATE	ENMD-2076@DROTRECOGIN ALFA@ETHANOLAMINE OLEATE#ANTITHROMBIN#METHYL 5-[(4-TERT-BUTYLBENZOYL)AMINO]-2H-1,2,4-TRIAZOLE-3-CARBOXYLATE@V3381#FELBAMATE#DIMIRACETAM#AM-101#DEXANABINOL#LATREPIRDINE#AZD-6765#EVT-101#EVT-103#MEMANTINE#CNS-5161#MEMANTINE#NERAMEXANE#NEU-2000#EVT-101#BESONPRODIL#TRAXOPRODIL#RGH-896#L-GLUTAMIC ACID#TENOCYCLIDINE#PETHIDINE#ACETYLCYSTEINE#FELBAMATE#HALOPERIDOL#IFENPRODIL#MEMANTINE#FELBAMATE#MEMANTINE#HOMOQUINOLINIC ACID#D-SERINE#D-ASPARTATE#GLYCINE#L-ASPARTATE#MG<SUP>2+</SUP>#[<SUP>3</SUP>H]GLYCINE#GV196771A#(<I>RS</I>)-(TETRAZOL-5-YL)GLYCINE#CGP37849#(+)-HA966#NMDA#5,7-DICHLOROKYNURENIC ACID#CONANTOKIN-G#D-AP5#D-CCPENE#[<SUP>3</SUP>H]CGP61594#AMANTIDINE#L701324#L689560#[<SUP>3</SUP>H]DIZOCILPINE#LY233053#PHENCYCLIDINE#N<SUP>1</SUP>-DANSYL-SPERMINE#KETAMINE#DIZOCILPINE#SELFOTEL#NVP-AAM077#UBP141#[<SUP>3</SUP>H]CGP39653#[<SUP>3</SUP>H]MDL105519#[<SUP>3</SUP>H]L689560#[<SUP>3</SUP>H]CPP#[<SUP>3</SUP>H]CGS19755#VALPROIC ACID@PYRIDOXAL PHOSPHATE#L-ALANINE#3-HYDROXYHIPPURIC ACID@[<SUP>14</SUP>C]ASCORBIC ACID#URSODEOXYCHOLIC ACID
drugs_in_module6	(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE#[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA-2,5-DIEN-1-YL]ACETONITRILE@METHYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE#N-({(2S,3S)-3-[(BENZYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINE#N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE#N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE#2-AMINOETHANIMIDIC ACID#DIPHENYLACETIC ACID#BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE#3-AMINO-4-OXYBENZYL-2-BUTANONE#N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO-2-METHYL-BUTANE#3-METHYLPHENYLALANINE#N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-#N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCINE#N-(3-PROPYLCARBAMOYLOXIRANE-2-CARBONYL)-ISOLEUCYL-PROLINE#2-PYRIDINETHIOL#Z-ARG-LEU-VAL-AGLY-ILE-VAL-OME@2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE#2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE@ANTIPSYCHOTICS@OLESOXIME#DIHYDROXYALUMINIUM#PRLX 93936#PRLX 93936	ANTIPSYCHOTICS	N-[O-PHOSPHONO-PYRIDOXYL]-ISOLEUCINE#ALPHA-KETOISOVALERATE#L-LEUCINE#L-GLUTAMIC ACID@PF-4523655@SPHINGOSINE 1-PHOSPHATE#PHYTOSPHINGOSINE 1-PHOSPHATE#COMPOUND 26 [PMID:16190743]#DIHYDROSP​HINGOSINE​-1-PHOSPH​ATE#VPC03090-P#VPC03090-P#SPHINGOSINE 1-PHOSPHATE#AFD(R)#FTY720-PHOSPHATE@ANTIPSYCHOTICS	METHOTREXATE@(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE#[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA-2,5-DIEN-1-YL]ACETONITRILE@ATORVASTATIN#ROSUVASTATIN@PF-4523655@7&BETA;-HYDROXYCHOLESTEROL#27-HYDROXYCHOLESTEROL#7&ALPHA;,25-DIHYDROXYCHOLESTEROL#7&ALPHA;,25-DIHYDROXYCHOLESTEROL#7&ALPHA;-HYDROXYCHOLESTEROL#7&BETA;, 25-DIHYDROXYCHOLESTEROL#7&BETA;, 27-DIHYDROXYCHOLESTEROL#25-HYDROXYCHOLESTEROL#7&ALPHA;,27-DIHYDROXYCHOLESTEROL@RONTALIZUMAB@MARIMASTAT@UROKINASE#TRANEXAMIC ACID#STREPTOKINASE#ALTEPLASE#RETEPLASE#ANISTREPLASE#AMINOCAPROIC ACID#TENECTEPLASE#BICINE#DESMOTEPLASE#APROTININ#ANTITHROMBIN#DESMOTEPLASE#AMEDIPLASE#ANISTREPLASE#ALTEPLASE#PLASMIN#UROKINASE#RETEPLASE#TRANEXAMIC ACID#AMINOCAPROIC ACID#TENECTEPLASE#UROKINASE#STREPTOKINASE#AMINOCAPROIC ACID#ANISTREPLASE#TENECTEPLASE#ALTEPLASE#UROKINASE#RETEPLASE#TRANEXAMIC ACID#STREPTOKINASE#RETEPLASE#ALTEPLASE#AMINOCAPROIC ACID#UROKINASE#RETEPLASE#TENECTEPLASE#STREPTOKINASE#TENECTEPLASE#UROKINASE#ALTEPLASE#TRANEXAMIC ACID#AMINOCAPROIC ACID#APROTININ#RETEPLASE#STREPTOKINASE#ANISTREPLASE#6-AMINOCAPROIC ACID#APROTININ#TRANEXAMIC ACID#BIS-TRIAZOLE DERIVATIVE 10@ALPHA-HYDROXY-BETA-PHENYL-PROPIONIC ACID#ANISOMYCIN#PUROMYCIN@SPHINGOSINE 1-PHOSPHATE#PHYTOSPHINGOSINE 1-PHOSPHATE#COMPOUND 26 [PMID:16190743]#DIHYDROSP​HINGOSINE​-1-PHOSPH​ATE#VPC03090-P#VPC03090-P#SPHINGOSINE 1-PHOSPHATE#AFD(R)#FTY720-PHOSPHATE@ANTIPSYCHOTICS	NA	UROKINASE#TRANEXAMIC ACID#STREPTOKINASE#ALTEPLASE#RETEPLASE#ANISTREPLASE#AMINOCAPROIC ACID#TENECTEPLASE#BICINE#DESMOTEPLASE#APROTININ#ANTITHROMBIN#DESMOTEPLASE#AMEDIPLASE#ANISTREPLASE#ALTEPLASE#PLASMIN#UROKINASE#RETEPLASE#TRANEXAMIC ACID#AMINOCAPROIC ACID#TENECTEPLASE#UROKINASE#STREPTOKINASE#AMINOCAPROIC ACID#ANISTREPLASE#TENECTEPLASE#ALTEPLASE#UROKINASE#RETEPLASE#TRANEXAMIC ACID#STREPTOKINASE#RETEPLASE#ALTEPLASE#AMINOCAPROIC ACID#UROKINASE#RETEPLASE#TENECTEPLASE#STREPTOKINASE#TENECTEPLASE#UROKINASE#ALTEPLASE#TRANEXAMIC ACID#AMINOCAPROIC ACID#APROTININ#RETEPLASE#STREPTOKINASE#ANISTREPLASE#6-AMINOCAPROIC ACID#APROTININ#TRANEXAMIC ACID#BIS-TRIAZOLE DERIVATIVE 10	ENMD-2076	NA	N-[O-PHOSPHONO-PYRIDOXYL]-ISOLEUCINE#ALPHA-KETOISOVALERATE#L-LEUCINE#L-GLUTAMIC ACID@CONATUMUMAB#EMRICASAN#Z-IETD-FMK@LITHIUM@METHYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE#N-({(2S,3S)-3-[(BENZYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINE#N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE#N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE#2-AMINOETHANIMIDIC ACID#DIPHENYLACETIC ACID#BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE#3-AMINO-4-OXYBENZYL-2-BUTANONE#N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO-2-METHYL-BUTANE#3-METHYLPHENYLALANINE#N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-#N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCINE#N-(3-PROPYLCARBAMOYLOXIRANE-2-CARBONYL)-ISOLEUCYL-PROLINE#2-PYRIDINETHIOL#Z-ARG-LEU-VAL-AGLY-ILE-VAL-OME@L-GLUTAMIC ACID#(1<I>S</I>,3<I>R</I>)-ACPD#L-GLUTAMIC ACID#D-AP4#L-CCG-I#L-AP4#MPPG#LY341495#L-SERINE-O-PHOSPHATE#DCG-IV#AZ12216052#[<SUP>3</SUP>H]AP4#(<I>S</I>)-3,4-DCPG#EGLUMEGAD#(<I>R,S</I>)-4-PPG@PEG-INTERFERON LAMBA#IFN-&LAMBDA;3#IFN-&LAMBDA;2#IFN-&LAMBDA;1@PF-00547659@2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE#2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE@NADH#2-MONOPHOSPHOADENOSINE 5-DIPHOSPHORIBOSE@OMALIZUMAB#R112#OMALIZUMAB#GEMCITABINE#TOSITUMOMAB@PSEUDOEPHEDRINE@2,6,8-TRIMETHYL-3-AMINO-9-BENZYL-9-METHOXYNONANOIC ACID#(2S,3S,4E,6E,8S,9S)-3-AMINO-9-METHOXY-2,6,8-TRIMETHYL-10-PHENYLDECA-4,6-DIENOIC ACID@ISIS 113715#TRODUSQUEMINE#TILUDRONATE#1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE#5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID#4-[3-(DIBENZYLAMINO)PHENYL]-2,4-DIOXOBUTANOIC ACID#5-(3-HYDROXYPHENYL)ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDE#N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE#ISOTHIAZOLIDINONE ANALOG#COMPOUND 12, N-ACETYL-4-[(CARBOXYCARBONYL)(2-CARBOXYPHENYL)AMINO]-N-PENTYL-1-NAPTHYLALANIAMIDE#DOUBLE OXIDIZED CYSTEINE#TILUDRONATE#6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID#PARA-(BENZOYL)-PHENYLALANINE#COMPOUND 9#(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER#5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE#2-(OXALYL-AMINO)-4,7-DIHYDRO-5H-THIENO[2,3-C]THIOPYRAN-3-CARBOXYLIC ACID#3(R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER#(4-{(2S)-2-[(TERT-BUTOXYCARBONYL)AMINO]-3-METHOXY-3-OXOPROPYL}PHENYL)METHANESELENINIC ACID#3-(3,5-DIBROMO-4-HYDROXY-BENZOYL)-2-ETHYL-BENZOFURAN-6-SULFONIC ACID (4-SULFAMOYL-PHENYL)-AMIDE#4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN#3-(OXALYL-AMINO)-NAPHTHALENE-2-CARBOXYLIC ACID#[[4-(AMINOMETHYL)PHENYL]AMINO]OXO-ACETIC ACID,#2-{4-[(2S)-2-[({[(1S)-1-CARBOXY-2-PHENYLETHYL]AMINO}CARBONYL)AMINO]-3-OXO-3-(PENTYLAMINO)PROPYL]PHENOXY}MALONIC ACID#COMPOUND 19#SP7343-SP7964#2-(OXALYL-AMINO)-BENZOIC ACID#{[2-(1H-1,2,3-BENZOTRIAZOL-1-YL)-2-(3,4-DIFLUOROPHENYL)PROPANE-1,3-DIYL]BIS[4,1-PHENYLENE(DIFLUOROMETHYLENE)]}BIS(PHOSPHONIC ACID)#NOVO NORDISK A/S COMPOUND#N-[4-(2-{2-[3-(2-BROMO-ACETYLAMINO)-PROPIONYLAMINO]-3-HYDROXY-PROPIONYLAMINO}-ETHYL)-PHENYL]-OXALAMIC ACID#3-(3,5-DIBROMO-4-HYDROXY-BENZOYL)-2-ETHYL-BENZOFURAN-6-SULFONIC ACID [4-(THIAZOL-2-YLSULFAMOYL)-PHENYL]-AMIDE#7-(1,1-DIOXO-1H-BENZO[D]ISOTHIAZOL-3-YLOXYMETHYL)-2-(OXALYL-AMINO)-4,7-DIHYDRO-5H-THIENO[2,3-C]PYRAN-3-CARBOXYLIC ACID#5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE#4-CARBAMOYL-4-{[6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBONYL]-AMINO}-BUTYRIC ACID#N-{1-[5-(1-CARBAMOYL-2-MERCAPTO-ETHYLCARBAMOYL)-PENTYLCARBAMOYL]-2-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-ETHYL}-3-{2-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-ACETYLAMINO}-SUCCINAMIC ACID#{4-[(2S,4E)-2-(1,3-BENZOTHIAZOL-2-YL)-2-(1H-1,2,3-BENZOTRIAZOL-1-YL)-5-PHENYLPENT-4-ENYL]PHENYL}(DIFLUORO)METHYLPHOSPHONIC ACID#4-BENZOYLAMINO-4-{1-{1-CARBAMOYL-2-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-ETHYLCARBAMOYL}-2-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-ETHYLCARBAMOYL}-BUTYRIC ACID#PNU177836#2-(OXALYL-AMINO)-4,7-DIHYDRO-5H-THIENO[2,3-C]PYRAN-3-CARBOXYLIC ACID#{[7-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALEN-2-YL]-DIFLUORO-METHYL}-PHOSPHONIC ACID#[(4-{4-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-BUTYL}-PHENYL)-DIFLUORO-METHYL]-PHOSPHONIC ACID#ISIS 113715#3-(CARBOXYMETHOXY)THIENO[2,3-B]PYRIDINE-2-CARBOXYLIC ACID#4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID#[{2-BROMO-4-[(2R)-3-OXO-2,3-DIPHENYLPROPYL]PHENYL}(DIFLUORO)METHYL]PHOSPHONIC ACID#3(S)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER#5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID#2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID#4-BROMO-3-(CARBOXYMETHOXY)-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID#4-BROMO-3-(CARBOXYMETHOXY)-5-(4-HYDROXYPHENYL)THIOPHENE-2-CARBOXYLIC ACID#3-(3,5-DIBROMO-4-HYDROXY-BENZOYL)-2-ETHYL-BENZOFURAN-6-SULFONIC ACID DIMETHYLAMIDE#CYSTEINESULFONIC ACID#2-(OXALYL-AMINO)-4,5,6,7-TETRAHYDRO-THIENO[2,3-C]PYRIDINE-3-CARBOXYLIC ACID#N-(ALLYLOXYCARBONYL)-4-[N-(CARBOXY-FORMYL)-2-(BENZOIC ACID)-AMINO]-L-PHENYLALANINYL-AMINO-BUTYLOXY-(6-HYDROXY-BENZOIC ACID METHYL ESTER)#COMPOUND 5, 2-(NAPHTHALEN-1-YL-OXALYL-AMINO)-BENZOICACID#6-(OXALYL-AMINO)-1H-INDOLE-5-CARBOXYLIC ACID#2-(CARBOXYMETHOXY)-5-[(2S)-2-({(2S)-2-[(3-CARBOXYPROPANOYL)AMINO] -3-PHENYLPROPANOYL}AMINO)-3-OXO-3-(PENTYLAMINO)PROPYL]BENZOIC ACID#1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID#TILUDRONATE#ISIS 113715#ISIS-PTP1B@ALPHA-HYDROXY-BETA-PHENYL-PROPIONIC ACID#ANISOMYCIN#PUROMYCIN@TALTIRELIN#METRH#PROTIRELIN
drugs_in_module7	CYT-6091#ETANERCEPT#TUMOUR NECROSIS FACTOR MEMBRANE FORM#LYMPHOTOXIN-&ALPHA;	UROKINASE#TRANEXAMIC ACID#STREPTOKINASE#ALTEPLASE#RETEPLASE#ANISTREPLASE#AMINOCAPROIC ACID#TENECTEPLASE#BICINE#DESMOTEPLASE#APROTININ#ANTITHROMBIN#DESMOTEPLASE#AMEDIPLASE#ANISTREPLASE#ALTEPLASE#PLASMIN#UROKINASE#RETEPLASE#TRANEXAMIC ACID#AMINOCAPROIC ACID#TENECTEPLASE#UROKINASE#STREPTOKINASE#AMINOCAPROIC ACID#ANISTREPLASE#TENECTEPLASE#ALTEPLASE#UROKINASE#RETEPLASE#TRANEXAMIC ACID#STREPTOKINASE#RETEPLASE#ALTEPLASE#AMINOCAPROIC ACID#UROKINASE#RETEPLASE#TENECTEPLASE#STREPTOKINASE#TENECTEPLASE#UROKINASE#ALTEPLASE#TRANEXAMIC ACID#AMINOCAPROIC ACID#APROTININ#RETEPLASE#STREPTOKINASE#ANISTREPLASE#6-AMINOCAPROIC ACID#APROTININ#TRANEXAMIC ACID#BIS-TRIAZOLE DERIVATIVE 10	NA	CONATUMUMAB#EMRICASAN#Z-IETD-FMK@PREDNISONE#MELPHALAN#IPILIMUMAB#TREMELIMUMAB#IPILIMUMAB#IPILIMUMAB#TREMELIMUMAB#IPILIMUMAB#IPILIMUMAB#TREMELIMUMAB#IPILIMUMAB#TREMELIMUMAB#IPILIMUMAB#IPILIMUMAB#CP-675206#IPILIMUMAB@DYSTROPHIN#PRO044@ETHANOLAMINE OLEATE#ANTITHROMBIN#METHYL 5-[(4-TERT-BUTYLBENZOYL)AMINO]-2H-1,2,4-TRIAZOLE-3-CARBOXYLATE@V3381#FELBAMATE#DIMIRACETAM#AM-101#DEXANABINOL#LATREPIRDINE#AZD-6765#EVT-101#EVT-103#MEMANTINE#CNS-5161#MEMANTINE#NERAMEXANE#NEU-2000#EVT-101#BESONPRODIL#TRAXOPRODIL#RGH-896#L-GLUTAMIC ACID#TENOCYCLIDINE#PETHIDINE#ACETYLCYSTEINE#FELBAMATE#HALOPERIDOL#IFENPRODIL#MEMANTINE#FELBAMATE#MEMANTINE#HOMOQUINOLINIC ACID#D-SERINE#D-ASPARTATE#GLYCINE#L-ASPARTATE#MG<SUP>2+</SUP>#[<SUP>3</SUP>H]GLYCINE#GV196771A#(<I>RS</I>)-(TETRAZOL-5-YL)GLYCINE#CGP37849#(+)-HA966#NMDA#5,7-DICHLOROKYNURENIC ACID#CONANTOKIN-G#D-AP5#D-CCPENE#[<SUP>3</SUP>H]CGP61594#AMANTIDINE#L701324#L689560#[<SUP>3</SUP>H]DIZOCILPINE#LY233053#PHENCYCLIDINE#N<SUP>1</SUP>-DANSYL-SPERMINE#KETAMINE#DIZOCILPINE#SELFOTEL#NVP-AAM077#UBP141#[<SUP>3</SUP>H]CGP39653#[<SUP>3</SUP>H]MDL105519#[<SUP>3</SUP>H]L689560#[<SUP>3</SUP>H]CPP#[<SUP>3</SUP>H]CGS19755#VALPROIC ACID@OMALIZUMAB#R112#OMALIZUMAB#GEMCITABINE#TOSITUMOMAB@N-(3-(AMINOMETHYL)BENZYL)ACETAMIDINE#1,2,4-TRIAZOLE-CARBOXAMIDINE#L-N(OMEGA)-NITROARGININE-(4R)-AMINO-L-PROLINE AMIDE#S,S'-(1,4-PHENYLENE-BIS(1,2-ETHANEDIYL))BIS-ISOTHIOUREA#7-NITROINDAZOLE#ETHYLISOTHIOUREA#2-AMINOTHIAZOLINE#S-ETHYL-N-PHENYL-ISOTHIOUREA#S,S'-(1,3-PHENYLENE-BIS(1,2-ETHANEDIYL))BIS-ISOTHIOUREA#SE-ETHYL-ISOSELENOUREA#6S-5,6,7,8-TETRAHYDROBIOPTERIN#S-(DIMETHYLARSENIC)CYSTEINE#L-HOMOARGININE#S-ISOPROPYL-ISOTHIOUREA#(6R,1'R,2'S)-5,6,7,8 TETRAHYDROBIOPTERIN#NITROARGININE#2,4-DIAMINO-6-PHENYL-5,6,7,8,-TETRAHYDROPTERIDINE#5-NITROINDAZOLE#N-(CHLOROPHENYL)-N-HYDROXYGUANIDINE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB02979	"N1,N14-BIS((S-METHYL)ISOTHIOUREIDO)TETRADECANE"
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB02994	HYDROXYDIMETHYLARSINE OXIDE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB07001	"(3S,5E)-3-PROPYL-3,4-DIHYDROTHIENO[2,3-F][1,4]OXAZEPIN-5(2H)-IMINE"
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03065	7-NITROINDAZOLE-2-CARBOXAMIDINE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	cofactor	DB00360	TETRAHYDROBIOPTERIN
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03100	6-NITROINDAZOLE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03144	N-OMEGA-HYDROXY-L-ARGININE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03305	N5-IMINOETHYL-L-ORNITHINE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03332	"5,6-CYCLIC-TETRAHYDROPTERIDINE"
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB00125	L-ARGININE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB07244	"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE"
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB00155	L-CITRULLINE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	inhibitor	DB01110	MICONAZOLE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB01686	"N,N-DIMETHYLARGININE"
NOS3	nitric oxide synthase 3 (endothelial cell)	TEND	n/a	TETRAHYDROBIOPTERIN	TETRAHYDROBIOPTERIN
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB02379	BETA-D-GLUCOSE
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB07359	"3-[(4-FLUOROPHENYL)SULFANYL]-N-(4-METHYL-1,3-THIAZOL-2-YL)-6-[(4-METHYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]PYRIDINE-2-CARBOXAMIDE"
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB07358	"2-AMINO-N-(4-METHYL-1,3-THIAZOL-2-YL)-5-[(4-METHYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]BENZAMIDE"
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB08118	"2-(METHYLAMINO)-N-(4-METHYL-1,3-THIAZOL-2-YL)-5-[(4-METHYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]BENZAMIDE"
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB08210	"2-AMINO-4-FLUORO-5-[(1-METHYL-1H-IMIDAZOL-2-YL)SULFANYL]-N-(1,3-THIAZOL-2-YL)BENZAMIDE"
GCK	glucokinase (hexokinase 4)	TdgClinicalTrial	n/a	LY-2599506	LY-2599506
GCK	glucokinase (hexokinase 4)	TdgClinicalTrial	n/a	ARRY-403	ARRY-403
GCK	glucokinase (hexokinase 4)	TTD	inhibitor	DCL000153	LONIDAMINE
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL000457	AZD1656
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL000475	AZD6370
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL000614	R7201
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL000201	PSN-101
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL001154	AZD5658
GCK	glucokinase (hexokinase 4)	GuideToPharmacologyInteractions	n/a	7701	AZD1656
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CERITINIB	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CERITINIB	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CERITINIB	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	ChEMBL	inhibitor	CHEMBL601719	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	ChEMBL	inhibitor	CHEMBL2403108	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	GANETESPIB	GANETESPIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	GANETESPIB	GANETESPIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	TSR-011	TSR-011
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	X-396	X-396
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	ASP3026	ASP3026
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	LDK378	LDK378
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	CH5424802	CH5424802
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	CancerCommons	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	CancerCommons	inhibitor	ASP3026	ASP3026
ALK	anaplastic lymphoma receptor tyrosine kinase	CancerCommons	inhibitor	LDK378	LDK378
ALK	anaplastic lymphoma receptor tyrosine kinase	CancerCommons	inhibitor	X-396	X-396
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	X-396	X-396
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	LDK378	LDK378
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	ASP3026	ASP3026
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	23344087	23344087
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	PF-06463922	PF-06463922
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	TAE684	TAE684
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	AUY922	AUY922
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	CERITINIB	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	PEMETREXED	PEMETREXED
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	CH5424802	CH5424802
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	TdgClinicalTrial	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7739	ALECTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7741	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7741	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7706	AZD3463
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7397	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	4903	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7476	PF-06463922
ALK	anaplastic lymphoma receptor tyrosine kinase	PharmGKB	n/a	PA165946122	CRIZOTINIB
KCNK6	"potassium channel, subfamily K, member 6"	DrugBank	inhibitor	DB00308	IBUTILIDE
KCNK6	"potassium channel, subfamily K, member 6"	DrugBank	inhibitor	DB00908	QUINIDINE
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	DrugBank	inhibitor	DB00230	PREGABALIN
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	DrugBank	inhibitor	DB00836	LOPERAMIDE
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	DrugBank	inhibitor	DB01244	BEPRIDIL
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	DrugBank	inhibitor	DB00661	VERAPAMIL
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TdgClinicalTrial	n/a	NISOLDIPINE	NISOLDIPINE
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TdgClinicalTrial	n/a	BEPRIDIL	BEPRIDIL
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TdgClinicalTrial	n/a	PREGABALIN	PREGABALIN
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TEND	n/a	PREGABALIN	PREGABALIN
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TEND	n/a	BEPRIDIL	BEPRIDIL
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TEND	n/a	NISOLDIPINE	NISOLDIPINE
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	PharmGKB	n/a	PA448871	CELECOXIB
TRBC1	T cell receptor beta constant 1	DrugBank	n/a	DB02740	3-INDOLEBUTYRIC ACID
MCOLN1	mucolipin 1	GuideToPharmacologyInteractions	n/a	2794	"PHOSPHATIDYL (3,5) INOSITOL BIPHOSPHATE"
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	AZD6244	AZD6244
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	AZD6244	AZD6244
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	GDC-0973	GDC-0973
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	SELUMETINIB	SELUMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	BAY869766	BAY869766
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	DABRAFENIB MESYLATE	DABRAFENIB MESYLATE
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	BAY869766	BAY869766
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	TdgClinicalTrial	n/a	WX-554	WX-554
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB04141	"2-HEXYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL"
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB08453	2-NONYL-4-HYDROXYQUINOLINE N-OXIDE
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB07778	FAMOXADONE
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB04799	"5-N-UNDECYL-6-HYDROXY-4,7-DIOXOBENZOTHIAZOLE"
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB07401	METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB08330	METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB07763	"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE"
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB08690	UBIQUINONE-2
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	3934	RESOLVIN D1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6240	MMK-1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6250	MHC BINDING PEPTIDE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	3411	[<SUP>3</SUP>H]LXA<SUB>4</SUB>
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6267	PSM&ALPHA;3
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1031	ANNEXIN I
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	3383	ATLA2
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6246	N36
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6239	ASPIRIN-TRIGGERED RESOLVIN D1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6265	QUIN-C1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	5831	"PYRAZOLONE, 1"
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6242	SERUM AMYLOID A
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	5555	RVD1-ME
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6251	SCK&BETA;8-1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6264	FPRL1-INHIBITOR PROTEIN
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6275	SHAAGTIDE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6248	V3 PEPTIDE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6249	UPAR FRAGMENT
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6245	T21/DP107
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1048	WKYMVM
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1043	PBP10
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1034	LXA<SUB>4</SUB>
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	5841	FMET-ILE-VAL-THR-LEU-PHE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6263	COMPOUND 1754-31
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1039	QUIN-C7
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6244	PRP<SUB>106-126</SUB>
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1022	FMET-LEU-PHE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1041	ISOPROPYLUREIDO-FLFLF
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6269	COMPOUND R-(-)-5F [PMID: 22607879]
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1030	T-BOC-FLFLF
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1040	WRWWWW
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1046	HP(2-20)
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6241	CGEN-855A
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6241	CGEN-855A
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6268	AG-26
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6198	[<SUP>125</SUP>I-TYR]AC2-26
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	4865	AMYLOID &BETA;
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	3933	ASPIRIN TRIGGERED LIPOXIN A4
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1044	ANNEXIN I-(2-26)
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6247	F PEPTIDE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1047	HUMANIN
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	5527	LL-37
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1023	FMET-MET-TYR-ALA-LEU-PHE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1034	LXA<SUB>4</SUB>
TNNT2	troponin T type 2 (cardiac)	TdgClinicalTrial	n/a	TIRAMSETIV	TIRAMSETIV
XPC	"xeroderma pigmentosum, complementation group C"	PharmGKB	n/a	PA449014	CISPLATIN
ECE1	endothelin converting enzyme 1	DrugBank	n/a	DB07171	"5-(2-HYDROXYETHYL)NONANE-1,9-DIOL"
ECE1	endothelin converting enzyme 1	GuideToPharmacologyInteractions	n/a	6506	DAGLUTRIL
ECE1	endothelin converting enzyme 1	GuideToPharmacologyInteractions	n/a	6562	(2S)-2-(2-BENZYL-3-{[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-PHENYLETHYL](HYDROXY)PHOSPHORYL}PROPANAMIDO)-3-(1H-INDOL-3-YL)PROPANOIC ACID
ECE1	endothelin converting enzyme 1	GuideToPharmacologyInteractions	n/a	6507	KC-12615
IL25	interleukin 25	TdgClinicalTrial	n/a	VIDOFLUDIMUS	VIDOFLUDIMUS
SLC7A9	"solute carrier family 7 (glycoprotein-associated amino acid transporter light chain, bo,+ system), member 9"	DrugBank	n/a	DB00138	L-CYSTINE
TERT	telomerase reverse transcriptase	DrugBank	inhibitor	DB00495	ZIDOVUDINE
TERT	telomerase reverse transcriptase	DrugBank	n/a	DB04937	GV1001
TERT	telomerase reverse transcriptase	DrugBank	n/a	DB05036	GRN163L
TERT	telomerase reverse transcriptase	TdgClinicalTrial	n/a	V934/V935	V934/V935
TERT	telomerase reverse transcriptase	TdgClinicalTrial	n/a	IMETELSTAT	IMETELSTAT
TERT	telomerase reverse transcriptase	TdgClinicalTrial	n/a	GV1001	GV1001
TERT	telomerase reverse transcriptase	TALC	inhibitor	IMETELSTAT	IMETELSTAT
TERT	telomerase reverse transcriptase	TALC	inhibitor	SODIUM METAARSENITE	SODIUM METAARSENITE
SLC22A16	"solute carrier family 22 (organic cation/carnitine transporter), member 16"	PharmGKB	n/a	PA449165	CYCLOPHOSPHAMIDE
SLC22A16	"solute carrier family 22 (organic cation/carnitine transporter), member 16"	PharmGKB	n/a	PA449412	DOXORUBICIN
SLC22A16	"solute carrier family 22 (organic cation/carnitine transporter), member 16"	PharmGKB	n/a	PA165291922	DOXORUBICINOL
GSS	glutathione synthetase	DrugBank	stimulator	DB06151	ACETYLCYSTEINE
GSS	glutathione synthetase	DrugBank	n/a	DB00143	GLUTATHIONE
GSS	glutathione synthetase	DrugBank	n/a	DB00145	GLYCINE
GSS	glutathione synthetase	DrugBank	n/a	DB00151	L-CYSTEINE
GSS	glutathione synthetase	DrugBank	n/a	DB03408	GAMMA-GLUTAMYLCYSTEINE
GSS	glutathione synthetase	DrugBank	n/a	DB04395	PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA448404	AMODIAQUINE
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA449782	GLIBENCLAMIDE
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA165857067	CHLORPROGUANIL
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA165111697	ARTESUNATE
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA449211	DAPSONE
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	DrugBank	n/a	DB04998	AGRO100
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	DrugBank	n/a	DB05289	MPC-7869
OAZ1	ornithine decarboxylase antizyme 1	DrugBank	n/a	DB00129	L-ORNITHINE
ALDH3B2	"aldehyde dehydrogenase 3 family, member B2"	DrugBank	n/a	DB00157	NADH
ARF6	ADP-ribosylation factor 6	DrugBank	n/a	DB01864	5-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE@TICLOPIDINE#AZD6140#TICAGRELOR#TREPROSTINIL#CLOPIDOGREL#EPOPROSTENOL#PRASUGREL#2MESADP#CLOPIDOGREL (ACTIVE METABOLITE)#CANGRELOR#CANGRELOR#[<SUP>3</SUP>H]2MESADP#COMPOUND 4 [PMID:23083103]#[<SUP>3</SUP>H]PSB-0413#ARL66096#BX 667#2MESATP#BX 048#ADP&BETA;S#ATP#COMPOUND 20O [PMID:22984835]#TICAGRELOR#ATP&GAMMA;S#AR-C67085#ADENOSINE DIPHOSPHATE#2MESAMP#INS49266#INS50589#R-138727#PSB-0739#PCMPS#PSB-0739#COMPOUND 4 [PMID:22984835]#CLOPIDOGREL BISULFATE#TICLOPIDINE HYDROCHLORIDE#PRASUGREL HYDROCHLORIDE#CLOPIDOGREL#TICAGRELOR#INS-50589#PRASUGREL#TICAGRELOR#TREPROSTINIL#CLOPIDOGREL#MC-1#TICLOPIDINE#ELINOGREL#CANGRELOR#CLOPIDOGREL#TICLOPIDINE#TICLOPIDINE#TREPROSTINIL#PRASUGREL#CLOPIDOGREL#CLOPIDOGREL#TICLOPIDINE#BRILINTA#AR-C69931 MX#PRASUGREL@[<SUP>14</SUP>C]ASCORBIC ACID#URSODEOXYCHOLIC ACID@DV1179#ANA773#AZD-8848#HYDROXYCHLOROQUINE#IMO-3100#IMIQUIMOD#CPG 52364#IMIQUIMOD#HYDROXYCHLOROQUINE SULFATE#DOCOSANOL#ANA773#HYDROXYCHLOROQUINE#IMO-3100#ISATORIBINE#RESIQUIMOD#CPG 52364#IMIQUIMOD#IMIQUIMOD#HYDROXYCHLOROQUINE#ANA971#SCV-07#ISATORIBINE#RESIQUIMOD#IMIQUIMOD#LOXORIBINE#HYDROXYCHLOROQUINE#IMIQUIMOD@HYALURONAN	NA	NA	NA	CITRIC ACID#ASPARTATE BERYLLIUM TRIFLUORIDE@2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE#2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE@5-[(Z)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE@CITRIC ACID@2,6,8-TRIMETHYL-3-AMINO-9-BENZYL-9-METHOXYNONANOIC ACID#(2S,3S,4E,6E,8S,9S)-3-AMINO-9-METHOXY-2,6,8-TRIMETHYL-10-PHENYLDECA-4,6-DIENOIC ACID@ALPHA-HYDROXY-BETA-PHENYL-PROPIONIC ACID#ANISOMYCIN#PUROMYCIN	METHOTREXATE@RONTALIZUMAB@[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}AMINO)PHENYL]ACETONITRILE#1-CYCLOBUTYL-3-(3,4-DIMETHOXYPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE#1-CYCLOPENTYL-3-(1H-PYRROLO[2,3-B]PYRIDIN-5-YL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE#1-(1-METHYLETHYL)-3-QUINOLIN-6-YL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE#2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE#N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE#(2E)-N-{4-[(3-BROMOPHENYL)AMINO]QUINAZOLIN-6-YL}-4-(DIMETHYLAMINO)BUT-2-ENAMIDE#3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL#RU78300#PONATINIB#RU82197#DPI59#N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE#NINTEDANIB#PHENYLPHOSPHATE#RU84687#1-[1-(3-AMINOPHENYL)-3-TERT-BUTYL-1H-PYRAZOL-5-YL]-3-PHENYLUREA#1-[1-(3-AMINOPHENYL)-3-TERT-BUTYL-1H-PYRAZOL-5-YL]-3-NAPHTHALEN-1-YLUREA#RU79073#RU79256#N6-BENZYL ADENOSINE-5-DIPHOSPHATE
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB01908	RU85493
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	multitarget	DB01254	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB01947	RU78262
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB01962	PHOSPHONOTYROSINE
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02175	MALONIC ACID
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02336	RU83876
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02432	RU90395
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02762	RU79072
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02908	RU78783
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03591	RU82209
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03628	ISO24
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03712	RU85053
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03023	"1-TERT-BUTYL-3-(4-CHLORO-PHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-YLAMINE"
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03828	RU78299
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03902	OXALIC ACID
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04080	RU78191
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	inhibitor	DB06616	BOSUTINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04272	CITRIC ACID
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03078	PASBN
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03104	RU82129
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03114	PAS219
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04495	RU81843
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04739	4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04751	PURVALANOL A
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB05184	XL228
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	GuideToPharmacologyInteractions	n/a	7731	SARACATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	GuideToPharmacologyInteractions	n/a	6048	SYK INHIBITOR III
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	GuideToPharmacologyInteractions	n/a	5976	GSK-3 INHIBITOR XIII
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	GuideToPharmacologyInteractions	n/a	6044	SU6656
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	ENMD-2076	ENMD-2076
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	DASATINIB	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	XL228	XL228
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	PONATINIB	PONATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	MASITINIB	MASITINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	KX2-391	KX2-391
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	BOSUTINIB	BOSUTINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	ChEMBL	inhibitor	CHEMBL24828	VANDETANIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	ChEMBL	inhibitor	CHEMBL288441	BOSUTINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TEND	n/a	DASATINIB	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	MyCancerGenome	inhibitor	KX2-391	KX2-391
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	MyCancerGenome	inhibitor	XL228	XL228
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	MyCancerGenome	inhibitor	SARACATINIB	SARACATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	CancerCommons	inhibitor	DASATINIB	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	XL228	XL228
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	DASATINIB	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	XL999	XL999
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	BOSUTINIB	BOSUTINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	KX2-391	KX2-391
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	SARACATINIB	SARACATINIB
SCPEP1	serine carboxypeptidase 1	DrugBank	n/a	DB07506	L-BENZYLSUCCINIC ACID
MMP24	matrix metallopeptidase 24 (membrane-inserted)	DrugBank	inhibitor	DB00786	MARIMASTAT
CCHCR1	coiled-coil alpha-helical rod protein 1	PharmGKB	n/a	PA450616	NEVIRAPINE
CCHCR1	coiled-coil alpha-helical rod protein 1	PharmGKB	n/a	PA448320	ALLOPURINOL
FGFR2	fibroblast growth factor receptor 2	DrugBank	antagonist	DB01041	THALIDOMIDE
FGFR2	fibroblast growth factor receptor 2	DrugBank	inhibitor	DB08901	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DrugBank	binder	DB00039	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	DrugBank	inhibitor	DB09078	LENVATINIB
FGFR2	fibroblast growth factor receptor 2	DrugBank	inhibitor	DB09079	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	DrugBank	n/a	DB02058	SU4984
FGFR2	fibroblast growth factor receptor 2	DrugBank	n/a	DB02491	4-[4-(1-AMINO-1-METHYLETHYL)PHENYL]-5-CHLORO-N-[4-(2-MORPHOLIN-4-YLETHYL)PHENYL]PYRIMIDIN-2-AMINE
FGFR2	fibroblast growth factor receptor 2	DrugBank	inhibitor	DB08896	REGORAFENIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PAZOPANIB	PAZOPANIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	TEND	n/a	PALIFERMIN	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	TEND	n/a	THALIDOMIDE	THALIDOMIDE
FGFR2	fibroblast growth factor receptor 2	ChEMBL	agonist	CHEMBL1201821	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	ChEMBL	inhibitor	CHEMBL1946170	REGORAFENIB
FGFR2	fibroblast growth factor receptor 2	TTD	inhibitor	DAP001025	PENTOSAN POLYSULFATE
FGFR2	fibroblast growth factor receptor 2	TTD	binder	DAP000801	"INTERFERON ALFA-2A, RECOMBINANT"
FGFR2	fibroblast growth factor receptor 2	TTD	activator	DCL001020	TRAFERMIN
FGFR2	fibroblast growth factor receptor 2	TTD	inhibitor	DCL000361	AEE-788
FGFR2	fibroblast growth factor receptor 2	TTD	binder	DAP001026	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	TRAFERMIN	TRAFERMIN
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	CVBT-141B	CVBT-141B
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	THALIDOMIDE	THALIDOMIDE
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	PALIFERMIN	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	NINTEDANIB	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	CVBT-141H	CVBT-141H
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	ENMD-2076	ENMD-2076
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	ACTB1003	ACTB1003
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	ARQ 087	ARQ 087
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	PI-88	PI-88
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	FP-1039	FP-1039
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenomeClinicalTrial	inhibitor	REGORAFENIB	REGORAFENIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenomeClinicalTrial	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	MyCancerGenomeClinicalTrial	inhibitor	BGJ398	BGJ398
FGFR2	fibroblast growth factor receptor 2	MyCancerGenomeClinicalTrial	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	ClearityFoundationClinicalTrial	n/a	ENMD-2076	ENMD-2076
FGFR2	fibroblast growth factor receptor 2	ClearityFoundationClinicalTrial	n/a	NINTEDANIB	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	ClearityFoundationClinicalTrial	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	ClearityFoundationClinicalTrial	n/a	NINTEDANIB	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	VARGATEF	VARGATEF
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	XL999	XL999
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	TSU-68	TSU-68
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	BGJ398	BGJ398
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	REGORAFENIB	REGORAFENIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	LENVATINIB	LENVATINIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	XL228	XL228
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	BRIVANIB	BRIVANIB
FGFR2	fibroblast growth factor receptor 2	TALC	antibody	FP-1039	FP-1039
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	MASITINIB	MASITINIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	XL228	XL228
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	BGJ398	BGJ398
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	NINTEDANIB	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	E-3810	E-3810
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	CancerCommons	inhibitor	BGJ398	BGJ398
FGFR2	fibroblast growth factor receptor 2	GuideToPharmacologyInteractions	n/a	6954	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	GuideToPharmacologyInteractions	n/a	7707	AZD4547
FGFR2	fibroblast growth factor receptor 2	GuideToPharmacologyInteractions	n/a	7877	BGJ-398
FGFR2	fibroblast growth factor receptor 2	GuideToPharmacologyInteractions	n/a	5936	NINTEDANIB
NPY	neuropeptide Y	DrugBank	n/a	DB03380	L-TYROSINAMIDE
NPY	neuropeptide Y	DrugBank	n/a	DB02952	ALPHA-AMINOISOBUTYRIC ACID
GLUD1	glutamate dehydrogenase 1	DrugBank	n/a	DB00142	L-GLUTAMIC ACID
GLUD1	glutamate dehydrogenase 1	DrugBank	n/a	DB00157	NADH
GLUD1	glutamate dehydrogenase 1	DrugBank	inhibitor	DB00756	HEXACHLOROPHENE
GLUD1	glutamate dehydrogenase 1	DrugBank	n/a	DB04137	GUANOSINE-5-TRIPHOSPHATE
drugs_in_module8	NA	GDC-0152#AZD5582#AT-406#SM-337#LCL161#GDC0917#AT-406#TL 32711#AEG40826#HGS1029	METHOTREXATE@CITRIC ACID@[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}AMINO)PHENYL]ACETONITRILE#1-CYCLOBUTYL-3-(3,4-DIMETHOXYPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE#1-CYCLOPENTYL-3-(1H-PYRROLO[2,3-B]PYRIDIN-5-YL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE#1-(1-METHYLETHYL)-3-QUINOLIN-6-YL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE#2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE#N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE#(2E)-N-{4-[(3-BROMOPHENYL)AMINO]QUINAZOLIN-6-YL}-4-(DIMETHYLAMINO)BUT-2-ENAMIDE#3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL#RU78300#PONATINIB#RU82197#DPI59#N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE#NINTEDANIB#PHENYLPHOSPHATE#RU84687#1-[1-(3-AMINOPHENYL)-3-TERT-BUTYL-1H-PYRAZOL-5-YL]-3-PHENYLUREA#1-[1-(3-AMINOPHENYL)-3-TERT-BUTYL-1H-PYRAZOL-5-YL]-3-NAPHTHALEN-1-YLUREA#RU79073#RU79256#N6-BENZYL ADENOSINE-5-DIPHOSPHATE
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB01908	RU85493
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	multitarget	DB01254	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB01947	RU78262
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB01962	PHOSPHONOTYROSINE
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02175	MALONIC ACID
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02336	RU83876
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02432	RU90395
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02762	RU79072
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02908	RU78783
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03591	RU82209
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03628	ISO24
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03712	RU85053
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03023	"1-TERT-BUTYL-3-(4-CHLORO-PHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-YLAMINE"
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03828	RU78299
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03902	OXALIC ACID
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04080	RU78191
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	inhibitor	DB06616	BOSUTINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04272	CITRIC ACID
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03078	PASBN
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03104	RU82129
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03114	PAS219
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04495	RU81843
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04739	4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04751	PURVALANOL A
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB05184	XL228
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	GuideToPharmacologyInteractions	n/a	7731	SARACATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	GuideToPharmacologyInteractions	n/a	6048	SYK INHIBITOR III
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	GuideToPharmacologyInteractions	n/a	5976	GSK-3 INHIBITOR XIII
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	GuideToPharmacologyInteractions	n/a	6044	SU6656
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	ENMD-2076	ENMD-2076
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	DASATINIB	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	XL228	XL228
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	PONATINIB	PONATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	MASITINIB	MASITINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	KX2-391	KX2-391
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	BOSUTINIB	BOSUTINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	ChEMBL	inhibitor	CHEMBL24828	VANDETANIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	ChEMBL	inhibitor	CHEMBL288441	BOSUTINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TEND	n/a	DASATINIB	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	MyCancerGenome	inhibitor	KX2-391	KX2-391
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	MyCancerGenome	inhibitor	XL228	XL228
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	MyCancerGenome	inhibitor	SARACATINIB	SARACATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	CancerCommons	inhibitor	DASATINIB	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	XL228	XL228
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	DASATINIB	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	XL999	XL999
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	BOSUTINIB	BOSUTINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	KX2-391	KX2-391
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	SARACATINIB	SARACATINIB
SCPEP1	serine carboxypeptidase 1	DrugBank	n/a	DB07506	L-BENZYLSUCCINIC ACID
MMP24	matrix metallopeptidase 24 (membrane-inserted)	DrugBank	inhibitor	DB00786	MARIMASTAT
CCHCR1	coiled-coil alpha-helical rod protein 1	PharmGKB	n/a	PA450616	NEVIRAPINE
CCHCR1	coiled-coil alpha-helical rod protein 1	PharmGKB	n/a	PA448320	ALLOPURINOL
FGFR2	fibroblast growth factor receptor 2	DrugBank	antagonist	DB01041	THALIDOMIDE
FGFR2	fibroblast growth factor receptor 2	DrugBank	inhibitor	DB08901	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DrugBank	binder	DB00039	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	DrugBank	inhibitor	DB09078	LENVATINIB
FGFR2	fibroblast growth factor receptor 2	DrugBank	inhibitor	DB09079	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	DrugBank	n/a	DB02058	SU4984
FGFR2	fibroblast growth factor receptor 2	DrugBank	n/a	DB02491	4-[4-(1-AMINO-1-METHYLETHYL)PHENYL]-5-CHLORO-N-[4-(2-MORPHOLIN-4-YLETHYL)PHENYL]PYRIMIDIN-2-AMINE
FGFR2	fibroblast growth factor receptor 2	DrugBank	inhibitor	DB08896	REGORAFENIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PAZOPANIB	PAZOPANIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	TEND	n/a	PALIFERMIN	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	TEND	n/a	THALIDOMIDE	THALIDOMIDE
FGFR2	fibroblast growth factor receptor 2	ChEMBL	agonist	CHEMBL1201821	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	ChEMBL	inhibitor	CHEMBL1946170	REGORAFENIB
FGFR2	fibroblast growth factor receptor 2	TTD	inhibitor	DAP001025	PENTOSAN POLYSULFATE
FGFR2	fibroblast growth factor receptor 2	TTD	binder	DAP000801	"INTERFERON ALFA-2A, RECOMBINANT"
FGFR2	fibroblast growth factor receptor 2	TTD	activator	DCL001020	TRAFERMIN
FGFR2	fibroblast growth factor receptor 2	TTD	inhibitor	DCL000361	AEE-788
FGFR2	fibroblast growth factor receptor 2	TTD	binder	DAP001026	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	TRAFERMIN	TRAFERMIN
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	CVBT-141B	CVBT-141B
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	THALIDOMIDE	THALIDOMIDE
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	PALIFERMIN	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	NINTEDANIB	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	CVBT-141H	CVBT-141H
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	ENMD-2076	ENMD-2076
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	ACTB1003	ACTB1003
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	ARQ 087	ARQ 087
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	PI-88	PI-88
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	FP-1039	FP-1039
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenomeClinicalTrial	inhibitor	REGORAFENIB	REGORAFENIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenomeClinicalTrial	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	MyCancerGenomeClinicalTrial	inhibitor	BGJ398	BGJ398
FGFR2	fibroblast growth factor receptor 2	MyCancerGenomeClinicalTrial	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	ClearityFoundationClinicalTrial	n/a	ENMD-2076	ENMD-2076
FGFR2	fibroblast growth factor receptor 2	ClearityFoundationClinicalTrial	n/a	NINTEDANIB	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	ClearityFoundationClinicalTrial	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	ClearityFoundationClinicalTrial	n/a	NINTEDANIB	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	VARGATEF	VARGATEF
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	XL999	XL999
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	TSU-68	TSU-68
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	BGJ398	BGJ398
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	REGORAFENIB	REGORAFENIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	LENVATINIB	LENVATINIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	XL228	XL228
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	BRIVANIB	BRIVANIB
FGFR2	fibroblast growth factor receptor 2	TALC	antibody	FP-1039	FP-1039
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	MASITINIB	MASITINIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	XL228	XL228
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	BGJ398	BGJ398
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	NINTEDANIB	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	E-3810	E-3810
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	CancerCommons	inhibitor	BGJ398	BGJ398
FGFR2	fibroblast growth factor receptor 2	GuideToPharmacologyInteractions	n/a	6954	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	GuideToPharmacologyInteractions	n/a	7707	AZD4547
FGFR2	fibroblast growth factor receptor 2	GuideToPharmacologyInteractions	n/a	7877	BGJ-398
FGFR2	fibroblast growth factor receptor 2	GuideToPharmacologyInteractions	n/a	5936	NINTEDANIB
NPY	neuropeptide Y	DrugBank	n/a	DB03380	L-TYROSINAMIDE
NPY	neuropeptide Y	DrugBank	n/a	DB02952	ALPHA-AMINOISOBUTYRIC ACID
GLUD1	glutamate dehydrogenase 1	DrugBank	n/a	DB00142	L-GLUTAMIC ACID
GLUD1	glutamate dehydrogenase 1	DrugBank	n/a	DB00157	NADH
GLUD1	glutamate dehydrogenase 1	DrugBank	inhibitor	DB00756	HEXACHLOROPHENE
GLUD1	glutamate dehydrogenase 1	DrugBank	n/a	DB04137	GUANOSINE-5-TRIPHOSPHATE	NA	NA	NA	V3381#FELBAMATE#DIMIRACETAM#AM-101#DEXANABINOL#LATREPIRDINE#AZD-6765#EVT-101#EVT-103#MEMANTINE#CNS-5161#MEMANTINE#NERAMEXANE#NEU-2000#EVT-101#BESONPRODIL#TRAXOPRODIL#RGH-896#L-GLUTAMIC ACID#TENOCYCLIDINE#PETHIDINE#ACETYLCYSTEINE#FELBAMATE#HALOPERIDOL#IFENPRODIL#MEMANTINE#FELBAMATE#MEMANTINE#HOMOQUINOLINIC ACID#D-SERINE#D-ASPARTATE#GLYCINE#L-ASPARTATE#MG<SUP>2+</SUP>#[<SUP>3</SUP>H]GLYCINE#GV196771A#(<I>RS</I>)-(TETRAZOL-5-YL)GLYCINE#CGP37849#(+)-HA966#NMDA#5,7-DICHLOROKYNURENIC ACID#CONANTOKIN-G#D-AP5#D-CCPENE#[<SUP>3</SUP>H]CGP61594#AMANTIDINE#L701324#L689560#[<SUP>3</SUP>H]DIZOCILPINE#LY233053#PHENCYCLIDINE#N<SUP>1</SUP>-DANSYL-SPERMINE#KETAMINE#DIZOCILPINE#SELFOTEL#NVP-AAM077#UBP141#[<SUP>3</SUP>H]CGP39653#[<SUP>3</SUP>H]MDL105519#[<SUP>3</SUP>H]L689560#[<SUP>3</SUP>H]CPP#[<SUP>3</SUP>H]CGS19755#VALPROIC ACID@OMALIZUMAB#R112#OMALIZUMAB#GEMCITABINE#TOSITUMOMAB	METHOTREXATE	PREDNISONE#MELPHALAN#IPILIMUMAB#TREMELIMUMAB#IPILIMUMAB#IPILIMUMAB#TREMELIMUMAB#IPILIMUMAB#IPILIMUMAB#TREMELIMUMAB#IPILIMUMAB#TREMELIMUMAB#IPILIMUMAB#IPILIMUMAB#CP-675206#IPILIMUMAB@N-(3-(AMINOMETHYL)BENZYL)ACETAMIDINE#1,2,4-TRIAZOLE-CARBOXAMIDINE#L-N(OMEGA)-NITROARGININE-(4R)-AMINO-L-PROLINE AMIDE#S,S'-(1,4-PHENYLENE-BIS(1,2-ETHANEDIYL))BIS-ISOTHIOUREA#7-NITROINDAZOLE#ETHYLISOTHIOUREA#2-AMINOTHIAZOLINE#S-ETHYL-N-PHENYL-ISOTHIOUREA#S,S'-(1,3-PHENYLENE-BIS(1,2-ETHANEDIYL))BIS-ISOTHIOUREA#SE-ETHYL-ISOSELENOUREA#6S-5,6,7,8-TETRAHYDROBIOPTERIN#S-(DIMETHYLARSENIC)CYSTEINE#L-HOMOARGININE#S-ISOPROPYL-ISOTHIOUREA#(6R,1'R,2'S)-5,6,7,8 TETRAHYDROBIOPTERIN#NITROARGININE#2,4-DIAMINO-6-PHENYL-5,6,7,8,-TETRAHYDROPTERIDINE#5-NITROINDAZOLE#N-(CHLOROPHENYL)-N-HYDROXYGUANIDINE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB02979	"N1,N14-BIS((S-METHYL)ISOTHIOUREIDO)TETRADECANE"
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB02994	HYDROXYDIMETHYLARSINE OXIDE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB07001	"(3S,5E)-3-PROPYL-3,4-DIHYDROTHIENO[2,3-F][1,4]OXAZEPIN-5(2H)-IMINE"
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03065	7-NITROINDAZOLE-2-CARBOXAMIDINE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	cofactor	DB00360	TETRAHYDROBIOPTERIN
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03100	6-NITROINDAZOLE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03144	N-OMEGA-HYDROXY-L-ARGININE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03305	N5-IMINOETHYL-L-ORNITHINE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03332	"5,6-CYCLIC-TETRAHYDROPTERIDINE"
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB00125	L-ARGININE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB07244	"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE"
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB00155	L-CITRULLINE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	inhibitor	DB01110	MICONAZOLE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB01686	"N,N-DIMETHYLARGININE"
NOS3	nitric oxide synthase 3 (endothelial cell)	TEND	n/a	TETRAHYDROBIOPTERIN	TETRAHYDROBIOPTERIN
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB02379	BETA-D-GLUCOSE
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB07359	"3-[(4-FLUOROPHENYL)SULFANYL]-N-(4-METHYL-1,3-THIAZOL-2-YL)-6-[(4-METHYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]PYRIDINE-2-CARBOXAMIDE"
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB07358	"2-AMINO-N-(4-METHYL-1,3-THIAZOL-2-YL)-5-[(4-METHYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]BENZAMIDE"
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB08118	"2-(METHYLAMINO)-N-(4-METHYL-1,3-THIAZOL-2-YL)-5-[(4-METHYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]BENZAMIDE"
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB08210	"2-AMINO-4-FLUORO-5-[(1-METHYL-1H-IMIDAZOL-2-YL)SULFANYL]-N-(1,3-THIAZOL-2-YL)BENZAMIDE"
GCK	glucokinase (hexokinase 4)	TdgClinicalTrial	n/a	LY-2599506	LY-2599506
GCK	glucokinase (hexokinase 4)	TdgClinicalTrial	n/a	ARRY-403	ARRY-403
GCK	glucokinase (hexokinase 4)	TTD	inhibitor	DCL000153	LONIDAMINE
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL000457	AZD1656
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL000475	AZD6370
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL000614	R7201
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL000201	PSN-101
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL001154	AZD5658
GCK	glucokinase (hexokinase 4)	GuideToPharmacologyInteractions	n/a	7701	AZD1656
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CERITINIB	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CERITINIB	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CERITINIB	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	ChEMBL	inhibitor	CHEMBL601719	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	ChEMBL	inhibitor	CHEMBL2403108	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	GANETESPIB	GANETESPIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	GANETESPIB	GANETESPIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	TSR-011	TSR-011
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	X-396	X-396
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	ASP3026	ASP3026
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	LDK378	LDK378
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	CH5424802	CH5424802
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	CancerCommons	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	CancerCommons	inhibitor	ASP3026	ASP3026
ALK	anaplastic lymphoma receptor tyrosine kinase	CancerCommons	inhibitor	LDK378	LDK378
ALK	anaplastic lymphoma receptor tyrosine kinase	CancerCommons	inhibitor	X-396	X-396
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	X-396	X-396
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	LDK378	LDK378
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	ASP3026	ASP3026
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	23344087	23344087
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	PF-06463922	PF-06463922
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	TAE684	TAE684
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	AUY922	AUY922
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	CERITINIB	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	PEMETREXED	PEMETREXED
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	CH5424802	CH5424802
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	TdgClinicalTrial	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7739	ALECTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7741	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7741	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7706	AZD3463
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7397	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	4903	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7476	PF-06463922
ALK	anaplastic lymphoma receptor tyrosine kinase	PharmGKB	n/a	PA165946122	CRIZOTINIB
KCNK6	"potassium channel, subfamily K, member 6"	DrugBank	inhibitor	DB00308	IBUTILIDE
KCNK6	"potassium channel, subfamily K, member 6"	DrugBank	inhibitor	DB00908	QUINIDINE
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	DrugBank	inhibitor	DB00230	PREGABALIN
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	DrugBank	inhibitor	DB00836	LOPERAMIDE
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	DrugBank	inhibitor	DB01244	BEPRIDIL
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	DrugBank	inhibitor	DB00661	VERAPAMIL
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TdgClinicalTrial	n/a	NISOLDIPINE	NISOLDIPINE
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TdgClinicalTrial	n/a	BEPRIDIL	BEPRIDIL
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TdgClinicalTrial	n/a	PREGABALIN	PREGABALIN
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TEND	n/a	PREGABALIN	PREGABALIN
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TEND	n/a	BEPRIDIL	BEPRIDIL
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TEND	n/a	NISOLDIPINE	NISOLDIPINE
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	PharmGKB	n/a	PA448871	CELECOXIB
TRBC1	T cell receptor beta constant 1	DrugBank	n/a	DB02740	3-INDOLEBUTYRIC ACID
MCOLN1	mucolipin 1	GuideToPharmacologyInteractions	n/a	2794	"PHOSPHATIDYL (3,5) INOSITOL BIPHOSPHATE"
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	AZD6244	AZD6244
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	AZD6244	AZD6244
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	GDC-0973	GDC-0973
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	SELUMETINIB	SELUMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	BAY869766	BAY869766
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	DABRAFENIB MESYLATE	DABRAFENIB MESYLATE
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	BAY869766	BAY869766
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	TdgClinicalTrial	n/a	WX-554	WX-554
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB04141	"2-HEXYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL"
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB08453	2-NONYL-4-HYDROXYQUINOLINE N-OXIDE
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB07778	FAMOXADONE
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB04799	"5-N-UNDECYL-6-HYDROXY-4,7-DIOXOBENZOTHIAZOLE"
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB07401	METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB08330	METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB07763	"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE"
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB08690	UBIQUINONE-2
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	3934	RESOLVIN D1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6240	MMK-1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6250	MHC BINDING PEPTIDE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	3411	[<SUP>3</SUP>H]LXA<SUB>4</SUB>
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6267	PSM&ALPHA;3
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1031	ANNEXIN I
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	3383	ATLA2
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6246	N36
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6239	ASPIRIN-TRIGGERED RESOLVIN D1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6265	QUIN-C1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	5831	"PYRAZOLONE, 1"
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6242	SERUM AMYLOID A
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	5555	RVD1-ME
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6251	SCK&BETA;8-1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6264	FPRL1-INHIBITOR PROTEIN
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6275	SHAAGTIDE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6248	V3 PEPTIDE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6249	UPAR FRAGMENT
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6245	T21/DP107
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1048	WKYMVM
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1043	PBP10
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1034	LXA<SUB>4</SUB>
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	5841	FMET-ILE-VAL-THR-LEU-PHE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6263	COMPOUND 1754-31
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1039	QUIN-C7
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6244	PRP<SUB>106-126</SUB>
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1022	FMET-LEU-PHE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1041	ISOPROPYLUREIDO-FLFLF
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6269	COMPOUND R-(-)-5F [PMID: 22607879]
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1030	T-BOC-FLFLF
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1040	WRWWWW
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1046	HP(2-20)
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6241	CGEN-855A
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6241	CGEN-855A
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6268	AG-26
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6198	[<SUP>125</SUP>I-TYR]AC2-26
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	4865	AMYLOID &BETA;
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	3933	ASPIRIN TRIGGERED LIPOXIN A4
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1044	ANNEXIN I-(2-26)
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6247	F PEPTIDE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1047	HUMANIN
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	5527	LL-37
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1023	FMET-MET-TYR-ALA-LEU-PHE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1034	LXA<SUB>4</SUB>
TNNT2	troponin T type 2 (cardiac)	TdgClinicalTrial	n/a	TIRAMSETIV	TIRAMSETIV
XPC	"xeroderma pigmentosum, complementation group C"	PharmGKB	n/a	PA449014	CISPLATIN
ECE1	endothelin converting enzyme 1	DrugBank	n/a	DB07171	"5-(2-HYDROXYETHYL)NONANE-1,9-DIOL"
ECE1	endothelin converting enzyme 1	GuideToPharmacologyInteractions	n/a	6506	DAGLUTRIL
ECE1	endothelin converting enzyme 1	GuideToPharmacologyInteractions	n/a	6562	(2S)-2-(2-BENZYL-3-{[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-PHENYLETHYL](HYDROXY)PHOSPHORYL}PROPANAMIDO)-3-(1H-INDOL-3-YL)PROPANOIC ACID
ECE1	endothelin converting enzyme 1	GuideToPharmacologyInteractions	n/a	6507	KC-12615
IL25	interleukin 25	TdgClinicalTrial	n/a	VIDOFLUDIMUS	VIDOFLUDIMUS
SLC7A9	"solute carrier family 7 (glycoprotein-associated amino acid transporter light chain, bo,+ system), member 9"	DrugBank	n/a	DB00138	L-CYSTINE
TERT	telomerase reverse transcriptase	DrugBank	inhibitor	DB00495	ZIDOVUDINE
TERT	telomerase reverse transcriptase	DrugBank	n/a	DB04937	GV1001
TERT	telomerase reverse transcriptase	DrugBank	n/a	DB05036	GRN163L
TERT	telomerase reverse transcriptase	TdgClinicalTrial	n/a	V934/V935	V934/V935
TERT	telomerase reverse transcriptase	TdgClinicalTrial	n/a	IMETELSTAT	IMETELSTAT
TERT	telomerase reverse transcriptase	TdgClinicalTrial	n/a	GV1001	GV1001
TERT	telomerase reverse transcriptase	TALC	inhibitor	IMETELSTAT	IMETELSTAT
TERT	telomerase reverse transcriptase	TALC	inhibitor	SODIUM METAARSENITE	SODIUM METAARSENITE
SLC22A16	"solute carrier family 22 (organic cation/carnitine transporter), member 16"	PharmGKB	n/a	PA449165	CYCLOPHOSPHAMIDE
SLC22A16	"solute carrier family 22 (organic cation/carnitine transporter), member 16"	PharmGKB	n/a	PA449412	DOXORUBICIN
SLC22A16	"solute carrier family 22 (organic cation/carnitine transporter), member 16"	PharmGKB	n/a	PA165291922	DOXORUBICINOL
GSS	glutathione synthetase	DrugBank	stimulator	DB06151	ACETYLCYSTEINE
GSS	glutathione synthetase	DrugBank	n/a	DB00143	GLUTATHIONE
GSS	glutathione synthetase	DrugBank	n/a	DB00145	GLYCINE
GSS	glutathione synthetase	DrugBank	n/a	DB00151	L-CYSTEINE
GSS	glutathione synthetase	DrugBank	n/a	DB03408	GAMMA-GLUTAMYLCYSTEINE
GSS	glutathione synthetase	DrugBank	n/a	DB04395	PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA448404	AMODIAQUINE
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA449782	GLIBENCLAMIDE
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA165857067	CHLORPROGUANIL
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA165111697	ARTESUNATE
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA449211	DAPSONE
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	DrugBank	n/a	DB04998	AGRO100
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	DrugBank	n/a	DB05289	MPC-7869
OAZ1	ornithine decarboxylase antizyme 1	DrugBank	n/a	DB00129	L-ORNITHINE
ALDH3B2	"aldehyde dehydrogenase 3 family, member B2"	DrugBank	n/a	DB00157	NADH
ARF6	ADP-ribosylation factor 6	DrugBank	n/a	DB01864	5-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE@TICLOPIDINE#AZD6140#TICAGRELOR#TREPROSTINIL#CLOPIDOGREL#EPOPROSTENOL#PRASUGREL#2MESADP#CLOPIDOGREL (ACTIVE METABOLITE)#CANGRELOR#CANGRELOR#[<SUP>3</SUP>H]2MESADP#COMPOUND 4 [PMID:23083103]#[<SUP>3</SUP>H]PSB-0413#ARL66096#BX 667#2MESATP#BX 048#ADP&BETA;S#ATP#COMPOUND 20O [PMID:22984835]#TICAGRELOR#ATP&GAMMA;S#AR-C67085#ADENOSINE DIPHOSPHATE#2MESAMP#INS49266#INS50589#R-138727#PSB-0739#PCMPS#PSB-0739#COMPOUND 4 [PMID:22984835]#CLOPIDOGREL BISULFATE#TICLOPIDINE HYDROCHLORIDE#PRASUGREL HYDROCHLORIDE#CLOPIDOGREL#TICAGRELOR#INS-50589#PRASUGREL#TICAGRELOR#TREPROSTINIL#CLOPIDOGREL#MC-1#TICLOPIDINE#ELINOGREL#CANGRELOR#CLOPIDOGREL#TICLOPIDINE#TICLOPIDINE#TREPROSTINIL#PRASUGREL#CLOPIDOGREL#CLOPIDOGREL#TICLOPIDINE#BRILINTA#AR-C69931 MX#PRASUGREL
drugs_in_module9	NA	NA	[<SUP>3</SUP>H]CPP#LY233053#L689560#GV196771A#(<I>RS</I>)-(TETRAZOL-5-YL)GLYCINE#D-SERINE#CONANTOKIN-G#L701324#NMDA#L-ASPARTATE#SELFOTEL#D-ASPARTATE#[<SUP>3</SUP>H]CGS19755#[<SUP>3</SUP>H]CGP39653#D-AP5#CGP37849#5,7-DICHLOROKYNURENIC ACID#[<SUP>3</SUP>H]CGP61594#PHENCYCLIDINE#UBP141#[<SUP>3</SUP>H]L689560#GLYCINE#[<SUP>3</SUP>H]MDL105519#AMANTIDINE#N<SUP>1</SUP>-DANSYL-SPERMINE#KETAMINE#DIZOCILPINE#MG<SUP>2+</SUP>#D-CCPENE#[<SUP>3</SUP>H]DIZOCILPINE#[<SUP>3</SUP>H]GLYCINE#HOMOQUINOLINIC ACID#CNS-5161#DIMIRACETAM#AZD-6765#LATREPIRDINE#ORPHENADRINE#V3381#DEXANABINOL#AM-101#NEU-2000#ORPHENADRINE#L-GLUTAMIC ACID#PETHIDINE#ORPHENADRINE#TENOCYCLIDINE#ACETYLCYSTEINE@PF-00547659@5-[(Z)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE@ISIS 113715#TRODUSQUEMINE#TILUDRONATE#1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE#5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID#4-[3-(DIBENZYLAMINO)PHENYL]-2,4-DIOXOBUTANOIC ACID#5-(3-HYDROXYPHENYL)ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDE#N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE#ISOTHIAZOLIDINONE ANALOG#COMPOUND 12, N-ACETYL-4-[(CARBOXYCARBONYL)(2-CARBOXYPHENYL)AMINO]-N-PENTYL-1-NAPTHYLALANIAMIDE#DOUBLE OXIDIZED CYSTEINE#TILUDRONATE#6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID#PARA-(BENZOYL)-PHENYLALANINE#COMPOUND 9#(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER#5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE#2-(OXALYL-AMINO)-4,7-DIHYDRO-5H-THIENO[2,3-C]THIOPYRAN-3-CARBOXYLIC ACID#3(R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER#(4-{(2S)-2-[(TERT-BUTOXYCARBONYL)AMINO]-3-METHOXY-3-OXOPROPYL}PHENYL)METHANESELENINIC ACID#3-(3,5-DIBROMO-4-HYDROXY-BENZOYL)-2-ETHYL-BENZOFURAN-6-SULFONIC ACID (4-SULFAMOYL-PHENYL)-AMIDE#4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN#3-(OXALYL-AMINO)-NAPHTHALENE-2-CARBOXYLIC ACID#[[4-(AMINOMETHYL)PHENYL]AMINO]OXO-ACETIC ACID,#2-{4-[(2S)-2-[({[(1S)-1-CARBOXY-2-PHENYLETHYL]AMINO}CARBONYL)AMINO]-3-OXO-3-(PENTYLAMINO)PROPYL]PHENOXY}MALONIC ACID#COMPOUND 19#SP7343-SP7964#2-(OXALYL-AMINO)-BENZOIC ACID#{[2-(1H-1,2,3-BENZOTRIAZOL-1-YL)-2-(3,4-DIFLUOROPHENYL)PROPANE-1,3-DIYL]BIS[4,1-PHENYLENE(DIFLUOROMETHYLENE)]}BIS(PHOSPHONIC ACID)#NOVO NORDISK A/S COMPOUND#N-[4-(2-{2-[3-(2-BROMO-ACETYLAMINO)-PROPIONYLAMINO]-3-HYDROXY-PROPIONYLAMINO}-ETHYL)-PHENYL]-OXALAMIC ACID#3-(3,5-DIBROMO-4-HYDROXY-BENZOYL)-2-ETHYL-BENZOFURAN-6-SULFONIC ACID [4-(THIAZOL-2-YLSULFAMOYL)-PHENYL]-AMIDE#7-(1,1-DIOXO-1H-BENZO[D]ISOTHIAZOL-3-YLOXYMETHYL)-2-(OXALYL-AMINO)-4,7-DIHYDRO-5H-THIENO[2,3-C]PYRAN-3-CARBOXYLIC ACID#5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE#4-CARBAMOYL-4-{[6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBONYL]-AMINO}-BUTYRIC ACID#N-{1-[5-(1-CARBAMOYL-2-MERCAPTO-ETHYLCARBAMOYL)-PENTYLCARBAMOYL]-2-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-ETHYL}-3-{2-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-ACETYLAMINO}-SUCCINAMIC ACID#{4-[(2S,4E)-2-(1,3-BENZOTHIAZOL-2-YL)-2-(1H-1,2,3-BENZOTRIAZOL-1-YL)-5-PHENYLPENT-4-ENYL]PHENYL}(DIFLUORO)METHYLPHOSPHONIC ACID#4-BENZOYLAMINO-4-{1-{1-CARBAMOYL-2-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-ETHYLCARBAMOYL}-2-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-ETHYLCARBAMOYL}-BUTYRIC ACID#PNU177836#2-(OXALYL-AMINO)-4,7-DIHYDRO-5H-THIENO[2,3-C]PYRAN-3-CARBOXYLIC ACID#{[7-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALEN-2-YL]-DIFLUORO-METHYL}-PHOSPHONIC ACID#[(4-{4-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-BUTYL}-PHENYL)-DIFLUORO-METHYL]-PHOSPHONIC ACID#ISIS 113715#3-(CARBOXYMETHOXY)THIENO[2,3-B]PYRIDINE-2-CARBOXYLIC ACID#4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID#[{2-BROMO-4-[(2R)-3-OXO-2,3-DIPHENYLPROPYL]PHENYL}(DIFLUORO)METHYL]PHOSPHONIC ACID#3(S)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER#5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID#2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID#4-BROMO-3-(CARBOXYMETHOXY)-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID#4-BROMO-3-(CARBOXYMETHOXY)-5-(4-HYDROXYPHENYL)THIOPHENE-2-CARBOXYLIC ACID#3-(3,5-DIBROMO-4-HYDROXY-BENZOYL)-2-ETHYL-BENZOFURAN-6-SULFONIC ACID DIMETHYLAMIDE#CYSTEINESULFONIC ACID#2-(OXALYL-AMINO)-4,5,6,7-TETRAHYDRO-THIENO[2,3-C]PYRIDINE-3-CARBOXYLIC ACID#N-(ALLYLOXYCARBONYL)-4-[N-(CARBOXY-FORMYL)-2-(BENZOIC ACID)-AMINO]-L-PHENYLALANINYL-AMINO-BUTYLOXY-(6-HYDROXY-BENZOIC ACID METHYL ESTER)#COMPOUND 5, 2-(NAPHTHALEN-1-YL-OXALYL-AMINO)-BENZOICACID#6-(OXALYL-AMINO)-1H-INDOLE-5-CARBOXYLIC ACID#2-(CARBOXYMETHOXY)-5-[(2S)-2-({(2S)-2-[(3-CARBOXYPROPANOYL)AMINO] -3-PHENYLPROPANOYL}AMINO)-3-OXO-3-(PENTYLAMINO)PROPYL]BENZOIC ACID#1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID#TILUDRONATE#ISIS 113715#ISIS-PTP1B@TALTIRELIN#METRH#PROTIRELIN	TALTIRELIN#METRH#PROTIRELIN	UROKINASE#TRANEXAMIC ACID#STREPTOKINASE#ALTEPLASE#RETEPLASE#ANISTREPLASE#AMINOCAPROIC ACID#TENECTEPLASE#BICINE#DESMOTEPLASE#APROTININ#ANTITHROMBIN#DESMOTEPLASE#AMEDIPLASE#ANISTREPLASE#ALTEPLASE#PLASMIN#UROKINASE#RETEPLASE#TRANEXAMIC ACID#AMINOCAPROIC ACID#TENECTEPLASE#UROKINASE#STREPTOKINASE#AMINOCAPROIC ACID#ANISTREPLASE#TENECTEPLASE#ALTEPLASE#UROKINASE#RETEPLASE#TRANEXAMIC ACID#STREPTOKINASE#RETEPLASE#ALTEPLASE#AMINOCAPROIC ACID#UROKINASE#RETEPLASE#TENECTEPLASE#STREPTOKINASE#TENECTEPLASE#UROKINASE#ALTEPLASE#TRANEXAMIC ACID#AMINOCAPROIC ACID#APROTININ#RETEPLASE#STREPTOKINASE#ANISTREPLASE#6-AMINOCAPROIC ACID#APROTININ#TRANEXAMIC ACID#BIS-TRIAZOLE DERIVATIVE 10	NA	ANTIPSYCHOTICS@OLESOXIME#DIHYDROXYALUMINIUM#PRLX 93936#PRLX 93936	[<SUP>3</SUP>H]CPP#LY233053#L689560#GV196771A#(<I>RS</I>)-(TETRAZOL-5-YL)GLYCINE#D-SERINE#CONANTOKIN-G#L701324#NMDA#L-ASPARTATE#SELFOTEL#D-ASPARTATE#[<SUP>3</SUP>H]CGS19755#[<SUP>3</SUP>H]CGP39653#D-AP5#CGP37849#5,7-DICHLOROKYNURENIC ACID#[<SUP>3</SUP>H]CGP61594#PHENCYCLIDINE#UBP141#[<SUP>3</SUP>H]L689560#GLYCINE#[<SUP>3</SUP>H]MDL105519#AMANTIDINE#N<SUP>1</SUP>-DANSYL-SPERMINE#KETAMINE#DIZOCILPINE#MG<SUP>2+</SUP>#D-CCPENE#[<SUP>3</SUP>H]DIZOCILPINE#[<SUP>3</SUP>H]GLYCINE#HOMOQUINOLINIC ACID#CNS-5161#DIMIRACETAM#AZD-6765#LATREPIRDINE#ORPHENADRINE#V3381#DEXANABINOL#AM-101#NEU-2000#ORPHENADRINE#L-GLUTAMIC ACID#PETHIDINE#ORPHENADRINE#TENOCYCLIDINE#ACETYLCYSTEINE	NA
drugs_in_module10	NA	CONATUMUMAB#EMRICASAN#Z-IETD-FMK@BUPROPION#NICOTINE@2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE#2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE@NADH#2-MONOPHOSPHOADENOSINE 5-DIPHOSPHORIBOSE@N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE#(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE#CARFILZOMIB#BORTEZOMIB@ISIS 113715#TRODUSQUEMINE#TILUDRONATE#1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE#5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID#4-[3-(DIBENZYLAMINO)PHENYL]-2,4-DIOXOBUTANOIC ACID#5-(3-HYDROXYPHENYL)ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDE#N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE#ISOTHIAZOLIDINONE ANALOG#COMPOUND 12, N-ACETYL-4-[(CARBOXYCARBONYL)(2-CARBOXYPHENYL)AMINO]-N-PENTYL-1-NAPTHYLALANIAMIDE#DOUBLE OXIDIZED CYSTEINE#TILUDRONATE#6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID#PARA-(BENZOYL)-PHENYLALANINE#COMPOUND 9#(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER#5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE#2-(OXALYL-AMINO)-4,7-DIHYDRO-5H-THIENO[2,3-C]THIOPYRAN-3-CARBOXYLIC ACID#3(R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER#(4-{(2S)-2-[(TERT-BUTOXYCARBONYL)AMINO]-3-METHOXY-3-OXOPROPYL}PHENYL)METHANESELENINIC ACID#3-(3,5-DIBROMO-4-HYDROXY-BENZOYL)-2-ETHYL-BENZOFURAN-6-SULFONIC ACID (4-SULFAMOYL-PHENYL)-AMIDE#4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN#3-(OXALYL-AMINO)-NAPHTHALENE-2-CARBOXYLIC ACID#[[4-(AMINOMETHYL)PHENYL]AMINO]OXO-ACETIC ACID,#2-{4-[(2S)-2-[({[(1S)-1-CARBOXY-2-PHENYLETHYL]AMINO}CARBONYL)AMINO]-3-OXO-3-(PENTYLAMINO)PROPYL]PHENOXY}MALONIC ACID#COMPOUND 19#SP7343-SP7964#2-(OXALYL-AMINO)-BENZOIC ACID#{[2-(1H-1,2,3-BENZOTRIAZOL-1-YL)-2-(3,4-DIFLUOROPHENYL)PROPANE-1,3-DIYL]BIS[4,1-PHENYLENE(DIFLUOROMETHYLENE)]}BIS(PHOSPHONIC ACID)#NOVO NORDISK A/S COMPOUND#N-[4-(2-{2-[3-(2-BROMO-ACETYLAMINO)-PROPIONYLAMINO]-3-HYDROXY-PROPIONYLAMINO}-ETHYL)-PHENYL]-OXALAMIC ACID#3-(3,5-DIBROMO-4-HYDROXY-BENZOYL)-2-ETHYL-BENZOFURAN-6-SULFONIC ACID [4-(THIAZOL-2-YLSULFAMOYL)-PHENYL]-AMIDE#7-(1,1-DIOXO-1H-BENZO[D]ISOTHIAZOL-3-YLOXYMETHYL)-2-(OXALYL-AMINO)-4,7-DIHYDRO-5H-THIENO[2,3-C]PYRAN-3-CARBOXYLIC ACID#5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE#4-CARBAMOYL-4-{[6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBONYL]-AMINO}-BUTYRIC ACID#N-{1-[5-(1-CARBAMOYL-2-MERCAPTO-ETHYLCARBAMOYL)-PENTYLCARBAMOYL]-2-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-ETHYL}-3-{2-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-ACETYLAMINO}-SUCCINAMIC ACID#{4-[(2S,4E)-2-(1,3-BENZOTHIAZOL-2-YL)-2-(1H-1,2,3-BENZOTRIAZOL-1-YL)-5-PHENYLPENT-4-ENYL]PHENYL}(DIFLUORO)METHYLPHOSPHONIC ACID#4-BENZOYLAMINO-4-{1-{1-CARBAMOYL-2-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-ETHYLCARBAMOYL}-2-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-ETHYLCARBAMOYL}-BUTYRIC ACID#PNU177836#2-(OXALYL-AMINO)-4,7-DIHYDRO-5H-THIENO[2,3-C]PYRAN-3-CARBOXYLIC ACID#{[7-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALEN-2-YL]-DIFLUORO-METHYL}-PHOSPHONIC ACID#[(4-{4-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-BUTYL}-PHENYL)-DIFLUORO-METHYL]-PHOSPHONIC ACID#ISIS 113715#3-(CARBOXYMETHOXY)THIENO[2,3-B]PYRIDINE-2-CARBOXYLIC ACID#4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID#[{2-BROMO-4-[(2R)-3-OXO-2,3-DIPHENYLPROPYL]PHENYL}(DIFLUORO)METHYL]PHOSPHONIC ACID#3(S)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER#5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID#2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID#4-BROMO-3-(CARBOXYMETHOXY)-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID#4-BROMO-3-(CARBOXYMETHOXY)-5-(4-HYDROXYPHENYL)THIOPHENE-2-CARBOXYLIC ACID#3-(3,5-DIBROMO-4-HYDROXY-BENZOYL)-2-ETHYL-BENZOFURAN-6-SULFONIC ACID DIMETHYLAMIDE#CYSTEINESULFONIC ACID#2-(OXALYL-AMINO)-4,5,6,7-TETRAHYDRO-THIENO[2,3-C]PYRIDINE-3-CARBOXYLIC ACID#N-(ALLYLOXYCARBONYL)-4-[N-(CARBOXY-FORMYL)-2-(BENZOIC ACID)-AMINO]-L-PHENYLALANINYL-AMINO-BUTYLOXY-(6-HYDROXY-BENZOIC ACID METHYL ESTER)#COMPOUND 5, 2-(NAPHTHALEN-1-YL-OXALYL-AMINO)-BENZOICACID#6-(OXALYL-AMINO)-1H-INDOLE-5-CARBOXYLIC ACID#2-(CARBOXYMETHOXY)-5-[(2S)-2-({(2S)-2-[(3-CARBOXYPROPANOYL)AMINO] -3-PHENYLPROPANOYL}AMINO)-3-OXO-3-(PENTYLAMINO)PROPYL]BENZOIC ACID#1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID#TILUDRONATE#ISIS 113715#ISIS-PTP1B	NA	NA	NA	NA	NA	7&BETA;-HYDROXYCHOLESTEROL#27-HYDROXYCHOLESTEROL#7&ALPHA;,25-DIHYDROXYCHOLESTEROL#7&ALPHA;,25-DIHYDROXYCHOLESTEROL#7&ALPHA;-HYDROXYCHOLESTEROL#7&BETA;, 25-DIHYDROXYCHOLESTEROL#7&BETA;, 27-DIHYDROXYCHOLESTEROL#25-HYDROXYCHOLESTEROL#7&ALPHA;,27-DIHYDROXYCHOLESTEROL@OLESOXIME#DIHYDROXYALUMINIUM#PRLX 93936#PRLX 93936	NA
drugs_in_module11	NA	PREDNISONE#MELPHALAN#IPILIMUMAB#TREMELIMUMAB#IPILIMUMAB#IPILIMUMAB#TREMELIMUMAB#IPILIMUMAB#IPILIMUMAB#TREMELIMUMAB#IPILIMUMAB#TREMELIMUMAB#IPILIMUMAB#IPILIMUMAB#CP-675206#IPILIMUMAB@V3381#FELBAMATE#DIMIRACETAM#AM-101#DEXANABINOL#LATREPIRDINE#AZD-6765#EVT-101#EVT-103#MEMANTINE#CNS-5161#MEMANTINE#NERAMEXANE#NEU-2000#EVT-101#BESONPRODIL#TRAXOPRODIL#RGH-896#L-GLUTAMIC ACID#TENOCYCLIDINE#PETHIDINE#ACETYLCYSTEINE#FELBAMATE#HALOPERIDOL#IFENPRODIL#MEMANTINE#FELBAMATE#MEMANTINE#HOMOQUINOLINIC ACID#D-SERINE#D-ASPARTATE#GLYCINE#L-ASPARTATE#MG<SUP>2+</SUP>#[<SUP>3</SUP>H]GLYCINE#GV196771A#(<I>RS</I>)-(TETRAZOL-5-YL)GLYCINE#CGP37849#(+)-HA966#NMDA#5,7-DICHLOROKYNURENIC ACID#CONANTOKIN-G#D-AP5#D-CCPENE#[<SUP>3</SUP>H]CGP61594#AMANTIDINE#L701324#L689560#[<SUP>3</SUP>H]DIZOCILPINE#LY233053#PHENCYCLIDINE#N<SUP>1</SUP>-DANSYL-SPERMINE#KETAMINE#DIZOCILPINE#SELFOTEL#NVP-AAM077#UBP141#[<SUP>3</SUP>H]CGP39653#[<SUP>3</SUP>H]MDL105519#[<SUP>3</SUP>H]L689560#[<SUP>3</SUP>H]CPP#[<SUP>3</SUP>H]CGS19755#VALPROIC ACID@N-(3-(AMINOMETHYL)BENZYL)ACETAMIDINE#1,2,4-TRIAZOLE-CARBOXAMIDINE#L-N(OMEGA)-NITROARGININE-(4R)-AMINO-L-PROLINE AMIDE#S,S'-(1,4-PHENYLENE-BIS(1,2-ETHANEDIYL))BIS-ISOTHIOUREA#7-NITROINDAZOLE#ETHYLISOTHIOUREA#2-AMINOTHIAZOLINE#S-ETHYL-N-PHENYL-ISOTHIOUREA#S,S'-(1,3-PHENYLENE-BIS(1,2-ETHANEDIYL))BIS-ISOTHIOUREA#SE-ETHYL-ISOSELENOUREA#6S-5,6,7,8-TETRAHYDROBIOPTERIN#S-(DIMETHYLARSENIC)CYSTEINE#L-HOMOARGININE#S-ISOPROPYL-ISOTHIOUREA#(6R,1'R,2'S)-5,6,7,8 TETRAHYDROBIOPTERIN#NITROARGININE#2,4-DIAMINO-6-PHENYL-5,6,7,8,-TETRAHYDROPTERIDINE#5-NITROINDAZOLE#N-(CHLOROPHENYL)-N-HYDROXYGUANIDINE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB02979	"N1,N14-BIS((S-METHYL)ISOTHIOUREIDO)TETRADECANE"
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB02994	HYDROXYDIMETHYLARSINE OXIDE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB07001	"(3S,5E)-3-PROPYL-3,4-DIHYDROTHIENO[2,3-F][1,4]OXAZEPIN-5(2H)-IMINE"
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03065	7-NITROINDAZOLE-2-CARBOXAMIDINE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	cofactor	DB00360	TETRAHYDROBIOPTERIN
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03100	6-NITROINDAZOLE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03144	N-OMEGA-HYDROXY-L-ARGININE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03305	N5-IMINOETHYL-L-ORNITHINE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03332	"5,6-CYCLIC-TETRAHYDROPTERIDINE"
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB00125	L-ARGININE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB07244	"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE"
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB00155	L-CITRULLINE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	inhibitor	DB01110	MICONAZOLE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB01686	"N,N-DIMETHYLARGININE"
NOS3	nitric oxide synthase 3 (endothelial cell)	TEND	n/a	TETRAHYDROBIOPTERIN	TETRAHYDROBIOPTERIN
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB02379	BETA-D-GLUCOSE
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB07359	"3-[(4-FLUOROPHENYL)SULFANYL]-N-(4-METHYL-1,3-THIAZOL-2-YL)-6-[(4-METHYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]PYRIDINE-2-CARBOXAMIDE"
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB07358	"2-AMINO-N-(4-METHYL-1,3-THIAZOL-2-YL)-5-[(4-METHYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]BENZAMIDE"
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB08118	"2-(METHYLAMINO)-N-(4-METHYL-1,3-THIAZOL-2-YL)-5-[(4-METHYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]BENZAMIDE"
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB08210	"2-AMINO-4-FLUORO-5-[(1-METHYL-1H-IMIDAZOL-2-YL)SULFANYL]-N-(1,3-THIAZOL-2-YL)BENZAMIDE"
GCK	glucokinase (hexokinase 4)	TdgClinicalTrial	n/a	LY-2599506	LY-2599506
GCK	glucokinase (hexokinase 4)	TdgClinicalTrial	n/a	ARRY-403	ARRY-403
GCK	glucokinase (hexokinase 4)	TTD	inhibitor	DCL000153	LONIDAMINE
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL000457	AZD1656
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL000475	AZD6370
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL000614	R7201
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL000201	PSN-101
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL001154	AZD5658
GCK	glucokinase (hexokinase 4)	GuideToPharmacologyInteractions	n/a	7701	AZD1656
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CERITINIB	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CERITINIB	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CERITINIB	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	ChEMBL	inhibitor	CHEMBL601719	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	ChEMBL	inhibitor	CHEMBL2403108	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	GANETESPIB	GANETESPIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	GANETESPIB	GANETESPIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	TSR-011	TSR-011
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	X-396	X-396
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	ASP3026	ASP3026
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	LDK378	LDK378
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	CH5424802	CH5424802
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	CancerCommons	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	CancerCommons	inhibitor	ASP3026	ASP3026
ALK	anaplastic lymphoma receptor tyrosine kinase	CancerCommons	inhibitor	LDK378	LDK378
ALK	anaplastic lymphoma receptor tyrosine kinase	CancerCommons	inhibitor	X-396	X-396
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	X-396	X-396
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	LDK378	LDK378
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	ASP3026	ASP3026
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	23344087	23344087
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	PF-06463922	PF-06463922
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	TAE684	TAE684
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	AUY922	AUY922
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	CERITINIB	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	PEMETREXED	PEMETREXED
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	CH5424802	CH5424802
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	TdgClinicalTrial	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7739	ALECTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7741	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7741	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7706	AZD3463
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7397	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	4903	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7476	PF-06463922
ALK	anaplastic lymphoma receptor tyrosine kinase	PharmGKB	n/a	PA165946122	CRIZOTINIB
KCNK6	"potassium channel, subfamily K, member 6"	DrugBank	inhibitor	DB00308	IBUTILIDE
KCNK6	"potassium channel, subfamily K, member 6"	DrugBank	inhibitor	DB00908	QUINIDINE
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	DrugBank	inhibitor	DB00230	PREGABALIN
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	DrugBank	inhibitor	DB00836	LOPERAMIDE
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	DrugBank	inhibitor	DB01244	BEPRIDIL
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	DrugBank	inhibitor	DB00661	VERAPAMIL
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TdgClinicalTrial	n/a	NISOLDIPINE	NISOLDIPINE
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TdgClinicalTrial	n/a	BEPRIDIL	BEPRIDIL
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TdgClinicalTrial	n/a	PREGABALIN	PREGABALIN
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TEND	n/a	PREGABALIN	PREGABALIN
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TEND	n/a	BEPRIDIL	BEPRIDIL
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TEND	n/a	NISOLDIPINE	NISOLDIPINE
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	PharmGKB	n/a	PA448871	CELECOXIB
TRBC1	T cell receptor beta constant 1	DrugBank	n/a	DB02740	3-INDOLEBUTYRIC ACID
MCOLN1	mucolipin 1	GuideToPharmacologyInteractions	n/a	2794	"PHOSPHATIDYL (3,5) INOSITOL BIPHOSPHATE"
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	AZD6244	AZD6244
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	AZD6244	AZD6244
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	GDC-0973	GDC-0973
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	SELUMETINIB	SELUMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	BAY869766	BAY869766
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	DABRAFENIB MESYLATE	DABRAFENIB MESYLATE
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	BAY869766	BAY869766
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	TdgClinicalTrial	n/a	WX-554	WX-554
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB04141	"2-HEXYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL"
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB08453	2-NONYL-4-HYDROXYQUINOLINE N-OXIDE
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB07778	FAMOXADONE
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB04799	"5-N-UNDECYL-6-HYDROXY-4,7-DIOXOBENZOTHIAZOLE"
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB07401	METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB08330	METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB07763	"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE"
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB08690	UBIQUINONE-2
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	3934	RESOLVIN D1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6240	MMK-1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6250	MHC BINDING PEPTIDE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	3411	[<SUP>3</SUP>H]LXA<SUB>4</SUB>
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6267	PSM&ALPHA;3
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1031	ANNEXIN I
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	3383	ATLA2
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6246	N36
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6239	ASPIRIN-TRIGGERED RESOLVIN D1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6265	QUIN-C1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	5831	"PYRAZOLONE, 1"
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6242	SERUM AMYLOID A
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	5555	RVD1-ME
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6251	SCK&BETA;8-1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6264	FPRL1-INHIBITOR PROTEIN
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6275	SHAAGTIDE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6248	V3 PEPTIDE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6249	UPAR FRAGMENT
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6245	T21/DP107
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1048	WKYMVM
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1043	PBP10
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1034	LXA<SUB>4</SUB>
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	5841	FMET-ILE-VAL-THR-LEU-PHE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6263	COMPOUND 1754-31
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1039	QUIN-C7
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6244	PRP<SUB>106-126</SUB>
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1022	FMET-LEU-PHE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1041	ISOPROPYLUREIDO-FLFLF
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6269	COMPOUND R-(-)-5F [PMID: 22607879]
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1030	T-BOC-FLFLF
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1040	WRWWWW
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1046	HP(2-20)
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6241	CGEN-855A
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6241	CGEN-855A
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6268	AG-26
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6198	[<SUP>125</SUP>I-TYR]AC2-26
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	4865	AMYLOID &BETA;
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	3933	ASPIRIN TRIGGERED LIPOXIN A4
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1044	ANNEXIN I-(2-26)
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6247	F PEPTIDE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1047	HUMANIN
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	5527	LL-37
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1023	FMET-MET-TYR-ALA-LEU-PHE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1034	LXA<SUB>4</SUB>
TNNT2	troponin T type 2 (cardiac)	TdgClinicalTrial	n/a	TIRAMSETIV	TIRAMSETIV
XPC	"xeroderma pigmentosum, complementation group C"	PharmGKB	n/a	PA449014	CISPLATIN
ECE1	endothelin converting enzyme 1	DrugBank	n/a	DB07171	"5-(2-HYDROXYETHYL)NONANE-1,9-DIOL"
ECE1	endothelin converting enzyme 1	GuideToPharmacologyInteractions	n/a	6506	DAGLUTRIL
ECE1	endothelin converting enzyme 1	GuideToPharmacologyInteractions	n/a	6562	(2S)-2-(2-BENZYL-3-{[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-PHENYLETHYL](HYDROXY)PHOSPHORYL}PROPANAMIDO)-3-(1H-INDOL-3-YL)PROPANOIC ACID
ECE1	endothelin converting enzyme 1	GuideToPharmacologyInteractions	n/a	6507	KC-12615
IL25	interleukin 25	TdgClinicalTrial	n/a	VIDOFLUDIMUS	VIDOFLUDIMUS
SLC7A9	"solute carrier family 7 (glycoprotein-associated amino acid transporter light chain, bo,+ system), member 9"	DrugBank	n/a	DB00138	L-CYSTINE
TERT	telomerase reverse transcriptase	DrugBank	inhibitor	DB00495	ZIDOVUDINE
TERT	telomerase reverse transcriptase	DrugBank	n/a	DB04937	GV1001
TERT	telomerase reverse transcriptase	DrugBank	n/a	DB05036	GRN163L
TERT	telomerase reverse transcriptase	TdgClinicalTrial	n/a	V934/V935	V934/V935
TERT	telomerase reverse transcriptase	TdgClinicalTrial	n/a	IMETELSTAT	IMETELSTAT
TERT	telomerase reverse transcriptase	TdgClinicalTrial	n/a	GV1001	GV1001
TERT	telomerase reverse transcriptase	TALC	inhibitor	IMETELSTAT	IMETELSTAT
TERT	telomerase reverse transcriptase	TALC	inhibitor	SODIUM METAARSENITE	SODIUM METAARSENITE
SLC22A16	"solute carrier family 22 (organic cation/carnitine transporter), member 16"	PharmGKB	n/a	PA449165	CYCLOPHOSPHAMIDE
SLC22A16	"solute carrier family 22 (organic cation/carnitine transporter), member 16"	PharmGKB	n/a	PA449412	DOXORUBICIN
SLC22A16	"solute carrier family 22 (organic cation/carnitine transporter), member 16"	PharmGKB	n/a	PA165291922	DOXORUBICINOL
GSS	glutathione synthetase	DrugBank	stimulator	DB06151	ACETYLCYSTEINE
GSS	glutathione synthetase	DrugBank	n/a	DB00143	GLUTATHIONE
GSS	glutathione synthetase	DrugBank	n/a	DB00145	GLYCINE
GSS	glutathione synthetase	DrugBank	n/a	DB00151	L-CYSTEINE
GSS	glutathione synthetase	DrugBank	n/a	DB03408	GAMMA-GLUTAMYLCYSTEINE
GSS	glutathione synthetase	DrugBank	n/a	DB04395	PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA448404	AMODIAQUINE
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA449782	GLIBENCLAMIDE
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA165857067	CHLORPROGUANIL
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA165111697	ARTESUNATE
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA449211	DAPSONE
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	DrugBank	n/a	DB04998	AGRO100
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	DrugBank	n/a	DB05289	MPC-7869
OAZ1	ornithine decarboxylase antizyme 1	DrugBank	n/a	DB00129	L-ORNITHINE
ALDH3B2	"aldehyde dehydrogenase 3 family, member B2"	DrugBank	n/a	DB00157	NADH
ARF6	ADP-ribosylation factor 6	DrugBank	n/a	DB01864	5-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE@TALTIRELIN#METRH#PROTIRELIN	NA	NA	NA	NA	7&BETA;-HYDROXYCHOLESTEROL#27-HYDROXYCHOLESTEROL#7&ALPHA;,25-DIHYDROXYCHOLESTEROL#7&ALPHA;,25-DIHYDROXYCHOLESTEROL#7&ALPHA;-HYDROXYCHOLESTEROL#7&BETA;, 25-DIHYDROXYCHOLESTEROL#7&BETA;, 27-DIHYDROXYCHOLESTEROL#25-HYDROXYCHOLESTEROL#7&ALPHA;,27-DIHYDROXYCHOLESTEROL@NADH#2-MONOPHOSPHOADENOSINE 5-DIPHOSPHORIBOSE@MARIMASTAT@PSEUDOEPHEDRINE@UROKINASE#TRANEXAMIC ACID#STREPTOKINASE#ALTEPLASE#RETEPLASE#ANISTREPLASE#AMINOCAPROIC ACID#TENECTEPLASE#BICINE#DESMOTEPLASE#APROTININ#ANTITHROMBIN#DESMOTEPLASE#AMEDIPLASE#ANISTREPLASE#ALTEPLASE#PLASMIN#UROKINASE#RETEPLASE#TRANEXAMIC ACID#AMINOCAPROIC ACID#TENECTEPLASE#UROKINASE#STREPTOKINASE#AMINOCAPROIC ACID#ANISTREPLASE#TENECTEPLASE#ALTEPLASE#UROKINASE#RETEPLASE#TRANEXAMIC ACID#STREPTOKINASE#RETEPLASE#ALTEPLASE#AMINOCAPROIC ACID#UROKINASE#RETEPLASE#TENECTEPLASE#STREPTOKINASE#TENECTEPLASE#UROKINASE#ALTEPLASE#TRANEXAMIC ACID#AMINOCAPROIC ACID#APROTININ#RETEPLASE#STREPTOKINASE#ANISTREPLASE#6-AMINOCAPROIC ACID#APROTININ#TRANEXAMIC ACID#BIS-TRIAZOLE DERIVATIVE 10	NA	NA
drugs_in_module12	METHOTREXATE@RONTALIZUMAB@[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}AMINO)PHENYL]ACETONITRILE#1-CYCLOBUTYL-3-(3,4-DIMETHOXYPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE#1-CYCLOPENTYL-3-(1H-PYRROLO[2,3-B]PYRIDIN-5-YL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE#1-(1-METHYLETHYL)-3-QUINOLIN-6-YL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE#2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE#N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE#(2E)-N-{4-[(3-BROMOPHENYL)AMINO]QUINAZOLIN-6-YL}-4-(DIMETHYLAMINO)BUT-2-ENAMIDE#3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL#RU78300#PONATINIB#RU82197#DPI59#N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE#NINTEDANIB#PHENYLPHOSPHATE#RU84687#1-[1-(3-AMINOPHENYL)-3-TERT-BUTYL-1H-PYRAZOL-5-YL]-3-PHENYLUREA#1-[1-(3-AMINOPHENYL)-3-TERT-BUTYL-1H-PYRAZOL-5-YL]-3-NAPHTHALEN-1-YLUREA#RU79073#RU79256#N6-BENZYL ADENOSINE-5-DIPHOSPHATE
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB01908	RU85493
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	multitarget	DB01254	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB01947	RU78262
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB01962	PHOSPHONOTYROSINE
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02175	MALONIC ACID
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02336	RU83876
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02432	RU90395
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02762	RU79072
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB02908	RU78783
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03591	RU82209
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03628	ISO24
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03712	RU85053
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03023	"1-TERT-BUTYL-3-(4-CHLORO-PHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-YLAMINE"
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03828	RU78299
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03902	OXALIC ACID
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04080	RU78191
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	inhibitor	DB06616	BOSUTINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04272	CITRIC ACID
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03078	PASBN
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03104	RU82129
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB03114	PAS219
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04495	RU81843
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04739	4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB04751	PURVALANOL A
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	DrugBank	n/a	DB05184	XL228
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	GuideToPharmacologyInteractions	n/a	7731	SARACATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	GuideToPharmacologyInteractions	n/a	6048	SYK INHIBITOR III
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	GuideToPharmacologyInteractions	n/a	5976	GSK-3 INHIBITOR XIII
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	GuideToPharmacologyInteractions	n/a	6044	SU6656
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	ENMD-2076	ENMD-2076
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	DASATINIB	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	XL228	XL228
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	PONATINIB	PONATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	MASITINIB	MASITINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	KX2-391	KX2-391
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TdgClinicalTrial	n/a	BOSUTINIB	BOSUTINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	ChEMBL	inhibitor	CHEMBL24828	VANDETANIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	ChEMBL	inhibitor	CHEMBL288441	BOSUTINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TEND	n/a	DASATINIB	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	MyCancerGenome	inhibitor	KX2-391	KX2-391
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	MyCancerGenome	inhibitor	XL228	XL228
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	MyCancerGenome	inhibitor	SARACATINIB	SARACATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	CancerCommons	inhibitor	DASATINIB	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	XL228	XL228
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	DASATINIB	DASATINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	XL999	XL999
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	BOSUTINIB	BOSUTINIB
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	KX2-391	KX2-391
SRC	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)	TALC	inhibitor	SARACATINIB	SARACATINIB
SCPEP1	serine carboxypeptidase 1	DrugBank	n/a	DB07506	L-BENZYLSUCCINIC ACID
MMP24	matrix metallopeptidase 24 (membrane-inserted)	DrugBank	inhibitor	DB00786	MARIMASTAT
CCHCR1	coiled-coil alpha-helical rod protein 1	PharmGKB	n/a	PA450616	NEVIRAPINE
CCHCR1	coiled-coil alpha-helical rod protein 1	PharmGKB	n/a	PA448320	ALLOPURINOL
FGFR2	fibroblast growth factor receptor 2	DrugBank	antagonist	DB01041	THALIDOMIDE
FGFR2	fibroblast growth factor receptor 2	DrugBank	inhibitor	DB08901	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DrugBank	binder	DB00039	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	DrugBank	inhibitor	DB09078	LENVATINIB
FGFR2	fibroblast growth factor receptor 2	DrugBank	inhibitor	DB09079	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	DrugBank	n/a	DB02058	SU4984
FGFR2	fibroblast growth factor receptor 2	DrugBank	n/a	DB02491	4-[4-(1-AMINO-1-METHYLETHYL)PHENYL]-5-CHLORO-N-[4-(2-MORPHOLIN-4-YLETHYL)PHENYL]PYRIMIDIN-2-AMINE
FGFR2	fibroblast growth factor receptor 2	DrugBank	inhibitor	DB08896	REGORAFENIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PAZOPANIB	PAZOPANIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	DoCM	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	TEND	n/a	PALIFERMIN	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	TEND	n/a	THALIDOMIDE	THALIDOMIDE
FGFR2	fibroblast growth factor receptor 2	ChEMBL	agonist	CHEMBL1201821	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	ChEMBL	inhibitor	CHEMBL1946170	REGORAFENIB
FGFR2	fibroblast growth factor receptor 2	TTD	inhibitor	DAP001025	PENTOSAN POLYSULFATE
FGFR2	fibroblast growth factor receptor 2	TTD	binder	DAP000801	"INTERFERON ALFA-2A, RECOMBINANT"
FGFR2	fibroblast growth factor receptor 2	TTD	activator	DCL001020	TRAFERMIN
FGFR2	fibroblast growth factor receptor 2	TTD	inhibitor	DCL000361	AEE-788
FGFR2	fibroblast growth factor receptor 2	TTD	binder	DAP001026	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	TRAFERMIN	TRAFERMIN
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	CVBT-141B	CVBT-141B
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	THALIDOMIDE	THALIDOMIDE
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	PALIFERMIN	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	NINTEDANIB	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	CVBT-141H	CVBT-141H
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	ENMD-2076	ENMD-2076
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	ACTB1003	ACTB1003
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	ARQ 087	ARQ 087
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	PI-88	PI-88
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	FP-1039	FP-1039
FGFR2	fibroblast growth factor receptor 2	TdgClinicalTrial	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenomeClinicalTrial	inhibitor	REGORAFENIB	REGORAFENIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenomeClinicalTrial	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	MyCancerGenomeClinicalTrial	inhibitor	BGJ398	BGJ398
FGFR2	fibroblast growth factor receptor 2	MyCancerGenomeClinicalTrial	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	ClearityFoundationClinicalTrial	n/a	ENMD-2076	ENMD-2076
FGFR2	fibroblast growth factor receptor 2	ClearityFoundationClinicalTrial	n/a	NINTEDANIB	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	ClearityFoundationClinicalTrial	n/a	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	ClearityFoundationClinicalTrial	n/a	NINTEDANIB	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	VARGATEF	VARGATEF
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	XL999	XL999
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	TSU-68	TSU-68
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	BGJ398	BGJ398
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	REGORAFENIB	REGORAFENIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	LENVATINIB	LENVATINIB
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	XL228	XL228
FGFR2	fibroblast growth factor receptor 2	TALC	inhibitor	BRIVANIB	BRIVANIB
FGFR2	fibroblast growth factor receptor 2	TALC	antibody	FP-1039	FP-1039
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	PONATINIB	PONATINIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	MASITINIB	MASITINIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	XL228	XL228
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	AZD4547	AZD4547
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	BGJ398	BGJ398
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	NINTEDANIB	NINTEDANIB
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	E-3810	E-3810
FGFR2	fibroblast growth factor receptor 2	MyCancerGenome	inhibitor	DOVITINIB	DOVITINIB
FGFR2	fibroblast growth factor receptor 2	CancerCommons	inhibitor	BGJ398	BGJ398
FGFR2	fibroblast growth factor receptor 2	GuideToPharmacologyInteractions	n/a	6954	PALIFERMIN
FGFR2	fibroblast growth factor receptor 2	GuideToPharmacologyInteractions	n/a	7707	AZD4547
FGFR2	fibroblast growth factor receptor 2	GuideToPharmacologyInteractions	n/a	7877	BGJ-398
FGFR2	fibroblast growth factor receptor 2	GuideToPharmacologyInteractions	n/a	5936	NINTEDANIB
NPY	neuropeptide Y	DrugBank	n/a	DB03380	L-TYROSINAMIDE
NPY	neuropeptide Y	DrugBank	n/a	DB02952	ALPHA-AMINOISOBUTYRIC ACID
GLUD1	glutamate dehydrogenase 1	DrugBank	n/a	DB00142	L-GLUTAMIC ACID
GLUD1	glutamate dehydrogenase 1	DrugBank	n/a	DB00157	NADH
GLUD1	glutamate dehydrogenase 1	DrugBank	inhibitor	DB00756	HEXACHLOROPHENE
GLUD1	glutamate dehydrogenase 1	DrugBank	n/a	DB04137	GUANOSINE-5-TRIPHOSPHATE	ENMD-2076@DROTRECOGIN ALFA	NA	PSEUDOEPHEDRINE	NA	NA	RONTALIZUMAB@SPHINGOSINE 1-PHOSPHATE#PHYTOSPHINGOSINE 1-PHOSPHATE#COMPOUND 26 [PMID:16190743]#DIHYDROSP​HINGOSINE​-1-PHOSPH​ATE#VPC03090-P#VPC03090-P#SPHINGOSINE 1-PHOSPHATE#AFD(R)#FTY720-PHOSPHATE	R-788#R788#R343#PACLITAXEL#N-(2-HYDROXY-1,1-DIMETHYLETHYL)-1-METHYL-3-(1H-PYRROLO[2,3-B]PYRIDIN-2-YL)-1H-INDOLE-5-CARBOXAMIDE#2-{[(1R,2S)-2-AMINOCYCLOHEXYL]AMINO}-4-[(3-METHYLPHENYL)AMINO]PYRIMIDINE-5-CARBOXAMIDE#STAUROSPORINE#ELLAGIC ACID#6-({5-FLUORO-2-[(3,4,5-TRIMETHOXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-2,2-DIMETHYL-2H-PYRIDO[3,2-B][1,4]OXAZIN-3(4H)-ONE#2-{2-[(3,5-DIMETHYLPHENYL)AMINO]PYRIMIDIN-4-YL}-N-[(1S)-2-HYDROXY-1-METHYLETHYL]-4-METHYL-1,3-THIAZOLE-5-CARBOXAMIDE#FOSTAMATINIB#PRT062607#ACU-XSP-001#R343#FOSTAMATINIB#SYK INHIBITOR#SYK INHIBITOR II#SYK INHIBITOR III#TAMATINIB	NA
drugs_in_module13	PREDNISONE#MELPHALAN#IPILIMUMAB#TREMELIMUMAB#IPILIMUMAB#IPILIMUMAB#TREMELIMUMAB#IPILIMUMAB#IPILIMUMAB#TREMELIMUMAB#IPILIMUMAB#TREMELIMUMAB#IPILIMUMAB#IPILIMUMAB#CP-675206#IPILIMUMAB@ETHANOLAMINE OLEATE#ANTITHROMBIN#METHYL 5-[(4-TERT-BUTYLBENZOYL)AMINO]-2H-1,2,4-TRIAZOLE-3-CARBOXYLATE@V3381#FELBAMATE#DIMIRACETAM#AM-101#DEXANABINOL#LATREPIRDINE#AZD-6765#EVT-101#EVT-103#MEMANTINE#CNS-5161#MEMANTINE#NERAMEXANE#NEU-2000#EVT-101#BESONPRODIL#TRAXOPRODIL#RGH-896#L-GLUTAMIC ACID#TENOCYCLIDINE#PETHIDINE#ACETYLCYSTEINE#FELBAMATE#HALOPERIDOL#IFENPRODIL#MEMANTINE#FELBAMATE#MEMANTINE#HOMOQUINOLINIC ACID#D-SERINE#D-ASPARTATE#GLYCINE#L-ASPARTATE#MG<SUP>2+</SUP>#[<SUP>3</SUP>H]GLYCINE#GV196771A#(<I>RS</I>)-(TETRAZOL-5-YL)GLYCINE#CGP37849#(+)-HA966#NMDA#5,7-DICHLOROKYNURENIC ACID#CONANTOKIN-G#D-AP5#D-CCPENE#[<SUP>3</SUP>H]CGP61594#AMANTIDINE#L701324#L689560#[<SUP>3</SUP>H]DIZOCILPINE#LY233053#PHENCYCLIDINE#N<SUP>1</SUP>-DANSYL-SPERMINE#KETAMINE#DIZOCILPINE#SELFOTEL#NVP-AAM077#UBP141#[<SUP>3</SUP>H]CGP39653#[<SUP>3</SUP>H]MDL105519#[<SUP>3</SUP>H]L689560#[<SUP>3</SUP>H]CPP#[<SUP>3</SUP>H]CGS19755#VALPROIC ACID	NA	L-GLUTAMIC ACID#(1<I>S</I>,3<I>R</I>)-ACPD#L-GLUTAMIC ACID#D-AP4#L-CCG-I#L-AP4#MPPG#LY341495#L-SERINE-O-PHOSPHATE#DCG-IV#AZ12216052#[<SUP>3</SUP>H]AP4#(<I>S</I>)-3,4-DCPG#EGLUMEGAD#(<I>R,S</I>)-4-PPG@N-(3-(AMINOMETHYL)BENZYL)ACETAMIDINE#1,2,4-TRIAZOLE-CARBOXAMIDINE#L-N(OMEGA)-NITROARGININE-(4R)-AMINO-L-PROLINE AMIDE#S,S'-(1,4-PHENYLENE-BIS(1,2-ETHANEDIYL))BIS-ISOTHIOUREA#7-NITROINDAZOLE#ETHYLISOTHIOUREA#2-AMINOTHIAZOLINE#S-ETHYL-N-PHENYL-ISOTHIOUREA#S,S'-(1,3-PHENYLENE-BIS(1,2-ETHANEDIYL))BIS-ISOTHIOUREA#SE-ETHYL-ISOSELENOUREA#6S-5,6,7,8-TETRAHYDROBIOPTERIN#S-(DIMETHYLARSENIC)CYSTEINE#L-HOMOARGININE#S-ISOPROPYL-ISOTHIOUREA#(6R,1'R,2'S)-5,6,7,8 TETRAHYDROBIOPTERIN#NITROARGININE#2,4-DIAMINO-6-PHENYL-5,6,7,8,-TETRAHYDROPTERIDINE#5-NITROINDAZOLE#N-(CHLOROPHENYL)-N-HYDROXYGUANIDINE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB02979	"N1,N14-BIS((S-METHYL)ISOTHIOUREIDO)TETRADECANE"
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB02994	HYDROXYDIMETHYLARSINE OXIDE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB07001	"(3S,5E)-3-PROPYL-3,4-DIHYDROTHIENO[2,3-F][1,4]OXAZEPIN-5(2H)-IMINE"
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03065	7-NITROINDAZOLE-2-CARBOXAMIDINE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	cofactor	DB00360	TETRAHYDROBIOPTERIN
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03100	6-NITROINDAZOLE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03144	N-OMEGA-HYDROXY-L-ARGININE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03305	N5-IMINOETHYL-L-ORNITHINE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03332	"5,6-CYCLIC-TETRAHYDROPTERIDINE"
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB00125	L-ARGININE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB07244	"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE"
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB00155	L-CITRULLINE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	inhibitor	DB01110	MICONAZOLE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB01686	"N,N-DIMETHYLARGININE"
NOS3	nitric oxide synthase 3 (endothelial cell)	TEND	n/a	TETRAHYDROBIOPTERIN	TETRAHYDROBIOPTERIN
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB02379	BETA-D-GLUCOSE
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB07359	"3-[(4-FLUOROPHENYL)SULFANYL]-N-(4-METHYL-1,3-THIAZOL-2-YL)-6-[(4-METHYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]PYRIDINE-2-CARBOXAMIDE"
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB07358	"2-AMINO-N-(4-METHYL-1,3-THIAZOL-2-YL)-5-[(4-METHYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]BENZAMIDE"
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB08118	"2-(METHYLAMINO)-N-(4-METHYL-1,3-THIAZOL-2-YL)-5-[(4-METHYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]BENZAMIDE"
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB08210	"2-AMINO-4-FLUORO-5-[(1-METHYL-1H-IMIDAZOL-2-YL)SULFANYL]-N-(1,3-THIAZOL-2-YL)BENZAMIDE"
GCK	glucokinase (hexokinase 4)	TdgClinicalTrial	n/a	LY-2599506	LY-2599506
GCK	glucokinase (hexokinase 4)	TdgClinicalTrial	n/a	ARRY-403	ARRY-403
GCK	glucokinase (hexokinase 4)	TTD	inhibitor	DCL000153	LONIDAMINE
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL000457	AZD1656
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL000475	AZD6370
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL000614	R7201
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL000201	PSN-101
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL001154	AZD5658
GCK	glucokinase (hexokinase 4)	GuideToPharmacologyInteractions	n/a	7701	AZD1656
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CERITINIB	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CERITINIB	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CERITINIB	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	ChEMBL	inhibitor	CHEMBL601719	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	ChEMBL	inhibitor	CHEMBL2403108	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	GANETESPIB	GANETESPIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	GANETESPIB	GANETESPIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	TSR-011	TSR-011
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	X-396	X-396
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	ASP3026	ASP3026
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	LDK378	LDK378
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	CH5424802	CH5424802
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	CancerCommons	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	CancerCommons	inhibitor	ASP3026	ASP3026
ALK	anaplastic lymphoma receptor tyrosine kinase	CancerCommons	inhibitor	LDK378	LDK378
ALK	anaplastic lymphoma receptor tyrosine kinase	CancerCommons	inhibitor	X-396	X-396
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	X-396	X-396
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	LDK378	LDK378
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	ASP3026	ASP3026
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	23344087	23344087
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	PF-06463922	PF-06463922
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	TAE684	TAE684
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	AUY922	AUY922
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	CERITINIB	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	PEMETREXED	PEMETREXED
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	CH5424802	CH5424802
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	TdgClinicalTrial	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7739	ALECTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7741	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7741	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7706	AZD3463
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7397	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	4903	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7476	PF-06463922
ALK	anaplastic lymphoma receptor tyrosine kinase	PharmGKB	n/a	PA165946122	CRIZOTINIB
KCNK6	"potassium channel, subfamily K, member 6"	DrugBank	inhibitor	DB00308	IBUTILIDE
KCNK6	"potassium channel, subfamily K, member 6"	DrugBank	inhibitor	DB00908	QUINIDINE
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	DrugBank	inhibitor	DB00230	PREGABALIN
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	DrugBank	inhibitor	DB00836	LOPERAMIDE
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	DrugBank	inhibitor	DB01244	BEPRIDIL
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	DrugBank	inhibitor	DB00661	VERAPAMIL
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TdgClinicalTrial	n/a	NISOLDIPINE	NISOLDIPINE
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TdgClinicalTrial	n/a	BEPRIDIL	BEPRIDIL
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TdgClinicalTrial	n/a	PREGABALIN	PREGABALIN
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TEND	n/a	PREGABALIN	PREGABALIN
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TEND	n/a	BEPRIDIL	BEPRIDIL
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TEND	n/a	NISOLDIPINE	NISOLDIPINE
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	PharmGKB	n/a	PA448871	CELECOXIB
TRBC1	T cell receptor beta constant 1	DrugBank	n/a	DB02740	3-INDOLEBUTYRIC ACID
MCOLN1	mucolipin 1	GuideToPharmacologyInteractions	n/a	2794	"PHOSPHATIDYL (3,5) INOSITOL BIPHOSPHATE"
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	AZD6244	AZD6244
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	AZD6244	AZD6244
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	GDC-0973	GDC-0973
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	SELUMETINIB	SELUMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	BAY869766	BAY869766
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	DABRAFENIB MESYLATE	DABRAFENIB MESYLATE
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	BAY869766	BAY869766
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	TdgClinicalTrial	n/a	WX-554	WX-554
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB04141	"2-HEXYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL"
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB08453	2-NONYL-4-HYDROXYQUINOLINE N-OXIDE
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB07778	FAMOXADONE
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB04799	"5-N-UNDECYL-6-HYDROXY-4,7-DIOXOBENZOTHIAZOLE"
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB07401	METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB08330	METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB07763	"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE"
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB08690	UBIQUINONE-2
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	3934	RESOLVIN D1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6240	MMK-1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6250	MHC BINDING PEPTIDE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	3411	[<SUP>3</SUP>H]LXA<SUB>4</SUB>
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6267	PSM&ALPHA;3
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1031	ANNEXIN I
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	3383	ATLA2
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6246	N36
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6239	ASPIRIN-TRIGGERED RESOLVIN D1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6265	QUIN-C1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	5831	"PYRAZOLONE, 1"
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6242	SERUM AMYLOID A
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	5555	RVD1-ME
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6251	SCK&BETA;8-1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6264	FPRL1-INHIBITOR PROTEIN
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6275	SHAAGTIDE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6248	V3 PEPTIDE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6249	UPAR FRAGMENT
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6245	T21/DP107
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1048	WKYMVM
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1043	PBP10
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1034	LXA<SUB>4</SUB>
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	5841	FMET-ILE-VAL-THR-LEU-PHE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6263	COMPOUND 1754-31
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1039	QUIN-C7
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6244	PRP<SUB>106-126</SUB>
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1022	FMET-LEU-PHE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1041	ISOPROPYLUREIDO-FLFLF
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6269	COMPOUND R-(-)-5F [PMID: 22607879]
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1030	T-BOC-FLFLF
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1040	WRWWWW
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1046	HP(2-20)
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6241	CGEN-855A
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6241	CGEN-855A
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6268	AG-26
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6198	[<SUP>125</SUP>I-TYR]AC2-26
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	4865	AMYLOID &BETA;
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	3933	ASPIRIN TRIGGERED LIPOXIN A4
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1044	ANNEXIN I-(2-26)
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6247	F PEPTIDE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1047	HUMANIN
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	5527	LL-37
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1023	FMET-MET-TYR-ALA-LEU-PHE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1034	LXA<SUB>4</SUB>
TNNT2	troponin T type 2 (cardiac)	TdgClinicalTrial	n/a	TIRAMSETIV	TIRAMSETIV
XPC	"xeroderma pigmentosum, complementation group C"	PharmGKB	n/a	PA449014	CISPLATIN
ECE1	endothelin converting enzyme 1	DrugBank	n/a	DB07171	"5-(2-HYDROXYETHYL)NONANE-1,9-DIOL"
ECE1	endothelin converting enzyme 1	GuideToPharmacologyInteractions	n/a	6506	DAGLUTRIL
ECE1	endothelin converting enzyme 1	GuideToPharmacologyInteractions	n/a	6562	(2S)-2-(2-BENZYL-3-{[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-PHENYLETHYL](HYDROXY)PHOSPHORYL}PROPANAMIDO)-3-(1H-INDOL-3-YL)PROPANOIC ACID
ECE1	endothelin converting enzyme 1	GuideToPharmacologyInteractions	n/a	6507	KC-12615
IL25	interleukin 25	TdgClinicalTrial	n/a	VIDOFLUDIMUS	VIDOFLUDIMUS
SLC7A9	"solute carrier family 7 (glycoprotein-associated amino acid transporter light chain, bo,+ system), member 9"	DrugBank	n/a	DB00138	L-CYSTINE
TERT	telomerase reverse transcriptase	DrugBank	inhibitor	DB00495	ZIDOVUDINE
TERT	telomerase reverse transcriptase	DrugBank	n/a	DB04937	GV1001
TERT	telomerase reverse transcriptase	DrugBank	n/a	DB05036	GRN163L
TERT	telomerase reverse transcriptase	TdgClinicalTrial	n/a	V934/V935	V934/V935
TERT	telomerase reverse transcriptase	TdgClinicalTrial	n/a	IMETELSTAT	IMETELSTAT
TERT	telomerase reverse transcriptase	TdgClinicalTrial	n/a	GV1001	GV1001
TERT	telomerase reverse transcriptase	TALC	inhibitor	IMETELSTAT	IMETELSTAT
TERT	telomerase reverse transcriptase	TALC	inhibitor	SODIUM METAARSENITE	SODIUM METAARSENITE
SLC22A16	"solute carrier family 22 (organic cation/carnitine transporter), member 16"	PharmGKB	n/a	PA449165	CYCLOPHOSPHAMIDE
SLC22A16	"solute carrier family 22 (organic cation/carnitine transporter), member 16"	PharmGKB	n/a	PA449412	DOXORUBICIN
SLC22A16	"solute carrier family 22 (organic cation/carnitine transporter), member 16"	PharmGKB	n/a	PA165291922	DOXORUBICINOL
GSS	glutathione synthetase	DrugBank	stimulator	DB06151	ACETYLCYSTEINE
GSS	glutathione synthetase	DrugBank	n/a	DB00143	GLUTATHIONE
GSS	glutathione synthetase	DrugBank	n/a	DB00145	GLYCINE
GSS	glutathione synthetase	DrugBank	n/a	DB00151	L-CYSTEINE
GSS	glutathione synthetase	DrugBank	n/a	DB03408	GAMMA-GLUTAMYLCYSTEINE
GSS	glutathione synthetase	DrugBank	n/a	DB04395	PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA448404	AMODIAQUINE
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA449782	GLIBENCLAMIDE
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA165857067	CHLORPROGUANIL
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA165111697	ARTESUNATE
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA449211	DAPSONE
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	DrugBank	n/a	DB04998	AGRO100
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	DrugBank	n/a	DB05289	MPC-7869
OAZ1	ornithine decarboxylase antizyme 1	DrugBank	n/a	DB00129	L-ORNITHINE
ALDH3B2	"aldehyde dehydrogenase 3 family, member B2"	DrugBank	n/a	DB00157	NADH
ARF6	ADP-ribosylation factor 6	DrugBank	n/a	DB01864	5-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE@[<SUP>14</SUP>C]ASCORBIC ACID#URSODEOXYCHOLIC ACID	NA	NA	NA	MDX-1105#MPDL3280A#MDX-1105#MPDL3280A#RG7446@RILUZOLE@N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE	V3381#FELBAMATE#DIMIRACETAM#AM-101#DEXANABINOL#LATREPIRDINE#AZD-6765#EVT-101#EVT-103#MEMANTINE#CNS-5161#MEMANTINE#NERAMEXANE#NEU-2000#EVT-101#BESONPRODIL#TRAXOPRODIL#RGH-896#L-GLUTAMIC ACID#TENOCYCLIDINE#PETHIDINE#ACETYLCYSTEINE#FELBAMATE#HALOPERIDOL#IFENPRODIL#MEMANTINE#FELBAMATE#MEMANTINE#HOMOQUINOLINIC ACID#D-SERINE#D-ASPARTATE#GLYCINE#L-ASPARTATE#MG<SUP>2+</SUP>#[<SUP>3</SUP>H]GLYCINE#GV196771A#(<I>RS</I>)-(TETRAZOL-5-YL)GLYCINE#CGP37849#(+)-HA966#NMDA#5,7-DICHLOROKYNURENIC ACID#CONANTOKIN-G#D-AP5#D-CCPENE#[<SUP>3</SUP>H]CGP61594#AMANTIDINE#L701324#L689560#[<SUP>3</SUP>H]DIZOCILPINE#LY233053#PHENCYCLIDINE#N<SUP>1</SUP>-DANSYL-SPERMINE#KETAMINE#DIZOCILPINE#SELFOTEL#NVP-AAM077#UBP141#[<SUP>3</SUP>H]CGP39653#[<SUP>3</SUP>H]MDL105519#[<SUP>3</SUP>H]L689560#[<SUP>3</SUP>H]CPP#[<SUP>3</SUP>H]CGS19755#VALPROIC ACID	5-[(Z)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE@N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE#(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE#CARFILZOMIB#BORTEZOMIB
drugs_in_module14	NA	TICLOPIDINE#AZD6140#TICAGRELOR#TREPROSTINIL#CLOPIDOGREL#EPOPROSTENOL#PRASUGREL#2MESADP#CLOPIDOGREL (ACTIVE METABOLITE)#CANGRELOR#CANGRELOR#[<SUP>3</SUP>H]2MESADP#COMPOUND 4 [PMID:23083103]#[<SUP>3</SUP>H]PSB-0413#ARL66096#BX 667#2MESATP#BX 048#ADP&BETA;S#ATP#COMPOUND 20O [PMID:22984835]#TICAGRELOR#ATP&GAMMA;S#AR-C67085#ADENOSINE DIPHOSPHATE#2MESAMP#INS49266#INS50589#R-138727#PSB-0739#PCMPS#PSB-0739#COMPOUND 4 [PMID:22984835]#CLOPIDOGREL BISULFATE#TICLOPIDINE HYDROCHLORIDE#PRASUGREL HYDROCHLORIDE#CLOPIDOGREL#TICAGRELOR#INS-50589#PRASUGREL#TICAGRELOR#TREPROSTINIL#CLOPIDOGREL#MC-1#TICLOPIDINE#ELINOGREL#CANGRELOR#CLOPIDOGREL#TICLOPIDINE#TICLOPIDINE#TREPROSTINIL#PRASUGREL#CLOPIDOGREL#CLOPIDOGREL#TICLOPIDINE#BRILINTA#AR-C69931 MX#PRASUGREL@HYALURONAN	NA	NA	NA	NA	2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE#2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE	METHYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE#N-({(2S,3S)-3-[(BENZYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINE#N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE#N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE#2-AMINOETHANIMIDIC ACID#DIPHENYLACETIC ACID#BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE#3-AMINO-4-OXYBENZYL-2-BUTANONE#N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO-2-METHYL-BUTANE#3-METHYLPHENYLALANINE#N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-#N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCINE#N-(3-PROPYLCARBAMOYLOXIRANE-2-CARBONYL)-ISOLEUCYL-PROLINE#2-PYRIDINETHIOL#Z-ARG-LEU-VAL-AGLY-ILE-VAL-OME	L-CITRULLINE
drugs_in_module15	NA	NA	ENMD-2076	DROTRECOGIN ALFA	NA	NA	NA	DROTRECOGIN ALFA@PREDNISONE#MELPHALAN#IPILIMUMAB#TREMELIMUMAB#IPILIMUMAB#IPILIMUMAB#TREMELIMUMAB#IPILIMUMAB#IPILIMUMAB#TREMELIMUMAB#IPILIMUMAB#TREMELIMUMAB#IPILIMUMAB#IPILIMUMAB#CP-675206#IPILIMUMAB@DYSTROPHIN#PRO044@N-(3-(AMINOMETHYL)BENZYL)ACETAMIDINE#1,2,4-TRIAZOLE-CARBOXAMIDINE#L-N(OMEGA)-NITROARGININE-(4R)-AMINO-L-PROLINE AMIDE#S,S'-(1,4-PHENYLENE-BIS(1,2-ETHANEDIYL))BIS-ISOTHIOUREA#7-NITROINDAZOLE#ETHYLISOTHIOUREA#2-AMINOTHIAZOLINE#S-ETHYL-N-PHENYL-ISOTHIOUREA#S,S'-(1,3-PHENYLENE-BIS(1,2-ETHANEDIYL))BIS-ISOTHIOUREA#SE-ETHYL-ISOSELENOUREA#6S-5,6,7,8-TETRAHYDROBIOPTERIN#S-(DIMETHYLARSENIC)CYSTEINE#L-HOMOARGININE#S-ISOPROPYL-ISOTHIOUREA#(6R,1'R,2'S)-5,6,7,8 TETRAHYDROBIOPTERIN#NITROARGININE#2,4-DIAMINO-6-PHENYL-5,6,7,8,-TETRAHYDROPTERIDINE#5-NITROINDAZOLE#N-(CHLOROPHENYL)-N-HYDROXYGUANIDINE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB02979	"N1,N14-BIS((S-METHYL)ISOTHIOUREIDO)TETRADECANE"
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB02994	HYDROXYDIMETHYLARSINE OXIDE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB07001	"(3S,5E)-3-PROPYL-3,4-DIHYDROTHIENO[2,3-F][1,4]OXAZEPIN-5(2H)-IMINE"
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03065	7-NITROINDAZOLE-2-CARBOXAMIDINE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	cofactor	DB00360	TETRAHYDROBIOPTERIN
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03100	6-NITROINDAZOLE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03144	N-OMEGA-HYDROXY-L-ARGININE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03305	N5-IMINOETHYL-L-ORNITHINE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03332	"5,6-CYCLIC-TETRAHYDROPTERIDINE"
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB00125	L-ARGININE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB07244	"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE"
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB00155	L-CITRULLINE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	inhibitor	DB01110	MICONAZOLE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB01686	"N,N-DIMETHYLARGININE"
NOS3	nitric oxide synthase 3 (endothelial cell)	TEND	n/a	TETRAHYDROBIOPTERIN	TETRAHYDROBIOPTERIN
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB02379	BETA-D-GLUCOSE
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB07359	"3-[(4-FLUOROPHENYL)SULFANYL]-N-(4-METHYL-1,3-THIAZOL-2-YL)-6-[(4-METHYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]PYRIDINE-2-CARBOXAMIDE"
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB07358	"2-AMINO-N-(4-METHYL-1,3-THIAZOL-2-YL)-5-[(4-METHYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]BENZAMIDE"
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB08118	"2-(METHYLAMINO)-N-(4-METHYL-1,3-THIAZOL-2-YL)-5-[(4-METHYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]BENZAMIDE"
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB08210	"2-AMINO-4-FLUORO-5-[(1-METHYL-1H-IMIDAZOL-2-YL)SULFANYL]-N-(1,3-THIAZOL-2-YL)BENZAMIDE"
GCK	glucokinase (hexokinase 4)	TdgClinicalTrial	n/a	LY-2599506	LY-2599506
GCK	glucokinase (hexokinase 4)	TdgClinicalTrial	n/a	ARRY-403	ARRY-403
GCK	glucokinase (hexokinase 4)	TTD	inhibitor	DCL000153	LONIDAMINE
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL000457	AZD1656
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL000475	AZD6370
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL000614	R7201
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL000201	PSN-101
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL001154	AZD5658
GCK	glucokinase (hexokinase 4)	GuideToPharmacologyInteractions	n/a	7701	AZD1656
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CERITINIB	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CERITINIB	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CERITINIB	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	ChEMBL	inhibitor	CHEMBL601719	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	ChEMBL	inhibitor	CHEMBL2403108	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	GANETESPIB	GANETESPIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	GANETESPIB	GANETESPIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	TSR-011	TSR-011
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	X-396	X-396
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	ASP3026	ASP3026
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	LDK378	LDK378
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	CH5424802	CH5424802
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	CancerCommons	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	CancerCommons	inhibitor	ASP3026	ASP3026
ALK	anaplastic lymphoma receptor tyrosine kinase	CancerCommons	inhibitor	LDK378	LDK378
ALK	anaplastic lymphoma receptor tyrosine kinase	CancerCommons	inhibitor	X-396	X-396
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	X-396	X-396
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	LDK378	LDK378
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	ASP3026	ASP3026
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	23344087	23344087
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	PF-06463922	PF-06463922
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	TAE684	TAE684
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	AUY922	AUY922
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	CERITINIB	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	PEMETREXED	PEMETREXED
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	CH5424802	CH5424802
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	TdgClinicalTrial	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7739	ALECTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7741	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7741	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7706	AZD3463
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7397	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	4903	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7476	PF-06463922
ALK	anaplastic lymphoma receptor tyrosine kinase	PharmGKB	n/a	PA165946122	CRIZOTINIB
KCNK6	"potassium channel, subfamily K, member 6"	DrugBank	inhibitor	DB00308	IBUTILIDE
KCNK6	"potassium channel, subfamily K, member 6"	DrugBank	inhibitor	DB00908	QUINIDINE
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	DrugBank	inhibitor	DB00230	PREGABALIN
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	DrugBank	inhibitor	DB00836	LOPERAMIDE
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	DrugBank	inhibitor	DB01244	BEPRIDIL
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	DrugBank	inhibitor	DB00661	VERAPAMIL
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TdgClinicalTrial	n/a	NISOLDIPINE	NISOLDIPINE
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TdgClinicalTrial	n/a	BEPRIDIL	BEPRIDIL
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TdgClinicalTrial	n/a	PREGABALIN	PREGABALIN
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TEND	n/a	PREGABALIN	PREGABALIN
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TEND	n/a	BEPRIDIL	BEPRIDIL
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TEND	n/a	NISOLDIPINE	NISOLDIPINE
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	PharmGKB	n/a	PA448871	CELECOXIB
TRBC1	T cell receptor beta constant 1	DrugBank	n/a	DB02740	3-INDOLEBUTYRIC ACID
MCOLN1	mucolipin 1	GuideToPharmacologyInteractions	n/a	2794	"PHOSPHATIDYL (3,5) INOSITOL BIPHOSPHATE"
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	AZD6244	AZD6244
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	AZD6244	AZD6244
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	GDC-0973	GDC-0973
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	SELUMETINIB	SELUMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	BAY869766	BAY869766
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	DABRAFENIB MESYLATE	DABRAFENIB MESYLATE
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	BAY869766	BAY869766
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	TdgClinicalTrial	n/a	WX-554	WX-554
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB04141	"2-HEXYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL"
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB08453	2-NONYL-4-HYDROXYQUINOLINE N-OXIDE
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB07778	FAMOXADONE
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB04799	"5-N-UNDECYL-6-HYDROXY-4,7-DIOXOBENZOTHIAZOLE"
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB07401	METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB08330	METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB07763	"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE"
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB08690	UBIQUINONE-2
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	3934	RESOLVIN D1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6240	MMK-1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6250	MHC BINDING PEPTIDE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	3411	[<SUP>3</SUP>H]LXA<SUB>4</SUB>
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6267	PSM&ALPHA;3
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1031	ANNEXIN I
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	3383	ATLA2
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6246	N36
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6239	ASPIRIN-TRIGGERED RESOLVIN D1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6265	QUIN-C1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	5831	"PYRAZOLONE, 1"
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6242	SERUM AMYLOID A
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	5555	RVD1-ME
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6251	SCK&BETA;8-1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6264	FPRL1-INHIBITOR PROTEIN
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6275	SHAAGTIDE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6248	V3 PEPTIDE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6249	UPAR FRAGMENT
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6245	T21/DP107
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1048	WKYMVM
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1043	PBP10
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1034	LXA<SUB>4</SUB>
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	5841	FMET-ILE-VAL-THR-LEU-PHE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6263	COMPOUND 1754-31
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1039	QUIN-C7
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6244	PRP<SUB>106-126</SUB>
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1022	FMET-LEU-PHE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1041	ISOPROPYLUREIDO-FLFLF
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6269	COMPOUND R-(-)-5F [PMID: 22607879]
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1030	T-BOC-FLFLF
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1040	WRWWWW
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1046	HP(2-20)
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6241	CGEN-855A
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6241	CGEN-855A
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6268	AG-26
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6198	[<SUP>125</SUP>I-TYR]AC2-26
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	4865	AMYLOID &BETA;
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	3933	ASPIRIN TRIGGERED LIPOXIN A4
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1044	ANNEXIN I-(2-26)
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6247	F PEPTIDE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1047	HUMANIN
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	5527	LL-37
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1023	FMET-MET-TYR-ALA-LEU-PHE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1034	LXA<SUB>4</SUB>
TNNT2	troponin T type 2 (cardiac)	TdgClinicalTrial	n/a	TIRAMSETIV	TIRAMSETIV
XPC	"xeroderma pigmentosum, complementation group C"	PharmGKB	n/a	PA449014	CISPLATIN
ECE1	endothelin converting enzyme 1	DrugBank	n/a	DB07171	"5-(2-HYDROXYETHYL)NONANE-1,9-DIOL"
ECE1	endothelin converting enzyme 1	GuideToPharmacologyInteractions	n/a	6506	DAGLUTRIL
ECE1	endothelin converting enzyme 1	GuideToPharmacologyInteractions	n/a	6562	(2S)-2-(2-BENZYL-3-{[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-PHENYLETHYL](HYDROXY)PHOSPHORYL}PROPANAMIDO)-3-(1H-INDOL-3-YL)PROPANOIC ACID
ECE1	endothelin converting enzyme 1	GuideToPharmacologyInteractions	n/a	6507	KC-12615
IL25	interleukin 25	TdgClinicalTrial	n/a	VIDOFLUDIMUS	VIDOFLUDIMUS
SLC7A9	"solute carrier family 7 (glycoprotein-associated amino acid transporter light chain, bo,+ system), member 9"	DrugBank	n/a	DB00138	L-CYSTINE
TERT	telomerase reverse transcriptase	DrugBank	inhibitor	DB00495	ZIDOVUDINE
TERT	telomerase reverse transcriptase	DrugBank	n/a	DB04937	GV1001
TERT	telomerase reverse transcriptase	DrugBank	n/a	DB05036	GRN163L
TERT	telomerase reverse transcriptase	TdgClinicalTrial	n/a	V934/V935	V934/V935
TERT	telomerase reverse transcriptase	TdgClinicalTrial	n/a	IMETELSTAT	IMETELSTAT
TERT	telomerase reverse transcriptase	TdgClinicalTrial	n/a	GV1001	GV1001
TERT	telomerase reverse transcriptase	TALC	inhibitor	IMETELSTAT	IMETELSTAT
TERT	telomerase reverse transcriptase	TALC	inhibitor	SODIUM METAARSENITE	SODIUM METAARSENITE
SLC22A16	"solute carrier family 22 (organic cation/carnitine transporter), member 16"	PharmGKB	n/a	PA449165	CYCLOPHOSPHAMIDE
SLC22A16	"solute carrier family 22 (organic cation/carnitine transporter), member 16"	PharmGKB	n/a	PA449412	DOXORUBICIN
SLC22A16	"solute carrier family 22 (organic cation/carnitine transporter), member 16"	PharmGKB	n/a	PA165291922	DOXORUBICINOL
GSS	glutathione synthetase	DrugBank	stimulator	DB06151	ACETYLCYSTEINE
GSS	glutathione synthetase	DrugBank	n/a	DB00143	GLUTATHIONE
GSS	glutathione synthetase	DrugBank	n/a	DB00145	GLYCINE
GSS	glutathione synthetase	DrugBank	n/a	DB00151	L-CYSTEINE
GSS	glutathione synthetase	DrugBank	n/a	DB03408	GAMMA-GLUTAMYLCYSTEINE
GSS	glutathione synthetase	DrugBank	n/a	DB04395	PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA448404	AMODIAQUINE
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA449782	GLIBENCLAMIDE
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA165857067	CHLORPROGUANIL
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA165111697	ARTESUNATE
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA449211	DAPSONE
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	DrugBank	n/a	DB04998	AGRO100
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	DrugBank	n/a	DB05289	MPC-7869
OAZ1	ornithine decarboxylase antizyme 1	DrugBank	n/a	DB00129	L-ORNITHINE
ALDH3B2	"aldehyde dehydrogenase 3 family, member B2"	DrugBank	n/a	DB00157	NADH
ARF6	ADP-ribosylation factor 6	DrugBank	n/a	DB01864	5-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE@[<SUP>14</SUP>C]ASCORBIC ACID#URSODEOXYCHOLIC ACID@CYT-6091#ETANERCEPT#TUMOUR NECROSIS FACTOR MEMBRANE FORM#LYMPHOTOXIN-&ALPHA;	NA
drugs_in_module16	CONATUMUMAB#EMRICASAN#Z-IETD-FMK@L-GLUTAMIC ACID#(1<I>S</I>,3<I>R</I>)-ACPD#L-GLUTAMIC ACID#D-AP4#L-CCG-I#L-AP4#MPPG#LY341495#L-SERINE-O-PHOSPHATE#DCG-IV#AZ12216052#[<SUP>3</SUP>H]AP4#(<I>S</I>)-3,4-DCPG#EGLUMEGAD#(<I>R,S</I>)-4-PPG@N-(3-(AMINOMETHYL)BENZYL)ACETAMIDINE#1,2,4-TRIAZOLE-CARBOXAMIDINE#L-N(OMEGA)-NITROARGININE-(4R)-AMINO-L-PROLINE AMIDE#S,S'-(1,4-PHENYLENE-BIS(1,2-ETHANEDIYL))BIS-ISOTHIOUREA#7-NITROINDAZOLE#ETHYLISOTHIOUREA#2-AMINOTHIAZOLINE#S-ETHYL-N-PHENYL-ISOTHIOUREA#S,S'-(1,3-PHENYLENE-BIS(1,2-ETHANEDIYL))BIS-ISOTHIOUREA#SE-ETHYL-ISOSELENOUREA#6S-5,6,7,8-TETRAHYDROBIOPTERIN#S-(DIMETHYLARSENIC)CYSTEINE#L-HOMOARGININE#S-ISOPROPYL-ISOTHIOUREA#(6R,1'R,2'S)-5,6,7,8 TETRAHYDROBIOPTERIN#NITROARGININE#2,4-DIAMINO-6-PHENYL-5,6,7,8,-TETRAHYDROPTERIDINE#5-NITROINDAZOLE#N-(CHLOROPHENYL)-N-HYDROXYGUANIDINE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB02979	"N1,N14-BIS((S-METHYL)ISOTHIOUREIDO)TETRADECANE"
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB02994	HYDROXYDIMETHYLARSINE OXIDE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB07001	"(3S,5E)-3-PROPYL-3,4-DIHYDROTHIENO[2,3-F][1,4]OXAZEPIN-5(2H)-IMINE"
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03065	7-NITROINDAZOLE-2-CARBOXAMIDINE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	cofactor	DB00360	TETRAHYDROBIOPTERIN
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03100	6-NITROINDAZOLE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03144	N-OMEGA-HYDROXY-L-ARGININE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03305	N5-IMINOETHYL-L-ORNITHINE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03332	"5,6-CYCLIC-TETRAHYDROPTERIDINE"
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB00125	L-ARGININE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB07244	"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE"
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB00155	L-CITRULLINE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	inhibitor	DB01110	MICONAZOLE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB01686	"N,N-DIMETHYLARGININE"
NOS3	nitric oxide synthase 3 (endothelial cell)	TEND	n/a	TETRAHYDROBIOPTERIN	TETRAHYDROBIOPTERIN
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB02379	BETA-D-GLUCOSE
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB07359	"3-[(4-FLUOROPHENYL)SULFANYL]-N-(4-METHYL-1,3-THIAZOL-2-YL)-6-[(4-METHYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]PYRIDINE-2-CARBOXAMIDE"
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB07358	"2-AMINO-N-(4-METHYL-1,3-THIAZOL-2-YL)-5-[(4-METHYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]BENZAMIDE"
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB08118	"2-(METHYLAMINO)-N-(4-METHYL-1,3-THIAZOL-2-YL)-5-[(4-METHYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]BENZAMIDE"
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB08210	"2-AMINO-4-FLUORO-5-[(1-METHYL-1H-IMIDAZOL-2-YL)SULFANYL]-N-(1,3-THIAZOL-2-YL)BENZAMIDE"
GCK	glucokinase (hexokinase 4)	TdgClinicalTrial	n/a	LY-2599506	LY-2599506
GCK	glucokinase (hexokinase 4)	TdgClinicalTrial	n/a	ARRY-403	ARRY-403
GCK	glucokinase (hexokinase 4)	TTD	inhibitor	DCL000153	LONIDAMINE
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL000457	AZD1656
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL000475	AZD6370
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL000614	R7201
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL000201	PSN-101
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL001154	AZD5658
GCK	glucokinase (hexokinase 4)	GuideToPharmacologyInteractions	n/a	7701	AZD1656
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CERITINIB	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CERITINIB	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CERITINIB	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	ChEMBL	inhibitor	CHEMBL601719	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	ChEMBL	inhibitor	CHEMBL2403108	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	GANETESPIB	GANETESPIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	GANETESPIB	GANETESPIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	TSR-011	TSR-011
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	X-396	X-396
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	ASP3026	ASP3026
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	LDK378	LDK378
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	CH5424802	CH5424802
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	CancerCommons	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	CancerCommons	inhibitor	ASP3026	ASP3026
ALK	anaplastic lymphoma receptor tyrosine kinase	CancerCommons	inhibitor	LDK378	LDK378
ALK	anaplastic lymphoma receptor tyrosine kinase	CancerCommons	inhibitor	X-396	X-396
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	X-396	X-396
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	LDK378	LDK378
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	ASP3026	ASP3026
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	23344087	23344087
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	PF-06463922	PF-06463922
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	TAE684	TAE684
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	AUY922	AUY922
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	CERITINIB	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	PEMETREXED	PEMETREXED
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	CH5424802	CH5424802
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	TdgClinicalTrial	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7739	ALECTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7741	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7741	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7706	AZD3463
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7397	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	4903	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7476	PF-06463922
ALK	anaplastic lymphoma receptor tyrosine kinase	PharmGKB	n/a	PA165946122	CRIZOTINIB
KCNK6	"potassium channel, subfamily K, member 6"	DrugBank	inhibitor	DB00308	IBUTILIDE
KCNK6	"potassium channel, subfamily K, member 6"	DrugBank	inhibitor	DB00908	QUINIDINE
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	DrugBank	inhibitor	DB00230	PREGABALIN
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	DrugBank	inhibitor	DB00836	LOPERAMIDE
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	DrugBank	inhibitor	DB01244	BEPRIDIL
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	DrugBank	inhibitor	DB00661	VERAPAMIL
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TdgClinicalTrial	n/a	NISOLDIPINE	NISOLDIPINE
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TdgClinicalTrial	n/a	BEPRIDIL	BEPRIDIL
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TdgClinicalTrial	n/a	PREGABALIN	PREGABALIN
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TEND	n/a	PREGABALIN	PREGABALIN
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TEND	n/a	BEPRIDIL	BEPRIDIL
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TEND	n/a	NISOLDIPINE	NISOLDIPINE
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	PharmGKB	n/a	PA448871	CELECOXIB
TRBC1	T cell receptor beta constant 1	DrugBank	n/a	DB02740	3-INDOLEBUTYRIC ACID
MCOLN1	mucolipin 1	GuideToPharmacologyInteractions	n/a	2794	"PHOSPHATIDYL (3,5) INOSITOL BIPHOSPHATE"
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	AZD6244	AZD6244
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	AZD6244	AZD6244
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	GDC-0973	GDC-0973
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	SELUMETINIB	SELUMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	BAY869766	BAY869766
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	DABRAFENIB MESYLATE	DABRAFENIB MESYLATE
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	BAY869766	BAY869766
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	TdgClinicalTrial	n/a	WX-554	WX-554
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB04141	"2-HEXYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL"
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB08453	2-NONYL-4-HYDROXYQUINOLINE N-OXIDE
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB07778	FAMOXADONE
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB04799	"5-N-UNDECYL-6-HYDROXY-4,7-DIOXOBENZOTHIAZOLE"
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB07401	METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB08330	METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB07763	"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE"
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB08690	UBIQUINONE-2
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	3934	RESOLVIN D1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6240	MMK-1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6250	MHC BINDING PEPTIDE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	3411	[<SUP>3</SUP>H]LXA<SUB>4</SUB>
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6267	PSM&ALPHA;3
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1031	ANNEXIN I
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	3383	ATLA2
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6246	N36
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6239	ASPIRIN-TRIGGERED RESOLVIN D1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6265	QUIN-C1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	5831	"PYRAZOLONE, 1"
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6242	SERUM AMYLOID A
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	5555	RVD1-ME
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6251	SCK&BETA;8-1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6264	FPRL1-INHIBITOR PROTEIN
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6275	SHAAGTIDE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6248	V3 PEPTIDE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6249	UPAR FRAGMENT
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6245	T21/DP107
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1048	WKYMVM
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1043	PBP10
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1034	LXA<SUB>4</SUB>
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	5841	FMET-ILE-VAL-THR-LEU-PHE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6263	COMPOUND 1754-31
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1039	QUIN-C7
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6244	PRP<SUB>106-126</SUB>
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1022	FMET-LEU-PHE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1041	ISOPROPYLUREIDO-FLFLF
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6269	COMPOUND R-(-)-5F [PMID: 22607879]
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1030	T-BOC-FLFLF
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1040	WRWWWW
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1046	HP(2-20)
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6241	CGEN-855A
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6241	CGEN-855A
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6268	AG-26
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6198	[<SUP>125</SUP>I-TYR]AC2-26
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	4865	AMYLOID &BETA;
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	3933	ASPIRIN TRIGGERED LIPOXIN A4
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1044	ANNEXIN I-(2-26)
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6247	F PEPTIDE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1047	HUMANIN
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	5527	LL-37
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1023	FMET-MET-TYR-ALA-LEU-PHE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1034	LXA<SUB>4</SUB>
TNNT2	troponin T type 2 (cardiac)	TdgClinicalTrial	n/a	TIRAMSETIV	TIRAMSETIV
XPC	"xeroderma pigmentosum, complementation group C"	PharmGKB	n/a	PA449014	CISPLATIN
ECE1	endothelin converting enzyme 1	DrugBank	n/a	DB07171	"5-(2-HYDROXYETHYL)NONANE-1,9-DIOL"
ECE1	endothelin converting enzyme 1	GuideToPharmacologyInteractions	n/a	6506	DAGLUTRIL
ECE1	endothelin converting enzyme 1	GuideToPharmacologyInteractions	n/a	6562	(2S)-2-(2-BENZYL-3-{[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-PHENYLETHYL](HYDROXY)PHOSPHORYL}PROPANAMIDO)-3-(1H-INDOL-3-YL)PROPANOIC ACID
ECE1	endothelin converting enzyme 1	GuideToPharmacologyInteractions	n/a	6507	KC-12615
IL25	interleukin 25	TdgClinicalTrial	n/a	VIDOFLUDIMUS	VIDOFLUDIMUS
SLC7A9	"solute carrier family 7 (glycoprotein-associated amino acid transporter light chain, bo,+ system), member 9"	DrugBank	n/a	DB00138	L-CYSTINE
TERT	telomerase reverse transcriptase	DrugBank	inhibitor	DB00495	ZIDOVUDINE
TERT	telomerase reverse transcriptase	DrugBank	n/a	DB04937	GV1001
TERT	telomerase reverse transcriptase	DrugBank	n/a	DB05036	GRN163L
TERT	telomerase reverse transcriptase	TdgClinicalTrial	n/a	V934/V935	V934/V935
TERT	telomerase reverse transcriptase	TdgClinicalTrial	n/a	IMETELSTAT	IMETELSTAT
TERT	telomerase reverse transcriptase	TdgClinicalTrial	n/a	GV1001	GV1001
TERT	telomerase reverse transcriptase	TALC	inhibitor	IMETELSTAT	IMETELSTAT
TERT	telomerase reverse transcriptase	TALC	inhibitor	SODIUM METAARSENITE	SODIUM METAARSENITE
SLC22A16	"solute carrier family 22 (organic cation/carnitine transporter), member 16"	PharmGKB	n/a	PA449165	CYCLOPHOSPHAMIDE
SLC22A16	"solute carrier family 22 (organic cation/carnitine transporter), member 16"	PharmGKB	n/a	PA449412	DOXORUBICIN
SLC22A16	"solute carrier family 22 (organic cation/carnitine transporter), member 16"	PharmGKB	n/a	PA165291922	DOXORUBICINOL
GSS	glutathione synthetase	DrugBank	stimulator	DB06151	ACETYLCYSTEINE
GSS	glutathione synthetase	DrugBank	n/a	DB00143	GLUTATHIONE
GSS	glutathione synthetase	DrugBank	n/a	DB00145	GLYCINE
GSS	glutathione synthetase	DrugBank	n/a	DB00151	L-CYSTEINE
GSS	glutathione synthetase	DrugBank	n/a	DB03408	GAMMA-GLUTAMYLCYSTEINE
GSS	glutathione synthetase	DrugBank	n/a	DB04395	PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA448404	AMODIAQUINE
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA449782	GLIBENCLAMIDE
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA165857067	CHLORPROGUANIL
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA165111697	ARTESUNATE
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA449211	DAPSONE
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	DrugBank	n/a	DB04998	AGRO100
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	DrugBank	n/a	DB05289	MPC-7869
OAZ1	ornithine decarboxylase antizyme 1	DrugBank	n/a	DB00129	L-ORNITHINE
ALDH3B2	"aldehyde dehydrogenase 3 family, member B2"	DrugBank	n/a	DB00157	NADH
ARF6	ADP-ribosylation factor 6	DrugBank	n/a	DB01864	5-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE	NA	NA	NA	NA	NA	ETHANOLAMINE OLEATE#ANTITHROMBIN#METHYL 5-[(4-TERT-BUTYLBENZOYL)AMINO]-2H-1,2,4-TRIAZOLE-3-CARBOXYLATE@TALTIRELIN#METRH#PROTIRELIN	NA	NA
drugs_in_module17	ISIS 113715#TRODUSQUEMINE#TILUDRONATE#1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE#5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID#4-[3-(DIBENZYLAMINO)PHENYL]-2,4-DIOXOBUTANOIC ACID#5-(3-HYDROXYPHENYL)ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDE#N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE#ISOTHIAZOLIDINONE ANALOG#COMPOUND 12, N-ACETYL-4-[(CARBOXYCARBONYL)(2-CARBOXYPHENYL)AMINO]-N-PENTYL-1-NAPTHYLALANIAMIDE#DOUBLE OXIDIZED CYSTEINE#TILUDRONATE#6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID#PARA-(BENZOYL)-PHENYLALANINE#COMPOUND 9#(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER#5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE#2-(OXALYL-AMINO)-4,7-DIHYDRO-5H-THIENO[2,3-C]THIOPYRAN-3-CARBOXYLIC ACID#3(R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER#(4-{(2S)-2-[(TERT-BUTOXYCARBONYL)AMINO]-3-METHOXY-3-OXOPROPYL}PHENYL)METHANESELENINIC ACID#3-(3,5-DIBROMO-4-HYDROXY-BENZOYL)-2-ETHYL-BENZOFURAN-6-SULFONIC ACID (4-SULFAMOYL-PHENYL)-AMIDE#4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN#3-(OXALYL-AMINO)-NAPHTHALENE-2-CARBOXYLIC ACID#[[4-(AMINOMETHYL)PHENYL]AMINO]OXO-ACETIC ACID,#2-{4-[(2S)-2-[({[(1S)-1-CARBOXY-2-PHENYLETHYL]AMINO}CARBONYL)AMINO]-3-OXO-3-(PENTYLAMINO)PROPYL]PHENOXY}MALONIC ACID#COMPOUND 19#SP7343-SP7964#2-(OXALYL-AMINO)-BENZOIC ACID#{[2-(1H-1,2,3-BENZOTRIAZOL-1-YL)-2-(3,4-DIFLUOROPHENYL)PROPANE-1,3-DIYL]BIS[4,1-PHENYLENE(DIFLUOROMETHYLENE)]}BIS(PHOSPHONIC ACID)#NOVO NORDISK A/S COMPOUND#N-[4-(2-{2-[3-(2-BROMO-ACETYLAMINO)-PROPIONYLAMINO]-3-HYDROXY-PROPIONYLAMINO}-ETHYL)-PHENYL]-OXALAMIC ACID#3-(3,5-DIBROMO-4-HYDROXY-BENZOYL)-2-ETHYL-BENZOFURAN-6-SULFONIC ACID [4-(THIAZOL-2-YLSULFAMOYL)-PHENYL]-AMIDE#7-(1,1-DIOXO-1H-BENZO[D]ISOTHIAZOL-3-YLOXYMETHYL)-2-(OXALYL-AMINO)-4,7-DIHYDRO-5H-THIENO[2,3-C]PYRAN-3-CARBOXYLIC ACID#5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE#4-CARBAMOYL-4-{[6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBONYL]-AMINO}-BUTYRIC ACID#N-{1-[5-(1-CARBAMOYL-2-MERCAPTO-ETHYLCARBAMOYL)-PENTYLCARBAMOYL]-2-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-ETHYL}-3-{2-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-ACETYLAMINO}-SUCCINAMIC ACID#{4-[(2S,4E)-2-(1,3-BENZOTHIAZOL-2-YL)-2-(1H-1,2,3-BENZOTRIAZOL-1-YL)-5-PHENYLPENT-4-ENYL]PHENYL}(DIFLUORO)METHYLPHOSPHONIC ACID#4-BENZOYLAMINO-4-{1-{1-CARBAMOYL-2-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-ETHYLCARBAMOYL}-2-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-ETHYLCARBAMOYL}-BUTYRIC ACID#PNU177836#2-(OXALYL-AMINO)-4,7-DIHYDRO-5H-THIENO[2,3-C]PYRAN-3-CARBOXYLIC ACID#{[7-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALEN-2-YL]-DIFLUORO-METHYL}-PHOSPHONIC ACID#[(4-{4-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-BUTYL}-PHENYL)-DIFLUORO-METHYL]-PHOSPHONIC ACID#ISIS 113715#3-(CARBOXYMETHOXY)THIENO[2,3-B]PYRIDINE-2-CARBOXYLIC ACID#4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID#[{2-BROMO-4-[(2R)-3-OXO-2,3-DIPHENYLPROPYL]PHENYL}(DIFLUORO)METHYL]PHOSPHONIC ACID#3(S)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER#5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID#2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID#4-BROMO-3-(CARBOXYMETHOXY)-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID#4-BROMO-3-(CARBOXYMETHOXY)-5-(4-HYDROXYPHENYL)THIOPHENE-2-CARBOXYLIC ACID#3-(3,5-DIBROMO-4-HYDROXY-BENZOYL)-2-ETHYL-BENZOFURAN-6-SULFONIC ACID DIMETHYLAMIDE#CYSTEINESULFONIC ACID#2-(OXALYL-AMINO)-4,5,6,7-TETRAHYDRO-THIENO[2,3-C]PYRIDINE-3-CARBOXYLIC ACID#N-(ALLYLOXYCARBONYL)-4-[N-(CARBOXY-FORMYL)-2-(BENZOIC ACID)-AMINO]-L-PHENYLALANINYL-AMINO-BUTYLOXY-(6-HYDROXY-BENZOIC ACID METHYL ESTER)#COMPOUND 5, 2-(NAPHTHALEN-1-YL-OXALYL-AMINO)-BENZOICACID#6-(OXALYL-AMINO)-1H-INDOLE-5-CARBOXYLIC ACID#2-(CARBOXYMETHOXY)-5-[(2S)-2-({(2S)-2-[(3-CARBOXYPROPANOYL)AMINO] -3-PHENYLPROPANOYL}AMINO)-3-OXO-3-(PENTYLAMINO)PROPYL]BENZOIC ACID#1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID#TILUDRONATE#ISIS 113715#ISIS-PTP1B@TALTIRELIN#METRH#PROTIRELIN	NA	NA	NA	NA	NA	CONATUMUMAB#EMRICASAN#Z-IETD-FMK	TICLOPIDINE#AZD6140#TICAGRELOR#TREPROSTINIL#CLOPIDOGREL#EPOPROSTENOL#PRASUGREL#2MESADP#CLOPIDOGREL (ACTIVE METABOLITE)#CANGRELOR#CANGRELOR#[<SUP>3</SUP>H]2MESADP#COMPOUND 4 [PMID:23083103]#[<SUP>3</SUP>H]PSB-0413#ARL66096#BX 667#2MESATP#BX 048#ADP&BETA;S#ATP#COMPOUND 20O [PMID:22984835]#TICAGRELOR#ATP&GAMMA;S#AR-C67085#ADENOSINE DIPHOSPHATE#2MESAMP#INS49266#INS50589#R-138727#PSB-0739#PCMPS#PSB-0739#COMPOUND 4 [PMID:22984835]#CLOPIDOGREL BISULFATE#TICLOPIDINE HYDROCHLORIDE#PRASUGREL HYDROCHLORIDE#CLOPIDOGREL#TICAGRELOR#INS-50589#PRASUGREL#TICAGRELOR#TREPROSTINIL#CLOPIDOGREL#MC-1#TICLOPIDINE#ELINOGREL#CANGRELOR#CLOPIDOGREL#TICLOPIDINE#TICLOPIDINE#TREPROSTINIL#PRASUGREL#CLOPIDOGREL#CLOPIDOGREL#TICLOPIDINE#BRILINTA#AR-C69931 MX#PRASUGREL@DV1179#ANA773#AZD-8848#HYDROXYCHLOROQUINE#IMO-3100#IMIQUIMOD#CPG 52364#IMIQUIMOD#HYDROXYCHLOROQUINE SULFATE#DOCOSANOL#ANA773#HYDROXYCHLOROQUINE#IMO-3100#ISATORIBINE#RESIQUIMOD#CPG 52364#IMIQUIMOD#IMIQUIMOD#HYDROXYCHLOROQUINE#ANA971#SCV-07#ISATORIBINE#RESIQUIMOD#IMIQUIMOD#LOXORIBINE#HYDROXYCHLOROQUINE#IMIQUIMOD	MARIMASTAT
drugs_in_module18	7&BETA;-HYDROXYCHOLESTEROL#27-HYDROXYCHOLESTEROL#7&ALPHA;,25-DIHYDROXYCHOLESTEROL#7&ALPHA;,25-DIHYDROXYCHOLESTEROL#7&ALPHA;-HYDROXYCHOLESTEROL#7&BETA;, 25-DIHYDROXYCHOLESTEROL#7&BETA;, 27-DIHYDROXYCHOLESTEROL#25-HYDROXYCHOLESTEROL#7&ALPHA;,27-DIHYDROXYCHOLESTEROL@MARIMASTAT@SPHINGOSINE 1-PHOSPHATE#PHYTOSPHINGOSINE 1-PHOSPHATE#COMPOUND 26 [PMID:16190743]#DIHYDROSP​HINGOSINE​-1-PHOSPH​ATE#VPC03090-P#VPC03090-P#SPHINGOSINE 1-PHOSPHATE#AFD(R)#FTY720-PHOSPHATE	NA	NA	NA	NA	NA	DROTRECOGIN ALFA@PREDNISONE#MELPHALAN#IPILIMUMAB#TREMELIMUMAB#IPILIMUMAB#IPILIMUMAB#TREMELIMUMAB#IPILIMUMAB#IPILIMUMAB#TREMELIMUMAB#IPILIMUMAB#TREMELIMUMAB#IPILIMUMAB#IPILIMUMAB#CP-675206#IPILIMUMAB@PYRIDOXAL PHOSPHATE#L-ALANINE#3-HYDROXYHIPPURIC ACID@N-(3-(AMINOMETHYL)BENZYL)ACETAMIDINE#1,2,4-TRIAZOLE-CARBOXAMIDINE#L-N(OMEGA)-NITROARGININE-(4R)-AMINO-L-PROLINE AMIDE#S,S'-(1,4-PHENYLENE-BIS(1,2-ETHANEDIYL))BIS-ISOTHIOUREA#7-NITROINDAZOLE#ETHYLISOTHIOUREA#2-AMINOTHIAZOLINE#S-ETHYL-N-PHENYL-ISOTHIOUREA#S,S'-(1,3-PHENYLENE-BIS(1,2-ETHANEDIYL))BIS-ISOTHIOUREA#SE-ETHYL-ISOSELENOUREA#6S-5,6,7,8-TETRAHYDROBIOPTERIN#S-(DIMETHYLARSENIC)CYSTEINE#L-HOMOARGININE#S-ISOPROPYL-ISOTHIOUREA#(6R,1'R,2'S)-5,6,7,8 TETRAHYDROBIOPTERIN#NITROARGININE#2,4-DIAMINO-6-PHENYL-5,6,7,8,-TETRAHYDROPTERIDINE#5-NITROINDAZOLE#N-(CHLOROPHENYL)-N-HYDROXYGUANIDINE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB02979	"N1,N14-BIS((S-METHYL)ISOTHIOUREIDO)TETRADECANE"
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB02994	HYDROXYDIMETHYLARSINE OXIDE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB07001	"(3S,5E)-3-PROPYL-3,4-DIHYDROTHIENO[2,3-F][1,4]OXAZEPIN-5(2H)-IMINE"
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03065	7-NITROINDAZOLE-2-CARBOXAMIDINE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	cofactor	DB00360	TETRAHYDROBIOPTERIN
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03100	6-NITROINDAZOLE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03144	N-OMEGA-HYDROXY-L-ARGININE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03305	N5-IMINOETHYL-L-ORNITHINE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB03332	"5,6-CYCLIC-TETRAHYDROPTERIDINE"
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB00125	L-ARGININE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB07244	"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE"
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB00155	L-CITRULLINE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	inhibitor	DB01110	MICONAZOLE
NOS3	nitric oxide synthase 3 (endothelial cell)	DrugBank	n/a	DB01686	"N,N-DIMETHYLARGININE"
NOS3	nitric oxide synthase 3 (endothelial cell)	TEND	n/a	TETRAHYDROBIOPTERIN	TETRAHYDROBIOPTERIN
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB02379	BETA-D-GLUCOSE
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB07359	"3-[(4-FLUOROPHENYL)SULFANYL]-N-(4-METHYL-1,3-THIAZOL-2-YL)-6-[(4-METHYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]PYRIDINE-2-CARBOXAMIDE"
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB07358	"2-AMINO-N-(4-METHYL-1,3-THIAZOL-2-YL)-5-[(4-METHYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]BENZAMIDE"
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB08118	"2-(METHYLAMINO)-N-(4-METHYL-1,3-THIAZOL-2-YL)-5-[(4-METHYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]BENZAMIDE"
GCK	glucokinase (hexokinase 4)	DrugBank	n/a	DB08210	"2-AMINO-4-FLUORO-5-[(1-METHYL-1H-IMIDAZOL-2-YL)SULFANYL]-N-(1,3-THIAZOL-2-YL)BENZAMIDE"
GCK	glucokinase (hexokinase 4)	TdgClinicalTrial	n/a	LY-2599506	LY-2599506
GCK	glucokinase (hexokinase 4)	TdgClinicalTrial	n/a	ARRY-403	ARRY-403
GCK	glucokinase (hexokinase 4)	TTD	inhibitor	DCL000153	LONIDAMINE
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL000457	AZD1656
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL000475	AZD6370
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL000614	R7201
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL000201	PSN-101
GCK	glucokinase (hexokinase 4)	TTD	activator	DCL001154	AZD5658
GCK	glucokinase (hexokinase 4)	GuideToPharmacologyInteractions	n/a	7701	AZD1656
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CERITINIB	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CERITINIB	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	DoCM	n/a	CERITINIB	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	ChEMBL	inhibitor	CHEMBL601719	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	ChEMBL	inhibitor	CHEMBL2403108	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	GANETESPIB	GANETESPIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	GANETESPIB	GANETESPIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRENOLANIB	CRENOLANIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenomeClinicalTrial	inhibitor	1032900-25-6	1032900-25-6
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	TSR-011	TSR-011
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	X-396	X-396
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	ASP3026	ASP3026
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	LDK378	LDK378
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	CH5424802	CH5424802
ALK	anaplastic lymphoma receptor tyrosine kinase	MyCancerGenome	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	CancerCommons	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	CancerCommons	inhibitor	ASP3026	ASP3026
ALK	anaplastic lymphoma receptor tyrosine kinase	CancerCommons	inhibitor	LDK378	LDK378
ALK	anaplastic lymphoma receptor tyrosine kinase	CancerCommons	inhibitor	X-396	X-396
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	AP26113	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	X-396	X-396
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	LDK378	LDK378
ALK	anaplastic lymphoma receptor tyrosine kinase	TALC	inhibitor	ASP3026	ASP3026
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	23344087	23344087
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	PF-06463922	PF-06463922
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	TAE684	TAE684
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	AUY922	AUY922
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	CERITINIB	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	PEMETREXED	PEMETREXED
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	CH5424802	CH5424802
ALK	anaplastic lymphoma receptor tyrosine kinase	CIViC	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	TdgClinicalTrial	n/a	CRIZOTINIB	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7739	ALECTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7741	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7741	AP26113
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7706	AZD3463
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7397	CERITINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	4903	CRIZOTINIB
ALK	anaplastic lymphoma receptor tyrosine kinase	GuideToPharmacologyInteractions	n/a	7476	PF-06463922
ALK	anaplastic lymphoma receptor tyrosine kinase	PharmGKB	n/a	PA165946122	CRIZOTINIB
KCNK6	"potassium channel, subfamily K, member 6"	DrugBank	inhibitor	DB00308	IBUTILIDE
KCNK6	"potassium channel, subfamily K, member 6"	DrugBank	inhibitor	DB00908	QUINIDINE
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	DrugBank	inhibitor	DB00230	PREGABALIN
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	DrugBank	inhibitor	DB00836	LOPERAMIDE
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	DrugBank	inhibitor	DB01244	BEPRIDIL
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	DrugBank	inhibitor	DB00661	VERAPAMIL
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TdgClinicalTrial	n/a	NISOLDIPINE	NISOLDIPINE
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TdgClinicalTrial	n/a	BEPRIDIL	BEPRIDIL
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TdgClinicalTrial	n/a	PREGABALIN	PREGABALIN
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TEND	n/a	PREGABALIN	PREGABALIN
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TEND	n/a	BEPRIDIL	BEPRIDIL
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	TEND	n/a	NISOLDIPINE	NISOLDIPINE
CACNA1A	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"	PharmGKB	n/a	PA448871	CELECOXIB
TRBC1	T cell receptor beta constant 1	DrugBank	n/a	DB02740	3-INDOLEBUTYRIC ACID
MCOLN1	mucolipin 1	GuideToPharmacologyInteractions	n/a	2794	"PHOSPHATIDYL (3,5) INOSITOL BIPHOSPHATE"
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	AZD6244	AZD6244
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	AZD6244	AZD6244
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	GDC-0973	GDC-0973
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	SELUMETINIB	SELUMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	BAY869766	BAY869766
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	DABRAFENIB MESYLATE	DABRAFENIB MESYLATE
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	BAY869766	BAY869766
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	MEK162	MEK162
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	TRAMETINIB	TRAMETINIB
MAP2K4	mitogen-activated protein kinase kinase 4	MyCancerGenomeClinicalTrial	inhibitor	PD 0325901	PD 0325901
MAP2K4	mitogen-activated protein kinase kinase 4	TdgClinicalTrial	n/a	WX-554	WX-554
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB04141	"2-HEXYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL"
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB08453	2-NONYL-4-HYDROXYQUINOLINE N-OXIDE
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB07778	FAMOXADONE
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB04799	"5-N-UNDECYL-6-HYDROXY-4,7-DIOXOBENZOTHIAZOLE"
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB07401	METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB08330	METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB07763	"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE"
UQCRQ	"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa"	DrugBank	n/a	DB08690	UBIQUINONE-2
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	3934	RESOLVIN D1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6240	MMK-1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6250	MHC BINDING PEPTIDE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	3411	[<SUP>3</SUP>H]LXA<SUB>4</SUB>
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6267	PSM&ALPHA;3
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1031	ANNEXIN I
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	3383	ATLA2
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6246	N36
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6239	ASPIRIN-TRIGGERED RESOLVIN D1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6265	QUIN-C1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	5831	"PYRAZOLONE, 1"
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6242	SERUM AMYLOID A
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	5555	RVD1-ME
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6251	SCK&BETA;8-1
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6264	FPRL1-INHIBITOR PROTEIN
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6275	SHAAGTIDE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6248	V3 PEPTIDE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6249	UPAR FRAGMENT
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6245	T21/DP107
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1048	WKYMVM
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1043	PBP10
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1034	LXA<SUB>4</SUB>
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	5841	FMET-ILE-VAL-THR-LEU-PHE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6263	COMPOUND 1754-31
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1039	QUIN-C7
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6244	PRP<SUB>106-126</SUB>
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1022	FMET-LEU-PHE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1041	ISOPROPYLUREIDO-FLFLF
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6269	COMPOUND R-(-)-5F [PMID: 22607879]
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1030	T-BOC-FLFLF
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1040	WRWWWW
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1046	HP(2-20)
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6241	CGEN-855A
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6241	CGEN-855A
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6268	AG-26
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6198	[<SUP>125</SUP>I-TYR]AC2-26
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	4865	AMYLOID &BETA;
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	3933	ASPIRIN TRIGGERED LIPOXIN A4
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1044	ANNEXIN I-(2-26)
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	6247	F PEPTIDE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1047	HUMANIN
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	5527	LL-37
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1023	FMET-MET-TYR-ALA-LEU-PHE
FPR2	formyl peptide receptor 2	GuideToPharmacologyInteractions	n/a	1034	LXA<SUB>4</SUB>
TNNT2	troponin T type 2 (cardiac)	TdgClinicalTrial	n/a	TIRAMSETIV	TIRAMSETIV
XPC	"xeroderma pigmentosum, complementation group C"	PharmGKB	n/a	PA449014	CISPLATIN
ECE1	endothelin converting enzyme 1	DrugBank	n/a	DB07171	"5-(2-HYDROXYETHYL)NONANE-1,9-DIOL"
ECE1	endothelin converting enzyme 1	GuideToPharmacologyInteractions	n/a	6506	DAGLUTRIL
ECE1	endothelin converting enzyme 1	GuideToPharmacologyInteractions	n/a	6562	(2S)-2-(2-BENZYL-3-{[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-PHENYLETHYL](HYDROXY)PHOSPHORYL}PROPANAMIDO)-3-(1H-INDOL-3-YL)PROPANOIC ACID
ECE1	endothelin converting enzyme 1	GuideToPharmacologyInteractions	n/a	6507	KC-12615
IL25	interleukin 25	TdgClinicalTrial	n/a	VIDOFLUDIMUS	VIDOFLUDIMUS
SLC7A9	"solute carrier family 7 (glycoprotein-associated amino acid transporter light chain, bo,+ system), member 9"	DrugBank	n/a	DB00138	L-CYSTINE
TERT	telomerase reverse transcriptase	DrugBank	inhibitor	DB00495	ZIDOVUDINE
TERT	telomerase reverse transcriptase	DrugBank	n/a	DB04937	GV1001
TERT	telomerase reverse transcriptase	DrugBank	n/a	DB05036	GRN163L
TERT	telomerase reverse transcriptase	TdgClinicalTrial	n/a	V934/V935	V934/V935
TERT	telomerase reverse transcriptase	TdgClinicalTrial	n/a	IMETELSTAT	IMETELSTAT
TERT	telomerase reverse transcriptase	TdgClinicalTrial	n/a	GV1001	GV1001
TERT	telomerase reverse transcriptase	TALC	inhibitor	IMETELSTAT	IMETELSTAT
TERT	telomerase reverse transcriptase	TALC	inhibitor	SODIUM METAARSENITE	SODIUM METAARSENITE
SLC22A16	"solute carrier family 22 (organic cation/carnitine transporter), member 16"	PharmGKB	n/a	PA449165	CYCLOPHOSPHAMIDE
SLC22A16	"solute carrier family 22 (organic cation/carnitine transporter), member 16"	PharmGKB	n/a	PA449412	DOXORUBICIN
SLC22A16	"solute carrier family 22 (organic cation/carnitine transporter), member 16"	PharmGKB	n/a	PA165291922	DOXORUBICINOL
GSS	glutathione synthetase	DrugBank	stimulator	DB06151	ACETYLCYSTEINE
GSS	glutathione synthetase	DrugBank	n/a	DB00143	GLUTATHIONE
GSS	glutathione synthetase	DrugBank	n/a	DB00145	GLYCINE
GSS	glutathione synthetase	DrugBank	n/a	DB00151	L-CYSTEINE
GSS	glutathione synthetase	DrugBank	n/a	DB03408	GAMMA-GLUTAMYLCYSTEINE
GSS	glutathione synthetase	DrugBank	n/a	DB04395	PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA448404	AMODIAQUINE
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA449782	GLIBENCLAMIDE
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA165857067	CHLORPROGUANIL
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA165111697	ARTESUNATE
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	PharmGKB	n/a	PA449211	DAPSONE
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	DrugBank	n/a	DB04998	AGRO100
IKBKG	"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma"	DrugBank	n/a	DB05289	MPC-7869
OAZ1	ornithine decarboxylase antizyme 1	DrugBank	n/a	DB00129	L-ORNITHINE
ALDH3B2	"aldehyde dehydrogenase 3 family, member B2"	DrugBank	n/a	DB00157	NADH
ARF6	ADP-ribosylation factor 6	DrugBank	n/a	DB01864	5-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE@TICLOPIDINE#AZD6140#TICAGRELOR#TREPROSTINIL#CLOPIDOGREL#EPOPROSTENOL#PRASUGREL#2MESADP#CLOPIDOGREL (ACTIVE METABOLITE)#CANGRELOR#CANGRELOR#[<SUP>3</SUP>H]2MESADP#COMPOUND 4 [PMID:23083103]#[<SUP>3</SUP>H]PSB-0413#ARL66096#BX 667#2MESATP#BX 048#ADP&BETA;S#ATP#COMPOUND 20O [PMID:22984835]#TICAGRELOR#ATP&GAMMA;S#AR-C67085#ADENOSINE DIPHOSPHATE#2MESAMP#INS49266#INS50589#R-138727#PSB-0739#PCMPS#PSB-0739#COMPOUND 4 [PMID:22984835]#CLOPIDOGREL BISULFATE#TICLOPIDINE HYDROCHLORIDE#PRASUGREL HYDROCHLORIDE#CLOPIDOGREL#TICAGRELOR#INS-50589#PRASUGREL#TICAGRELOR#TREPROSTINIL#CLOPIDOGREL#MC-1#TICLOPIDINE#ELINOGREL#CANGRELOR#CLOPIDOGREL#TICLOPIDINE#TICLOPIDINE#TREPROSTINIL#PRASUGREL#CLOPIDOGREL#CLOPIDOGREL#TICLOPIDINE#BRILINTA#AR-C69931 MX#PRASUGREL@DV1179#ANA773#AZD-8848#HYDROXYCHLOROQUINE#IMO-3100#IMIQUIMOD#CPG 52364#IMIQUIMOD#HYDROXYCHLOROQUINE SULFATE#DOCOSANOL#ANA773#HYDROXYCHLOROQUINE#IMO-3100#ISATORIBINE#RESIQUIMOD#CPG 52364#IMIQUIMOD#IMIQUIMOD#HYDROXYCHLOROQUINE#ANA971#SCV-07#ISATORIBINE#RESIQUIMOD#IMIQUIMOD#LOXORIBINE#HYDROXYCHLOROQUINE#IMIQUIMOD	NA	NA
drugs_in_module19	GDC-0152#AZD5582#AT-406#SM-337#LCL161#GDC0917#AT-406#TL 32711#AEG40826#HGS1029@BUPROPION#NICOTINE@PF-00547659	NA	METHYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE#N-({(2S,3S)-3-[(BENZYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINE#N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE#N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE#2-AMINOETHANIMIDIC ACID#DIPHENYLACETIC ACID#BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE#3-AMINO-4-OXYBENZYL-2-BUTANONE#N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO-2-METHYL-BUTANE#3-METHYLPHENYLALANINE#N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-#N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCINE#N-(3-PROPYLCARBAMOYLOXIRANE-2-CARBONYL)-ISOLEUCYL-PROLINE#2-PYRIDINETHIOL#Z-ARG-LEU-VAL-AGLY-ILE-VAL-OME	METHYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE#N-({(2S,3S)-3-[(BENZYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINE#N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE#N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE#2-AMINOETHANIMIDIC ACID#DIPHENYLACETIC ACID#BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE#3-AMINO-4-OXYBENZYL-2-BUTANONE#N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO-2-METHYL-BUTANE#3-METHYLPHENYLALANINE#N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-#N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCINE#N-(3-PROPYLCARBAMOYLOXIRANE-2-CARBONYL)-ISOLEUCYL-PROLINE#2-PYRIDINETHIOL#Z-ARG-LEU-VAL-AGLY-ILE-VAL-OME	NA	NA	NA	NA	NA
drugs_in_module20	NA	LITHIUM@IRON DEXTRAN@RILUZOLE	BUPROPION#NICOTINE	NA	NA	NA	NA	NA	NA
drugs_in_module21	NA	NA	NA	NA	NA	NA	N-[O-PHOSPHONO-PYRIDOXYL]-ISOLEUCINE#ALPHA-KETOISOVALERATE#L-LEUCINE#L-GLUTAMIC ACID@PEG-INTERFERON LAMBA#IFN-&LAMBDA;3#IFN-&LAMBDA;2#IFN-&LAMBDA;1	NA	NA
drugs_in_module22	PF-4523655	5-[(Z)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE	NA	NA	NA	NA	PF-4523655@PF-00547659	NA	NA
drugs_in_module23	ENMD-2076@DROTRECOGIN ALFA@PYRIDOXAL PHOSPHATE#L-ALANINE#3-HYDROXYHIPPURIC ACID	NA	NA	NA	NA	NA	NA	L-CITRULLINE	NA
drugs_in_module24	NA	OMALIZUMAB#R112#OMALIZUMAB#GEMCITABINE#TOSITUMOMAB	PYRIDOXAL PHOSPHATE#L-ALANINE#3-HYDROXYHIPPURIC ACID	GDC-0152#AZD5582#AT-406#SM-337#LCL161#GDC0917#AT-406#TL 32711#AEG40826#HGS1029	NA	NA	LITHIUM	PYRIDOXAL PHOSPHATE#L-ALANINE#3-HYDROXYHIPPURIC ACID	NA
drugs_in_module25	NA	NA	NA	NA	NA	NA	NA	NA	NA
drugs_in_module26	OMALIZUMAB#R112#OMALIZUMAB#GEMCITABINE#TOSITUMOMAB	NA	NA	OLESOXIME#DIHYDROXYALUMINIUM#PRLX 93936#PRLX 93936	NA	NA	NA	NA	NA
drugs_in_module27	NA	NA	L-CITRULLINE	NA	NA	NA	NA	NA	NA
drugs_in_module28	NA	NA	NA	NA	NA	NA	NA	NA	CYT-6091#ETANERCEPT#TUMOUR NECROSIS FACTOR MEMBRANE FORM#LYMPHOTOXIN-&ALPHA;
drugs_in_module29	NA	NA	OMALIZUMAB#R112#OMALIZUMAB#GEMCITABINE#TOSITUMOMAB	NA	NA	NA	NA	HYALURONAN	NA
drugs_in_module30	NA	NA	NA	NA	NA	NA	[<SUP>14</SUP>C]ASCORBIC ACID#URSODEOXYCHOLIC ACID	NA	NA
drugs_in_module31	NA	NA	NA	ENMD-2076	NA	NA	NA	NA	ANTIPSYCHOTICS
drugs_in_module32	[<SUP>14</SUP>C]ASCORBIC ACID#URSODEOXYCHOLIC ACID	ETHANOLAMINE OLEATE#ANTITHROMBIN#METHYL 5-[(4-TERT-BUTYLBENZOYL)AMINO]-2H-1,2,4-TRIAZOLE-3-CARBOXYLATE@PYRIDOXAL PHOSPHATE#L-ALANINE#3-HYDROXYHIPPURIC ACID	NA	NA	NA	NA	NA	ENMD-2076	NA
drugs_in_module33	NA	NA	NA	NA	NA	NA	NA	NA	R-788#R788#R343#PACLITAXEL#N-(2-HYDROXY-1,1-DIMETHYLETHYL)-1-METHYL-3-(1H-PYRROLO[2,3-B]PYRIDIN-2-YL)-1H-INDOLE-5-CARBOXAMIDE#2-{[(1R,2S)-2-AMINOCYCLOHEXYL]AMINO}-4-[(3-METHYLPHENYL)AMINO]PYRIMIDINE-5-CARBOXAMIDE#STAUROSPORINE#ELLAGIC ACID#6-({5-FLUORO-2-[(3,4,5-TRIMETHOXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-2,2-DIMETHYL-2H-PYRIDO[3,2-B][1,4]OXAZIN-3(4H)-ONE#2-{2-[(3,5-DIMETHYLPHENYL)AMINO]PYRIMIDIN-4-YL}-N-[(1S)-2-HYDROXY-1-METHYLETHYL]-4-METHYL-1,3-THIAZOLE-5-CARBOXAMIDE#FOSTAMATINIB#PRT062607#ACU-XSP-001#R343#FOSTAMATINIB#SYK INHIBITOR#SYK INHIBITOR II#SYK INHIBITOR III#TAMATINIB
drugs_in_module34	NA	NA	V3381#FELBAMATE#DIMIRACETAM#AM-101#DEXANABINOL#LATREPIRDINE#AZD-6765#EVT-101#EVT-103#MEMANTINE#CNS-5161#MEMANTINE#NERAMEXANE#NEU-2000#EVT-101#BESONPRODIL#TRAXOPRODIL#RGH-896#L-GLUTAMIC ACID#TENOCYCLIDINE#PETHIDINE#ACETYLCYSTEINE#FELBAMATE#HALOPERIDOL#IFENPRODIL#MEMANTINE#FELBAMATE#MEMANTINE#HOMOQUINOLINIC ACID#D-SERINE#D-ASPARTATE#GLYCINE#L-ASPARTATE#MG<SUP>2+</SUP>#[<SUP>3</SUP>H]GLYCINE#GV196771A#(<I>RS</I>)-(TETRAZOL-5-YL)GLYCINE#CGP37849#(+)-HA966#NMDA#5,7-DICHLOROKYNURENIC ACID#CONANTOKIN-G#D-AP5#D-CCPENE#[<SUP>3</SUP>H]CGP61594#AMANTIDINE#L701324#L689560#[<SUP>3</SUP>H]DIZOCILPINE#LY233053#PHENCYCLIDINE#N<SUP>1</SUP>-DANSYL-SPERMINE#KETAMINE#DIZOCILPINE#SELFOTEL#NVP-AAM077#UBP141#[<SUP>3</SUP>H]CGP39653#[<SUP>3</SUP>H]MDL105519#[<SUP>3</SUP>H]L689560#[<SUP>3</SUP>H]CPP#[<SUP>3</SUP>H]CGS19755#VALPROIC ACID	NA	NA	NA	NA	NA	NA
drugs_in_module35	NA	NA	NA	NA	NA	NA	NA	NA	NA
drugs_in_module36	NA	METHOTREXATE	NA	NA	NA	NA	NA	NA	NA
drugs_in_module37	NA	NA	NA	NA	NA	NA	NA	NA	NA
drugs_in_module38	NA	NA	NA	NA	NA	NA	NA	NA	NA
drugs_in_module39	NA	NA	NA	NA	NA	NA	R-788#R788#R343#PACLITAXEL#N-(2-HYDROXY-1,1-DIMETHYLETHYL)-1-METHYL-3-(1H-PYRROLO[2,3-B]PYRIDIN-2-YL)-1H-INDOLE-5-CARBOXAMIDE#2-{[(1R,2S)-2-AMINOCYCLOHEXYL]AMINO}-4-[(3-METHYLPHENYL)AMINO]PYRIMIDINE-5-CARBOXAMIDE#STAUROSPORINE#ELLAGIC ACID#6-({5-FLUORO-2-[(3,4,5-TRIMETHOXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-2,2-DIMETHYL-2H-PYRIDO[3,2-B][1,4]OXAZIN-3(4H)-ONE#2-{2-[(3,5-DIMETHYLPHENYL)AMINO]PYRIMIDIN-4-YL}-N-[(1S)-2-HYDROXY-1-METHYLETHYL]-4-METHYL-1,3-THIAZOLE-5-CARBOXAMIDE#FOSTAMATINIB#PRT062607#ACU-XSP-001#R343#FOSTAMATINIB#SYK INHIBITOR#SYK INHIBITOR II#SYK INHIBITOR III#TAMATINIB	NA	NA
drugs_in_module40	NA	NA	NA	NA	NA	NA	NA	NA	NA
drugs_in_module41	NA	NA	NA	NA	NA	NA	NA	NA	NA
drugs_in_module42	NA	NA	NA	NA	NA	NA	NA	NA	NA
drugs_in_module43	NA	NA	NA	NA	NA	NA	NA	NA	NA
drugs_in_module44	NA	NA	NA	NA	NA	NA	NA	NA	NA
drugs_in_module45	NA	NA	NA	NA	NA	NA	NA	NA	NA
drugs_in_module46	NA	NA	NA	NA	NA	NA	NA	NA	NA
score_alteration_module(deltaa)1	0.428571428571429	0.428571428571429	0.571428571428571	0.428571428571429	0.142857142857143	0.142857142857143	0.285714285714286	0.428571428571429	0.571428571428571
score_alteration_module(deltaa)2	0.428571428571429	0.428571428571429	0.428571428571429	0.428571428571429	0.285714285714286	0.285714285714286	0.285714285714286	0.428571428571429	0.428571428571429
score_alteration_module(deltaa)3	0.428571428571429	0.571428571428571	0.571428571428571	0.571428571428571	0.142857142857143	0	0.571428571428571	0.571428571428571	0.428571428571429
score_alteration_module(deltaa)4	0.571428571428571	0.428571428571429	0.571428571428571	0.571428571428571	0.142857142857143	0.285714285714286	0.428571428571429	0.428571428571429	0.428571428571429
score_alteration_module(deltaa)5	0.571428571428571	0.428571428571429	0.285714285714286	0.571428571428571	0.142857142857143	0.285714285714286	0.571428571428571	0.428571428571429	0.571428571428571
score_alteration_module(deltaa)6	0.428571428571429	0.285714285714286	0.285714285714286	0.428571428571429	0.285714285714286	0.142857142857143	0.285714285714286	0.285714285714286	0.571428571428571
score_alteration_module(deltaa)7	0.428571428571429	0.285714285714286	0.428571428571429	0.571428571428571	0.142857142857143	0.142857142857143	0.142857142857143	0.428571428571429	0.428571428571429
score_alteration_module(deltaa)8	0.428571428571429	0.428571428571429	0.285714285714286	0.428571428571429	0.142857142857143	NA	0.428571428571429	0.428571428571429	0.571428571428571
score_alteration_module(deltaa)9	0.428571428571429	0.285714285714286	0.428571428571429	0.428571428571429	0	NA	0.285714285714286	0.428571428571429	0.285714285714286
score_alteration_module(deltaa)10	0.285714285714286	0.571428571428571	0.285714285714286	0.285714285714286	0.142857142857143	NA	0.428571428571429	0.285714285714286	0.285714285714286
score_alteration_module(deltaa)11	0.285714285714286	0.571428571428571	0.285714285714286	0.428571428571429	0.285714285714286	NA	0.428571428571429	0.285714285714286	0.285714285714286
score_alteration_module(deltaa)12	0.285714285714286	0.428571428571429	0.285714285714286	0.428571428571429	0.285714285714286	NA	0.285714285714286	0.571428571428571	0.428571428571429
score_alteration_module(deltaa)13	0.571428571428571	0.428571428571429	0.428571428571429	0.428571428571429	NA	NA	0.428571428571429	0.428571428571429	0.428571428571429
score_alteration_module(deltaa)14	0.285714285714286	0.428571428571429	0.142857142857143	0.285714285714286	NA	NA	0.428571428571429	0.285714285714286	0.428571428571429
score_alteration_module(deltaa)15	0.428571428571429	0.571428571428571	0.428571428571429	0.428571428571429	NA	NA	0.285714285714286	0.571428571428571	0.285714285714286
score_alteration_module(deltaa)16	0.571428571428571	0.285714285714286	0.285714285714286	0.428571428571429	NA	NA	0.428571428571429	0.428571428571429	0.428571428571429
score_alteration_module(deltaa)17	0.428571428571429	0.428571428571429	0.285714285714286	0.285714285714286	NA	NA	0.571428571428571	0.428571428571429	0.285714285714286
score_alteration_module(deltaa)18	0.285714285714286	0.428571428571429	0.428571428571429	0.142857142857143	NA	NA	0.571428571428571	0.428571428571429	0.428571428571429
score_alteration_module(deltaa)19	0.428571428571429	0.285714285714286	0.428571428571429	0.285714285714286	NA	NA	0.428571428571429	0.285714285714286	0.428571428571429
score_alteration_module(deltaa)20	0.428571428571429	0.428571428571429	0.428571428571429	0.142857142857143	NA	NA	0.285714285714286	0.428571428571429	0.285714285714286
score_alteration_module(deltaa)21	0.285714285714286	0.142857142857143	0.285714285714286	0.285714285714286	NA	NA	0.428571428571429	0.285714285714286	0.428571428571429
score_alteration_module(deltaa)22	0.428571428571429	0.285714285714286	0.428571428571429	0.285714285714286	NA	NA	0.428571428571429	0.571428571428571	0.285714285714286
score_alteration_module(deltaa)23	0.428571428571429	0.142857142857143	0.285714285714286	0.285714285714286	NA	NA	0.142857142857143	0.428571428571429	0.285714285714286
score_alteration_module(deltaa)24	0.285714285714286	0.285714285714286	0.428571428571429	0.428571428571429	NA	NA	0.285714285714286	0.428571428571429	0.285714285714286
score_alteration_module(deltaa)25	0.142857142857143	0.285714285714286	0.142857142857143	0.142857142857143	NA	NA	0.285714285714286	0.285714285714286	0.428571428571429
score_alteration_module(deltaa)26	0.285714285714286	0.285714285714286	0.428571428571429	0.285714285714286	NA	NA	0.142857142857143	0.285714285714286	0.428571428571429
score_alteration_module(deltaa)27	0.285714285714286	0.428571428571429	0.428571428571429	0.428571428571429	NA	NA	0.142857142857143	0.428571428571429	0.285714285714286
score_alteration_module(deltaa)28	0.285714285714286	0.285714285714286	0.285714285714286	0.285714285714286	NA	NA	0.428571428571429	0.285714285714286	0.428571428571429
score_alteration_module(deltaa)29	0.285714285714286	0.142857142857143	0.571428571428571	0.428571428571429	NA	NA	0.285714285714286	0.285714285714286	0.142857142857143
score_alteration_module(deltaa)30	0.142857142857143	0.285714285714286	0.142857142857143	0.285714285714286	NA	NA	0.428571428571429	0.142857142857143	0.285714285714286
score_alteration_module(deltaa)31	0.285714285714286	0.285714285714286	0.428571428571429	0.285714285714286	NA	NA	0.285714285714286	0.285714285714286	0.142857142857143
score_alteration_module(deltaa)32	0.428571428571429	0.428571428571429	0.285714285714286	0.285714285714286	NA	NA	0.285714285714286	0.285714285714286	0.428571428571429
score_alteration_module(deltaa)33	0.285714285714286	0.428571428571429	0.285714285714286	0.285714285714286	NA	NA	0.285714285714286	0.285714285714286	0.285714285714286
score_alteration_module(deltaa)34	0.142857142857143	0.428571428571429	0.285714285714286	NA	NA	NA	0.285714285714286	0.142857142857143	0.428571428571429
score_alteration_module(deltaa)35	0.428571428571429	0.142857142857143	0.428571428571429	NA	NA	NA	0.142857142857143	0.285714285714286	0.285714285714286
score_alteration_module(deltaa)36	0.285714285714286	0.285714285714286	0.285714285714286	NA	NA	NA	0.428571428571429	0.285714285714286	0.285714285714286
score_alteration_module(deltaa)37	0.285714285714286	0.285714285714286	NA	NA	NA	NA	0.428571428571429	0.428571428571429	0.285714285714286
score_alteration_module(deltaa)38	0.285714285714286	0.428571428571429	NA	NA	NA	NA	0.428571428571429	NA	0.285714285714286
score_alteration_module(deltaa)39	0.428571428571429	0.285714285714286	NA	NA	NA	NA	0.285714285714286	NA	0.142857142857143
score_alteration_module(deltaa)40	0.285714285714286	0.285714285714286	NA	NA	NA	NA	0.285714285714286	NA	NA
score_alteration_module(deltaa)41	0.142857142857143	0.142857142857143	NA	NA	NA	NA	0.142857142857143	NA	NA
score_alteration_module(deltaa)42	0.142857142857143	NA	NA	NA	NA	NA	0.285714285714286	NA	NA
score_alteration_module(deltaa)43	NA	NA	NA	NA	NA	NA	0.285714285714286	NA	NA
score_alteration_module(deltaa)44	NA	NA	NA	NA	NA	NA	0.285714285714286	NA	NA
score_alteration_module(deltaa)45	NA	NA	NA	NA	NA	NA	0.285714285714286	NA	NA
score_alteration_module(deltaa)46	NA	NA	NA	NA	NA	NA	0.428571428571429	NA	NA
score_alteration_drugs(deltad)1	-1	0	-0.875	-0.714285714285714	-1	-1	-1	-0.5	-0.777777777777778
score_alteration_drugs(deltad)2	-0.875	-0.862068965517241	-0.893203883495146	-0.901639344262295	-0.428571428571429	-1	-0.881188118811881	-0.89010989010989	-0.917159763313609
score_alteration_drugs(deltad)3	-0.789473684210526	-0.828326180257511	-0.739837398373984	-0.904761904761905	-1	-1	-0.808219178082192	-0.825136612021858	-0.857142857142857
score_alteration_drugs(deltad)4	-0.897435897435897	-0.931372549019608	-0.857142857142857	-0.80327868852459	-1	-0.818181818181818	-0.844155844155844	-0.789473684210526	-0.636363636363636
score_alteration_drugs(deltad)5	-0.820359281437126	-1	-0.902439024390244	-0.92	-1	1	-0.829787234042553	-0.942857142857143	-0.755102040816326
score_alteration_drugs(deltad)6	-0.940828402366864	-0.923076923076923	-0.938461538461538	-0.916349809885932	-1	-0.666666666666667	-0.666666666666667	-1	-0.825581395348837
score_alteration_drugs(deltad)7	-0.818181818181818	-0.933333333333333	-1	-0.702702702702703	-1	-1	-1	-0.823529411764706	-0.890909090909091
score_alteration_drugs(deltad)8	-1	-0.846153846153846	-0.727272727272727	-1	-1	NA	-0.764705882352941	-0.894736842105263	-0.846153846153846
score_alteration_drugs(deltad)9	-1	-1	-0.824561403508772	-0.5	1	NA	-0.866666666666667	-0.833333333333333	-1
score_alteration_drugs(deltad)10	-1	-0.80327868852459	-1	-1	-1	NA	-1	-0.826086956521739	-1
score_alteration_drugs(deltad)11	-1	-0.826086956521739	-1	-1	-1	NA	-0.912280701754386	-1	-1
score_alteration_drugs(deltad)12	-0.769230769230769	-0.789473684210526	-1	-0.894736842105263	-1	NA	-0.931034482758621	-0.95	-1
score_alteration_drugs(deltad)13	-0.86046511627907	-1	-0.769230769230769	-1	NA	NA	-0.777777777777778	-0.777777777777778	-0.833333333333333
score_alteration_drugs(deltad)14	-1	-0.666666666666667	-1	-1	NA	NA	-0.947368421052632	-0.972602739726027	-0.9
score_alteration_drugs(deltad)15	-1	-1	-0.714285714285714	-0.846153846153846	NA	NA	-1	-0.75	-1
score_alteration_drugs(deltad)16	-0.7	-1	-1	-1	NA	NA	-0.84	-1	-1
score_alteration_drugs(deltad)17	-0.733333333333333	-1	-1	-1	NA	NA	-0.8	-0.636363636363636	-0.909090909090909
score_alteration_drugs(deltad)18	-0.888888888888889	-1	-1	-1	NA	NA	-0.586206896551724	-1	-1
score_alteration_drugs(deltad)19	-0.75	-1	-0.894736842105263	-0.846153846153846	NA	NA	-1	-1	-1
score_alteration_drugs(deltad)20	-1	-0.8	-0.866666666666667	-1	NA	NA	-1	-1	-1
score_alteration_drugs(deltad)21	-1	-1	-1	-1	NA	NA	-0.878787878787879	-1	-1
score_alteration_drugs(deltad)22	-0.75	1	-1	-1	NA	NA	-0.84	-1	-1
score_alteration_drugs(deltad)23	-0.25	-1	-1	-1	NA	NA	-1	-0.833333333333333	-1
score_alteration_drugs(deltad)24	-1	0	-0.666666666666667	-0.5	NA	NA	-0.875	-0.714285714285714	-1
score_alteration_drugs(deltad)25	-1	-1	-1	-1	NA	NA	-1	-1	-1
score_alteration_drugs(deltad)26	1	-1	-1	0	NA	NA	-1	-1	-1
score_alteration_drugs(deltad)27	-1	-1	-0.333333333333333	-1	NA	NA	-1	-1	-1
score_alteration_drugs(deltad)28	-1	-1	-1	-1	NA	NA	-1	-1	-0.333333333333333
score_alteration_drugs(deltad)29	-1	-1	-0.777777777777778	-1	NA	NA	-1	-0.5	-1
score_alteration_drugs(deltad)30	-1	-1	-1	-1	NA	NA	-0.833333333333333	-1	-1
score_alteration_drugs(deltad)31	-1	-1	-1	0	NA	NA	-1	-1	0
score_alteration_drugs(deltad)32	1	-0.333333333333333	-1	-1	NA	NA	-1	-0.5	-1
score_alteration_drugs(deltad)33	-1	-1	-1	-1	NA	NA	-1	-1	1
score_alteration_drugs(deltad)34	-1	-1	-0.666666666666667	NA	NA	NA	-1	-1	-1
score_alteration_drugs(deltad)35	-1	-1	-1	NA	NA	NA	-1	-1	-1
score_alteration_drugs(deltad)36	-1	-0.333333333333333	-1	NA	NA	NA	-1	-1	-1
score_alteration_drugs(deltad)37	-1	-1	NA	NA	NA	NA	-1	-1	-1
score_alteration_drugs(deltad)38	-1	-1	NA	NA	NA	NA	-1	NA	-1
score_alteration_drugs(deltad)39	-1	-1	NA	NA	NA	NA	1	NA	-1
score_alteration_drugs(deltad)40	-1	-1	NA	NA	NA	NA	-1	NA	NA
score_alteration_drugs(deltad)41	-1	-1	NA	NA	NA	NA	-1	NA	NA
score_alteration_drugs(deltad)42	-1	NA	NA	NA	NA	NA	-1	NA	NA
score_alteration_drugs(deltad)43	NA	NA	NA	NA	NA	NA	-1	NA	NA
score_alteration_drugs(deltad)44	NA	NA	NA	NA	NA	NA	-1	NA	NA
score_alteration_drugs(deltad)45	NA	NA	NA	NA	NA	NA	-1	NA	NA
score_alteration_drugs(deltad)46	NA	NA	NA	NA	NA	NA	-1	NA	NA
score_sad1	-0.571428571428571	0.428571428571429	-0.303571428571429	-0.285714285714286	-0.857142857142857	-0.857142857142857	-0.714285714285714	-0.0714285714285714	-0.206349206349206
score_sad2	-0.446428571428571	-0.433497536945813	-0.464632454923717	-0.473067915690866	-0.142857142857143	-0.714285714285714	-0.595473833097595	-0.461538461538461	-0.488588334742181
score_sad3	-0.360902255639098	-0.256897608828939	-0.168408826945412	-0.333333333333333	-0.857142857142857	-1	-0.23679060665362	-0.253708040593287	-0.428571428571429
score_sad4	-0.326007326007326	-0.502801120448179	-0.285714285714286	-0.231850117096019	-0.857142857142857	-0.532467532467532	-0.415584415584416	-0.360902255639098	-0.207792207792208
score_sad5	-0.248930710008554	-0.571428571428571	-0.616724738675958	-0.348571428571429	-0.857142857142857	1.28571428571429	-0.258358662613982	-0.514285714285714	-0.183673469387755
score_sad6	-0.512256973795435	-0.637362637362637	-0.652747252747253	-0.487778381314503	-0.714285714285714	-0.523809523809524	-0.380952380952381	-0.714285714285714	-0.254152823920266
score_sad7	-0.38961038961039	-0.647619047619048	-0.571428571428571	-0.131274131274131	-0.857142857142857	-0.857142857142857	-0.857142857142857	-0.394957983193277	-0.462337662337662
score_sad8	-0.571428571428571	-0.417582417582418	-0.441558441558442	-0.571428571428571	-0.857142857142857	NA	-0.336134453781513	-0.466165413533834	-0.274725274725275
score_sad9	-0.571428571428571	-0.714285714285714	-0.395989974937343	-0.0714285714285714	1	NA	-0.580952380952381	-0.404761904761905	-0.714285714285714
score_sad10	-0.714285714285714	-0.231850117096019	-0.714285714285714	-0.714285714285714	-0.857142857142857	NA	-0.571428571428571	-0.540372670807453	-0.714285714285714
score_sad11	-0.714285714285714	-0.254658385093168	-0.714285714285714	-0.571428571428571	-0.714285714285714	NA	-0.483709273182957	-0.714285714285714	-0.714285714285714
score_sad12	-0.483516483516483	-0.360902255639098	-0.714285714285714	-0.466165413533834	-0.714285714285714	NA	-0.645320197044335	-0.378571428571429	-0.571428571428571
score_sad13	-0.289036544850498	-0.571428571428571	-0.340659340659341	-0.571428571428571	NA	NA	-0.349206349206349	-0.349206349206349	-0.404761904761905
score_sad14	-0.714285714285714	-0.238095238095238	-0.857142857142857	-0.714285714285714	NA	NA	-0.518796992481203	-0.686888454011741	-0.471428571428571
score_sad15	-0.571428571428571	-0.428571428571429	-0.285714285714286	-0.417582417582418	NA	NA	-0.714285714285714	-0.178571428571429	-0.714285714285714
score_sad16	-0.128571428571429	-0.714285714285714	-0.714285714285714	-0.571428571428571	NA	NA	-0.411428571428571	-0.571428571428571	-0.571428571428571
score_sad17	-0.304761904761905	-0.571428571428571	-0.714285714285714	-0.714285714285714	NA	NA	-0.228571428571429	-0.207792207792208	-0.623376623376623
score_sad18	-0.603174603174603	-0.571428571428571	-0.571428571428571	-0.857142857142857	NA	NA	-0.0147783251231528	-0.571428571428571	-0.571428571428571
score_sad19	-0.321428571428571	-0.714285714285714	-0.466165413533834	-0.56043956043956	NA	NA	-0.571428571428571	-0.714285714285714	-0.571428571428571
score_sad20	-0.571428571428571	-0.371428571428571	-0.438095238095238	-0.857142857142857	NA	NA	-0.714285714285714	-0.571428571428571	-0.714285714285714
score_sad21	-0.714285714285714	-0.857142857142857	-0.714285714285714	-0.714285714285714	NA	NA	-0.45021645021645	-0.714285714285714	-0.571428571428571
score_sad22	-0.321428571428571	1.28571428571429	-0.571428571428571	-0.714285714285714	NA	NA	-0.411428571428571	-0.428571428571429	-0.714285714285714
score_sad23	0.178571428571429	-0.857142857142857	-0.714285714285714	-0.714285714285714	NA	NA	-0.857142857142857	-0.404761904761905	-0.714285714285714
score_sad24	-0.714285714285714	0.285714285714286	-0.238095238095238	-0.0714285714285714	NA	NA	-0.589285714285714	-0.285714285714286	-0.714285714285714
score_sad25	-0.857142857142857	-0.714285714285714	-0.857142857142857	-0.857142857142857	NA	NA	-0.714285714285714	-0.714285714285714	-0.571428571428571
score_sad26	1.28571428571429	-0.714285714285714	-0.571428571428571	0.285714285714286	NA	NA	-0.857142857142857	-0.714285714285714	-0.571428571428571
score_sad27	-0.714285714285714	-0.571428571428571	0.0952380952380953	-0.571428571428571	NA	NA	-0.857142857142857	-0.571428571428571	-0.714285714285714
score_sad28	-0.714285714285714	-0.714285714285714	-0.714285714285714	-0.714285714285714	NA	NA	-0.571428571428571	-0.714285714285714	0.0952380952380953
score_sad29	-0.714285714285714	-0.857142857142857	-0.206349206349206	-0.571428571428571	NA	NA	-0.714285714285714	-0.214285714285714	-0.857142857142857
score_sad30	-0.857142857142857	-0.714285714285714	-0.857142857142857	-0.714285714285714	NA	NA	-0.404761904761905	-0.857142857142857	-0.714285714285714
score_sad31	-0.714285714285714	-0.714285714285714	-0.571428571428571	0.285714285714286	NA	NA	-0.714285714285714	-0.714285714285714	0.142857142857143
score_sad32	1.42857142857143	0.0952380952380953	-0.714285714285714	-0.714285714285714	NA	NA	-0.714285714285714	-0.214285714285714	-0.571428571428571
score_sad33	-0.714285714285714	-0.571428571428571	-0.714285714285714	-0.714285714285714	NA	NA	-0.714285714285714	-0.714285714285714	1.28571428571429
score_sad34	-0.857142857142857	-0.571428571428571	-0.380952380952381	NA	NA	NA	-0.714285714285714	-0.857142857142857	-0.571428571428571
score_sad35	-0.571428571428571	-0.857142857142857	-0.571428571428571	NA	NA	NA	-0.857142857142857	-0.714285714285714	-0.714285714285714
score_sad36	-0.714285714285714	-0.0476190476190476	-0.714285714285714	NA	NA	NA	-0.571428571428571	-0.714285714285714	-0.714285714285714
score_sad37	-0.714285714285714	-0.714285714285714	NA	NA	NA	NA	-0.571428571428571	-0.571428571428571	-0.714285714285714
score_sad38	-0.714285714285714	-0.571428571428571	NA	NA	NA	NA	-0.571428571428571	NA	-0.714285714285714
score_sad39	-0.571428571428571	-0.714285714285714	NA	NA	NA	NA	1.28571428571429	NA	-0.857142857142857
score_sad40	-0.714285714285714	-0.714285714285714	NA	NA	NA	NA	-0.714285714285714	NA	NA
score_sad41	-0.857142857142857	-0.857142857142857	NA	NA	NA	NA	-0.857142857142857	NA	NA
score_sad42	-0.857142857142857	NA	NA	NA	NA	NA	-0.714285714285714	NA	NA
score_sad43	NA	NA	NA	NA	NA	NA	-0.714285714285714	NA	NA
score_sad44	NA	NA	NA	NA	NA	NA	-0.714285714285714	NA	NA
score_sad45	NA	NA	NA	NA	NA	NA	-0.714285714285714	NA	NA
score_sad46	NA	NA	NA	NA	NA	NA	-0.571428571428571	NA	NA
rule_module2	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,CNV_EC_gain=1,CNV_gain=0,CNV_TF_categorization_TF=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_TF=1}	FC_GE_TF=1,CNV_EC_gain=1,CNV_depletion=0,CNV_TF_categorization_TF=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}
rule_module3	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,CNV_EC_gain=1,CNV_gain=0,CNV_TF_categorization_TF=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_TF=1}	FC_GE_TF=1,CNV_EC_gain=1,CNV_depletion=1,CNV_TF_categorization_TF=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}
rule_module14	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	NA	NA	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}
rule_module4	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,CNV_EC_gain=1,CNV_depletion=1,CNV_TF_categorization_TF=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_TF=1}	FC_GE_TF=1,CNV_EC_gain=1,CNV_depletion=0,CNV_TF_categorization_TF=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}
rule_module16	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	NA	NA	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}
rule_module6	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,CNV_EC_gain=1,CNV_gain=0,CNV_TF_categorization_TF=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_TF=1}	FC_GE_TF=1,CNV_EC_gain=1,CNV_depletion=0,CNV_TF_categorization_TF=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}
rule_module10	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_underexpressed=1,CNV_EC_gain=1,CNV_TF_categorization_TF=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_TF=1}	NA	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}
rule_module7	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,CNV_EC_gain=1,CNV_gain=0,CNV_TF_categorization_TF=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_TF=1}	FC_GE_TF=1,CNV_EC_gain=1,CNV_gain=1,CNV_TF_categorization_TF=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}
rule_module9	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,CNV_EC_gain=1,CNV_depletion=1,CNV_TF_categorization_TF=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_TF=1}	NA	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}
rule_module13	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	NA	NA	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}
rule_module8	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,CNV_EC_gain=1,CNV_depletion=1,CNV_TF_categorization_TF=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_TF=1}	NA	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}
rule_module5	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,CNV_EC_gain=1,CNV_depletion=1,CNV_TF_categorization_TF=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_TF=1}	FC_GE_TF=1,CNV_EC_gain=1,CNV_gain=1,CNV_TF_categorization_TF=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}
rule_module15	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	NA	NA	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}
rule_module1	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=1,CNV_EC_gain=1,CNV_TF_categorization_TF=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_TF=1}	FC_GE_TF=1,CNV_EC_gain=1,CNV_depletion=1,CNV_TF_categorization_TF=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}
rule_module11	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,CNV_EC_gain=1,CNV_gain=0,CNV_TF_categorization_TF=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_TF=1}	NA	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}
rule_module12	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,CNV_EC_gain=1,CNV_gain=0,CNV_TF_categorization_TF=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_TF=1}	NA	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}
rule_module19	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	NA	NA	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}
rule_module22	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	NA	NA	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}
rule_module31	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	NA	NA	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}
rule_module32	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=1,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	NA	NA	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}
rule_module23	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=1,MUT_TF=1}	NA	NA	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}
rule_module24	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	NA	NA	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}
rule_module41	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	NA	NA	NA	NA	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	NA	NA
rule_module28	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	NA	NA	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=1,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}
rule_module34	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	NA	NA	NA	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}
rule_module37	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	NA	NA	NA	NA	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}
rule_module35	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	NA	NA	NA	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}
rule_module36	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	NA	NA	NA	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}
rule_module20	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	NA	NA	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}
rule_module27	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	NA	NA	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=1,MUT_TF=1}
rule_module30	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	NA	NA	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}
rule_module26	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=1,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	NA	NA	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}
rule_module40	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	NA	NA	NA	NA	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	NA	NA
rule_module42	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	NA	NA	NA	NA	NA	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	NA	NA
rule_module29	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=1,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	NA	NA	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}
rule_module18	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	NA	NA	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}
rule_module17	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	NA	NA	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}
rule_module38	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	NA	NA	NA	NA	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	NA	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}
rule_module39	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	NA	NA	NA	NA	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	NA	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}
rule_module33	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	NA	NA	FC_GE_TF=1,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=1,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}
rule_module25	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	NA	NA	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}
rule_module21	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	NA	NA	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=1,MUT_genes=0,MUT_TF=1}	FC_GE_TF=1,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}
rule_module43	NA	NA	NA	NA	NA	NA	FC_GE_TF=0,Genes_overexpressed=0,Genes_underexpressed=1,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	NA	NA
rule_module46	NA	NA	NA	NA	NA	NA	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	NA	NA
rule_module45	NA	NA	NA	NA	NA	NA	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=0,CNV_depletion=1,METH_EC_hypo=1,METH_hyper=1,METH_hypo=0,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	NA	NA
rule_module44	NA	NA	NA	NA	NA	NA	FC_GE_TF=0,Genes_overexpressed=1,Genes_underexpressed=0,CNV_gain=1,CNV_depletion=0,METH_EC_hypo=1,METH_hyper=0,METH_hypo=1,METH_TF_categorization_TF=0,MUT_genes=0,MUT_TF=1}	NA	NA
PATIENT_ID	TCGA.A1.A0SE.01	TCGA.A1.A0SH.01	TCGA.A1.A0SJ.01	TCGA.A1.A0SK.01	TCGA.A1.A0SM.01	TCGA.A1.A0SO.01	TCGA.A1.A0SP.01	TCGA.A2.A04N.01	TCGA.A2.A04P.01
Gender	FEMALE	FEMALE	FEMALE	FEMALE	MALE	FEMALE	FEMALE	FEMALE	FEMALE
AGE	56	39	39	54	77	67	40	66	36
ER.Status	Positive	Negative	Positive	Negative	Positive	Negative	Negative	Positive	Negative
PR.Status	Positive	Positive	Positive	Negative	Negative	Negative	Negative	Positive	Negative
HER2.Final.Status	Negative	Negative	Negative	Negative	Positive	Negative	Negative	Negative	Negative
Tumor	T1	T2	T3	T2	T2	T2	T2	T1	T2
Tumor..T1.Coded	T1	T_Other	T_Other	T_Other	T_Other	T_Other	T_Other	T1	T_Other
Node	N0	N0	N1	N0	N0	N1	N0	N0	N3
Node.Coded	Negative	Negative	Positive	Negative	Negative	Positive	Negative	Negative	Positive
Metastasis	M0	M0	M0	M0	M0	M0	M0	M0	M0
Metastasis.Coded	Negative	Negative	Negative	Negative	Negative	Negative	Negative	Negative	Negative
AJCC.Stage	Stage I	Stage IIA	Stage IIIA	Stage IIA	Stage IIA	Stage IIB	Stage IIA	Stage IA	Stage IIIC
Converted.Stage	Stage I	Stage IIA	Stage IIIA	Stage IIA	Stage IIA	Stage IIB	Stage IIA	Stage I	No_Conversion
Survival.Data.Form	enrollment	enrollment	enrollment	followup	enrollment	enrollment	enrollment	followup	followup
OS_STATUS	LIVING	LIVING	LIVING	DECEASED	LIVING	LIVING	LIVING	LIVING	DECEASED
OS_MONTHS	 43.37	 47.21	 14.00	 31.77	  7.95	 27.99	 19.15	104.74	 17.97
PAM50.Subtype	Luminal A	Luminal A	Luminal A	Basal-like	Luminal B	Basal-like	NA	Luminal A	Basal-like
SigClust.Unsupervised.mRNA	-7	-7	-3	-6	-3	 0	NA	-3	 0
SigClust.Intrinsic.mRNA	 -5	 -5	 -3	-13	 -1	-13	NA	 -5	-13
miRNA.Clusters	 6	 4	 4	 5	 4	 5	NA	 6	 5
methylation.Clusters	 1	 2	 4	 5	 4	 5	NA	 2	 5
RPPA.Clusters	NA	Her2	ReacI	Basal	NA	Basal	NA	LumA	Basal
CN.Clusters	 2	 5	 3	 1	 2	 1	NA	 4	 1
Integrated.Clusters..with.PAM50.	NA	 1	 3	 2	NA	 2	NA	 3	 2
Integrated.Clusters..no.exp.	NA	 1	 1	 2	NA	 2	NA	 3	 2
Integrated.Clusters..unsup.exp.	NA	 1	 3	 2	NA	 2	NA	 3	 2
CANCER_TYPE	Breast Cancer	Breast Cancer	Breast Cancer	Breast Cancer	Breast Cancer	Breast Cancer	Breast Cancer	Breast Cancer	Breast Cancer
CANCER_TYPE_DETAILED	Invasive Breast Carcinoma	Invasive Breast Carcinoma	Invasive Breast Carcinoma	Invasive Breast Carcinoma	Invasive Breast Carcinoma	Invasive Breast Carcinoma	Invasive Breast Carcinoma	Invasive Breast Carcinoma	Invasive Breast Carcinoma
